Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",A1BG,Alpha-1B-glycoprotein,21281,43,0.94 [0.19-4.68],0.9393829701056016
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AAMDC,Mth938 domain-containing protein,20670,44,0.44 [0.25-0.78],0.0046946574649736
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,24384,48,1.05 [0.67-1.64],0.8444829535477549
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ABCA2,ATP-binding cassette sub-family A member 2,20593,42,1.29 [0.61-2.71],0.4991128436077128
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ABHD14B,Protein ABHD14B,24257,45,0.71 [0.45-1.12],0.1414253209924798
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ABL1,Tyrosine-protein kinase ABL1,24384,48,0.91 [0.62-1.33],0.625313787805456
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ABO,Histo-blood group ABO system transferase,21262,44,1.17 [0.96-1.43],0.1169970039373832
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ABRAXAS2,BRISC complex subunit Abraxas 2,20593,42,0.58 [0.36-0.94],0.0257196736251385
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",23919,48,0.76 [0.55-1.07],0.1120114534681612
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",20859,45,1.30 [0.99-1.70],0.06179032387623
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",21256,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACAN,Aggrecan core protein,24288,49,2.29 [0.95-5.50],0.0641950323337932
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACE,Angiotensin-converting enzyme,21262,44,1.49 [0.50-4.49],0.4769023341426935
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,24075,50,0.81 [0.49-1.35],0.4200463562659283
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACHE,Acetylcholinesterase,20778,43,1.83 [0.86-3.90],0.1169698843814493
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACOT13,Acyl-coenzyme A thioesterase 13,21165,44,0.97 [0.75-1.25],0.79345771434986
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,24515,49,0.91 [0.54-1.54],0.726640720948177
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACP1,Low molecular weight phosphotyrosine protein phosphatase,20649,43,0.86 [0.45-1.67],0.6575221933655047
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACP5,Tartrate-resistant acid phosphatase type 5,24587,50,1.68 [0.82-3.44],0.1546697940871899
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACP6,Lysophosphatidic acid phosphatase type 6,24691,49,0.98 [0.68-1.42],0.9184922833973558
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACRBP,Acrosin-binding protein,21142,45,0.58 [0.26-1.29],0.183319245914648
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACRV1,Acrosomal protein SP-10,20649,43,1.02 [0.78-1.33],0.8962125213254248
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACSL1,Long-chain-fatty-acid--CoA ligase 1,20593,42,0.67 [0.26-1.77],0.4213754922449096
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",24075,50,0.87 [0.47-1.62],0.6599177195197428
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACTN2,Alpha-actinin-2,20593,42,0.68 [0.38-1.21],0.1865487987819449
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACTN4,Alpha-actinin-4,24058,48,0.69 [0.27-1.78],0.4386694715794366
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,24303,45,1.97 [0.67-5.80],0.2204964604491759
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACY1,Aminoacylase-1,24515,49,0.89 [0.60-1.33],0.568554465333566
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACYP1,Acylphosphatase-1,20699,43,0.90 [0.58-1.41],0.6460372431841519
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADA,Adenosine deaminase,24803,49,0.71 [0.33-1.50],0.3688020001112406
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,24325,48,2.23 [1.27-3.90],0.0052074542113162
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,20649,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,24075,50,1.05 [0.48-2.29],0.9066817491163002
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,24344,45,2.19 [1.01-4.71],0.0463788798749581
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,24803,49,1.51 [0.70-3.26],0.2924127480519222
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,24700,48,1.71 [0.71-4.11],0.2298527337873228
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,21165,44,0.74 [0.27-1.99],0.5468334269926809
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,20649,43,1.42 [0.69-2.93],0.3366232160345344
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,24798,50,4.65 [1.53-14.12],0.0067589522946508
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,24384,48,1.46 [0.78-2.74],0.2394587935075234
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,24075,50,0.91 [0.43-1.91],0.7955720988914081
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,20649,43,0.54 [0.23-1.27],0.1558918426511986
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,24552,49,1.23 [0.71-2.13],0.4661449975863302
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,21249,44,1.29 [0.53-3.14],0.5787045094041797
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAMTSL4,ADAMTS-like protein 4,20670,44,1.48 [0.40-5.40],0.5549293439857352
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAMTSL5,ADAMTS-like protein 5,21256,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,23919,48,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADD1,Alpha-adducin,20778,43,0.80 [0.52-1.22],0.2985278392984124
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADGRB3,Adhesion G protein-coupled receptor B3,24303,45,1.54 [0.70-3.39],0.2839372346679237
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,20778,43,0.70 [0.34-1.45],0.3372757529634239
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,21165,44,0.64 [0.37-1.13],0.12347529500749
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,24599,50,1.82 [0.77-4.33],0.1751594291009438
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,24660,49,2.51 [1.21-5.20],0.0130190107186778
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADGRF5,Adhesion G protein-coupled receptor F5,21256,43,0.57 [0.21-1.52],0.2629584282238022
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADGRG1,Adhesion G-protein coupled receptor G1,24384,48,1.30 [0.89-1.91],0.1776785916845361
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADGRG2,Adhesion G-protein coupled receptor G2,24515,49,1.76 [0.72-4.29],0.2133910227878683
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADGRV1,Adhesion G-protein coupled receptor V1,20603,44,0.95 [0.95-0.95],0.0
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADH1B,All-trans-retinol dehydrogenase,20778,43,1.07 [0.73-1.56],0.7370536513254087
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,24075,50,0.96 [0.72-1.29],0.7999777537685424
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADIPOQ,Adiponectin,21281,43,1.04 [0.71-1.52],0.8573922044509421
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADM,Pro-adrenomedullin,24723,49,2.96 [1.11-7.86],0.0295783520882829
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADRA2A,Alpha-2A adrenergic receptor,20593,42,0.69 [0.41-1.19],0.1825530955918121
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AFAP1,Actin filament-associated protein 1,20778,43,1.05 [0.75-1.47],0.7679197269035719
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AFM,Afamin,21281,43,1.24 [0.27-5.65],0.77916005216924
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,24267,45,0.92 [0.62-1.36],0.6760821401369779
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AGBL2,Cytosolic carboxypeptidase 2,20603,44,1.19 [0.87-1.64],0.2815655421769805
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,24432,49,0.76 [0.40-1.44],0.3970500753871646
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AGR2,Anterior gradient protein 2 homolog,23730,49,1.11 [0.86-1.43],0.4209852178858637
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AGR3,Anterior gradient protein 3,23888,48,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,24599,50,1.33 [0.62-2.85],0.4568302365988878
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AGRP,Agouti-related protein,24803,49,0.69 [0.45-1.08],0.1064897769028747
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AGT,Angiotensinogen,21262,44,1.65 [0.57-4.74],0.3564966607832961
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AGXT,Serine--pyruvate aminotransferase,24515,49,0.85 [0.60-1.19],0.3354862264278602
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AHCY,Adenosylhomocysteinase,24515,49,0.90 [0.62-1.30],0.574106906992329
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AHNAK2,Protein AHNAK2,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,21142,45,1.16 [0.81-1.66],0.4324128973235847
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AHSG,Alpha-2-HS-glycoprotein,21262,44,0.88 [0.30-2.55],0.8138339101835308
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AHSP,Alpha-hemoglobin-stabilizing protein,24455,47,1.14 [0.85-1.52],0.3903225371767813
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AIDA,"Axin interactor, dorsalization-associated protein",20673,44,0.69 [0.44-1.09],0.1092683089253138
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AIF1,Allograft inflammatory factor 1,23919,48,1.02 [0.63-1.66],0.9299327296717188
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AIF1L,Allograft inflammatory factor 1-like,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",24340,48,0.96 [0.75-1.23],0.729991602099963
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AK1,Adenylate kinase isoenzyme 1,24515,49,0.95 [0.64-1.40],0.7895991968915489
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AK2,"Adenylate kinase 2, mitochondrial",21200,44,0.91 [0.69-1.19],0.4809028915165106
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,20778,43,0.28 [0.06-1.28],0.1012778491445122
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AKR1B1,Aldo-keto reductase family 1 member B1,23919,48,1.05 [0.75-1.47],0.7776951289747283
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AKR1B10,Aldo-keto reductase family 1 member B10,20673,44,1.30 [0.87-1.93],0.2007101542884829
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AKR1C4,Aldo-keto reductase family 1 member C4,24075,50,0.79 [0.46-1.37],0.4077511420233936
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AKR7L,Aflatoxin B1 aldehyde reductase member 4,20649,43,1.21 [0.84-1.73],0.3018730788335613
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AKT1S1,Proline-rich AKT1 substrate 1,23928,49,0.89 [0.61-1.30],0.5440574038092882
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AKT2,RAC-beta serine/threonine-protein kinase,21225,45,0.94 [0.76-1.18],0.6187840884895071
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AKT3,RAC-gamma serine/threonine-protein kinase,23792,48,0.78 [0.50-1.22],0.2800030947439758
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,24798,50,2.22 [0.66-7.43],0.1967944103548738
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,24493,47,0.96 [0.60-1.54],0.8741676334983256
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ALDH2,"Aldehyde dehydrogenase, mitochondrial",21142,45,0.68 [0.33-1.41],0.3034936012138893
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",24465,49,0.92 [0.61-1.39],0.7010017845840046
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",21225,45,0.98 [0.54-1.80],0.9562323850857176
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ALMS1,Alstrom syndrome protein 1,20859,45,0.92 [0.48-1.76],0.7928611785630352
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ALPI,Intestinal-type alkaline phosphatase,20649,43,0.98 [0.77-1.25],0.88584647326111
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ALPP,"Alkaline phosphatase, placental type",24384,48,,
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMBN,Ameloblastin,24058,48,0.86 [0.31-2.35],0.7645571669370417
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMBP,Protein AMBP,24692,49,1.79 [0.48-6.67],0.3826271798733186
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,21249,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMFR,E3 ubiquitin-protein ligase AMFR,23928,49,1.20 [0.86-1.68],0.2890927360594816
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMIGO1,Amphoterin-induced protein 1,20673,44,0.73 [0.37-1.43],0.3606413896406351
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMIGO2,Amphoterin-induced protein 2,24384,48,2.14 [0.71-6.44],0.1773461415475951
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMN,Protein amnionless,24058,48,0.84 [0.49-1.45],0.5299166106242007
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,20778,43,1.11 [0.58-2.12],0.754387443547898
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMOTL2,Angiomotin-like protein 2,21075,45,0.83 [0.44-1.56],0.5548959525691742
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMPD3,AMP deaminase 3,21200,44,1.09 [0.74-1.61],0.6774652396911922
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,19928,42,1.05 [0.58-1.92],0.8658793504324553
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMY2A,Pancreatic alpha-amylase,23589,46,1.22 [0.69-2.14],0.490158061850851
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMY2B,Alpha-amylase 2B,22851,46,1.33 [0.77-2.30],0.3044101191290197
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANG,Angiogenin,24400,48,0.99 [0.49-2.03],0.9843227900572052
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANGPT1,Angiopoietin-1,24422,50,1.01 [0.75-1.36],0.934817107375854
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,24723,49,1.77 [0.97-3.22],0.060767943595397
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANGPTL1,Angiopoietin-related protein 1,24155,49,1.01 [0.43-2.37],0.9889055510983634
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANGPTL2,Angiopoietin-related protein 2,24518,50,1.48 [0.79-2.79],0.2191815470743492
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANGPTL3,Angiopoietin-related protein 3,24489,48,1.05 [0.52-2.10],0.8950053072388152
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,24564,50,1.05 [0.60-1.83],0.8685852302237453
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANGPTL7,Angiopoietin-related protein 7,24723,49,1.53 [0.80-2.95],0.1986765111254065
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANK2,Ankyrin-2,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,20649,43,0.91 [0.63-1.32],0.6105425997432197
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANKRA2,Ankyrin repeat family A protein 2,20504,44,0.83 [0.48-1.43],0.5016699898911348
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANKRD54,Ankyrin repeat domain-containing protein 54,23919,48,1.03 [0.67-1.58],0.9071913245937396
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANPEP,Aminopeptidase N,24516,49,1.13 [0.47-2.74],0.7831125936014168
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANXA1,Annexin A1,20649,43,1.45 [0.89-2.35],0.1350499269488393
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANXA10,Annexin A10,23928,49,0.89 [0.63-1.27],0.5320929494784095
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANXA11,Annexin A11,24451,49,1.08 [0.73-1.58],0.7062134323427736
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,20373,43,0.81 [0.52-1.26],0.3532609765484835
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANXA3,Annexin A3,24700,48,0.91 [0.64-1.31],0.6254662337355968
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANXA4,Annexin A4,24390,48,0.95 [0.66-1.35],0.7620323018205218
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANXA5,Annexin A5,23855,49,1.22 [0.55-2.71],0.6239451559623004
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AOC1,Amiloride-sensitive amine oxidase [copper-containing],24058,48,0.98 [0.61-1.57],0.9209027561731628
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,24561,49,1.73 [0.75-3.98],0.1994058680252758
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AP1G2,AP-1 complex subunit gamma-like 2,21142,45,0.93 [0.65-1.33],0.6761912603732252
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AP2B1,AP-2 complex subunit beta,20673,44,0.69 [0.36-1.33],0.2659519917985942
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AP3B1,AP-3 complex subunit beta-1,21165,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AP3S2,AP-3 complex subunit sigma-2,21200,44,0.73 [0.38-1.41],0.3512929375019482
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,24384,48,0.90 [0.51-1.59],0.7214242075316235
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APCS,Serum amyloid P-component,21103,42,0.67 [0.31-1.44],0.305714089151563
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,24657,48,0.87 [0.56-1.35],0.5301969614463383
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APLP1,Amyloid-like protein 1,24515,49,1.31 [0.81-2.13],0.2662851764795005
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOA1,Apolipoprotein A-I,21281,43,1.17 [0.46-3.01],0.7388642647310839
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOA2,Apolipoprotein A-II,21262,44,1.25 [0.69-2.24],0.463212558903983
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOA4,Apolipoprotein A-IV,21281,43,0.94 [0.41-2.17],0.8904323186711685
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOB,Apolipoprotein B-100,21262,44,1.18 [0.33-4.19],0.8014431478360038
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,21239,43,0.73 [0.32-1.63],0.4379010414329651
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOD,Apolipoprotein D,20279,38,0.47 [0.16-1.34],0.1574043253833035
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOE,Apolipoprotein E,21281,43,0.87 [0.54-1.40],0.5643126715978208
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,21262,44,1.59 [0.39-6.59],0.5193574640092327
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOH,Beta-2-glycoprotein 1,24493,47,1.00 [0.48-2.06],0.9959409200883272
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOL1,Apolipoprotein L1,21262,44,0.80 [0.47-1.34],0.3971317374659685
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,24532,49,0.97 [0.38-2.49],0.9556128374052468
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APP,Amyloid-beta precursor protein,24451,47,1.17 [0.80-1.72],0.4128826768778766
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APPL2,DCC-interacting protein 13-beta,20778,43,0.90 [0.70-1.17],0.4407772524079661
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APRT,Adenine phosphoribosyltransferase,24317,45,0.84 [0.49-1.44],0.5297867610357052
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARAF,Serine/threonine-protein kinase A-Raf,20859,45,0.81 [0.51-1.29],0.3814701507466486
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,24384,48,1.09 [0.62-1.91],0.767023561257246
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARF6,ADP-ribosylation factor 6,21165,44,0.94 [0.72-1.22],0.6204090571656949
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARFIP1,Arfaptin-1,21225,45,0.94 [0.62-1.42],0.7534095022314122
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARG1,Arginase-1,24387,48,0.96 [0.59-1.55],0.859453588962261
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARG2,"Arginase-2, mitochondrial",21142,45,0.71 [0.33-1.52],0.3773170929881024
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARHGAP1,Rho GTPase-activating protein 1,23919,48,1.25 [0.72-2.15],0.4270363494665748
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,23919,48,0.96 [0.63-1.48],0.8645532274214878
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARHGAP30,Rho GTPase-activating protein 30,20859,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARHGAP45,Rho GTPase-activating protein 45,20778,43,0.88 [0.61-1.25],0.4691932964815357
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARHGAP5,Rho GTPase-activating protein 5,20504,44,0.74 [0.47-1.17],0.1949469730824544
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARHGEF1,Rho guanine nucleotide exchange factor 1,21200,44,0.92 [0.67-1.26],0.6012434898654568
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARHGEF10,Rho guanine nucleotide exchange factor 10,21225,45,0.93 [0.68-1.26],0.6381678994158919
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARHGEF12,Rho guanine nucleotide exchange factor 12,24494,49,0.92 [0.72-1.17],0.4835946124496066
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARHGEF5,Rho guanine nucleotide exchange factor 5,20603,44,0.90 [0.60-1.37],0.6277297700325846
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARID3A,AT-rich interactive domain-containing protein 3A,20603,44,0.88 [0.42-1.85],0.7420531934040078
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,23928,49,0.79 [0.40-1.59],0.5169798467682685
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARL13B,ADP-ribosylation factor-like protein 13B,20593,42,0.72 [0.45-1.15],0.1706824536982312
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,20593,42,0.75 [0.36-1.58],0.4531120447768324
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARMCX2,Armadillo repeat-containing X-linked protein 2,20603,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARNT,Aryl hydrocarbon receptor nuclear translocator,24058,48,0.94 [0.48-1.85],0.8492625073326442
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARSA,Arylsulfatase A,24493,47,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARSB,Arylsulfatase B,24384,48,0.92 [0.57-1.46],0.7106098153269815
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ART3,Ecto-ADP-ribosyltransferase 3,24561,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ART5,Ecto-ADP-ribosyltransferase 5,20603,44,0.90 [0.54-1.51],0.6860635785380528
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARTN,Artemin,24058,48,1.04 [0.60-1.78],0.9004912377996362
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ASAH1,Acid ceramidase,21072,44,1.35 [0.80-2.29],0.2671305574003514
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ASAH2,Neutral ceramidase,24344,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,24344,45,0.60 [0.23-1.54],0.287341227897132
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ASGR2,Asialoglycoprotein receptor 2,21262,44,2.14 [0.71-6.42],0.1745726451949507
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,21256,43,1.16 [0.41-3.22],0.7812989580173195
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ASPSCR1,Tether containing UBX domain for GLUT4,21225,45,0.83 [0.54-1.26],0.3805134372245634
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ASRGL1,Isoaspartyl peptidase/L-asparaginase,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ASS1,Argininosuccinate synthase,20593,42,0.81 [0.56-1.17],0.2689914494375309
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATF2,Cyclic AMP-dependent transcription factor ATF-2,23928,49,0.91 [0.61-1.37],0.6562919793314159
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATF4,Cyclic AMP-dependent transcription factor ATF-4,20504,44,1.00 [0.42-2.36],0.9940020319618862
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATG16L1,Autophagy-related protein 16-1,21165,44,0.97 [0.70-1.36],0.8721006352768415
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATG4A,Cysteine protease ATG4A,23919,48,1.01 [0.66-1.55],0.9591911983396764
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATOX1,Copper transport protein ATOX1,24552,49,1.00 [0.71-1.41],0.9992065090881466
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,20593,42,0.69 [0.29-1.65],0.4058674593292977
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP1B4,Protein ATP1B4,20504,44,0.87 [0.42-1.81],0.7070166941357598
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP2B4,Plasma membrane calcium-transporting ATPase 4,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP5F1D,"ATP synthase subunit delta, mitochondrial",20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP5IF1,"ATPase inhibitor, mitochondrial",24599,50,0.94 [0.75-1.18],0.5911743494487245
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP5PO,"ATP synthase subunit O, mitochondrial",23928,49,1.10 [0.63-1.91],0.7422037027079265
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP6AP2,Renin receptor,23919,48,1.17 [0.67-2.03],0.5810612766812373
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP6V1D,V-type proton ATPase subunit D,24384,48,1.69 [0.88-3.27],0.1155119642649443
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP6V1F,V-type proton ATPase subunit F,23881,49,1.07 [0.74-1.55],0.7066788888311628
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP6V1G1,V-type proton ATPase subunit G 1,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP6V1G2,V-type proton ATPase subunit G 2,20593,42,0.89 [0.65-1.23],0.484826074640902
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,21165,44,1.30 [0.63-2.69],0.476292565912386
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATRN,"Attractin, Isoform 2",21281,43,0.88 [0.15-5.07],0.8879228568514742
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATXN10,Ataxin-10,23928,49,0.86 [0.61-1.22],0.3977525901595081
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATXN2,Ataxin-2,20603,44,0.73 [0.51-1.04],0.0808025548790411
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATXN2L,Ataxin-2-like protein,21225,45,0.44 [0.21-0.94],0.0329188731801498
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATXN3,Ataxin-3,21200,44,0.81 [0.04-18.79],0.8970064432037106
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AXIN1,Axin-1,24494,49,0.87 [0.67-1.13],0.3051733546812513
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,24561,49,3.16 [1.41-7.09],0.005329558646806
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AZI2,5-azacytidine-induced protein 2,21225,45,0.91 [0.54-1.53],0.7267156035687494
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AZU1,Azurocidin,23754,48,1.40 [1.09-1.79],0.0082458892248254
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,21281,43,1.21 [0.62-2.36],0.5778531674899978
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",20670,44,1.90 [0.90-4.02],0.0910211004423532
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",24599,50,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",B4GAT1,"Beta-1,4-glucuronyltransferase 1",24493,47,0.93 [0.32-2.67],0.8932522242547791
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BABAM1,BRISC and BRCA1-A complex member 1,20649,43,0.86 [0.31-2.42],0.773265191224842
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BACH1,Transcription regulator protein BACH1,24494,49,0.83 [0.58-1.18],0.3081894781714165
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BAG3,BAG family molecular chaperone regulator 3,24303,45,1.35 [0.68-2.68],0.3882885375225083
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,20649,43,0.79 [0.43-1.48],0.4706591810910895
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BAG6,Large proline-rich protein BAG6,24075,50,0.85 [0.42-1.72],0.6585838999599156
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,23919,48,0.98 [0.65-1.48],0.9281197409724457
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,23919,48,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BANK1,B-cell scaffold protein with ankyrin repeats,24494,49,0.90 [0.71-1.13],0.3670068960982096
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,21200,44,1.08 [0.73-1.58],0.7133955051458878
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BATF,Basic leucine zipper transcriptional factor ATF-like,20673,44,0.87 [0.58-1.29],0.4842730003548724
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BAX,Apoptosis regulator BAX,23891,49,0.83 [0.62-1.11],0.205612754329151
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,24493,47,1.47 [0.50-4.35],0.4857028733932301
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCAN,Brevican core protein,24344,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",21256,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",20603,44,0.52 [0.24-1.11],0.0899359921980456
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCHE,Cholinesterase,20863,43,1.01 [0.43-2.34],0.9878483356792848
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,21165,44,0.71 [0.36-1.40],0.3201128189771185
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCL2L1,Bcl-2-like protein 1,21200,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",24494,49,0.81 [0.48-1.38],0.4455729121222073
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCL2L15,Bcl-2-like protein 15,20649,43,1.13 [0.71-1.79],0.6003213101333567
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCL7A,B-cell CLL/lymphoma 7 protein family member A,20504,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCL7B,B-cell CLL/lymphoma 7 protein family member B,21142,45,1.22 [0.73-2.02],0.443694656994518
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCR,Breakpoint cluster region protein,24494,49,0.86 [0.65-1.14],0.2893429332052128
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BDNF,Brain-derived neurotrophic factor,21249,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BECN1,Beclin-1,20670,44,0.72 [0.44-1.20],0.2125659431133738
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BEX3,Protein BEX3,20504,44,1.28 [0.80-2.04],0.3085327662372544
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BGLAP,Osteocalcin,21249,44,0.82 [0.59-1.16],0.2627815855394846
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,23886,48,1.01 [0.81-1.25],0.9519431257231455
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BHLHE40,Class E basic helix-loop-helix protein 40,20603,44,0.90 [0.58-1.40],0.6542475895352557
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BID,BH3-interacting domain death agonist,24494,49,0.85 [0.57-1.25],0.4073354373654841
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BIN2,Bridging integrator 2,24493,47,1.06 [0.80-1.40],0.6920367117471504
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BIRC2,Baculoviral IAP repeat-containing protein 2,23919,48,0.85 [0.57-1.28],0.4389185842751525
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BLMH,Bleomycin hydrolase,24798,50,0.68 [0.31-1.48],0.3305874843292999
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,20649,43,1.09 [0.52-2.31],0.8186568901846328
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,20603,44,1.13 [0.80-1.60],0.4798183339799382
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,21200,44,0.63 [0.29-1.36],0.2413711086600177
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BLVRB,Flavin reductase,24493,47,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BMP10,Bone morphogenetic protein 10,20778,43,1.45 [0.52-4.01],0.47318142539992
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BMP4,Bone morphogenetic protein 4,24303,45,1.21 [0.71-2.06],0.4897065886798832
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BMP6,Bone morphogenetic protein 6,24028,50,1.28 [0.69-2.37],0.4303724405767517
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,20778,43,0.95 [0.25-3.58],0.9419610260851732
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,21256,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,20649,43,1.05 [0.56-1.99],0.8693786227608986
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BOC,Brother of CDO,24075,50,0.61 [0.21-1.79],0.3709780574372309
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BOLA1,BolA-like protein 1,20603,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BOLA2_BOLA2B,BolA-like protein 2,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BPIFA2,BPI fold-containing family A member 2,19934,41,1.12 [0.84-1.47],0.4433763516082459
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BPIFB1,BPI fold-containing family B member 1,24454,48,0.98 [0.67-1.44],0.9210844104118732
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BPIFB2,BPI fold-containing family B member 2,21222,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BRAP,BRCA1-associated protein,20967,44,0.92 [0.71-1.20],0.5444763344519534
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BRD1,Bromodomain-containing protein 1,20859,45,0.58 [0.20-1.68],0.3147003279989354
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BRD2,Bromodomain-containing protein 2,20603,44,1.38 [0.67-2.82],0.382554292041391
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BRD3,Bromodomain-containing protein 3,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BRDT,Bromodomain testis-specific protein,20593,42,0.56 [0.24-1.30],0.1759417820541161
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BRK1,Protein BRICK1,23928,49,0.70 [0.39-1.26],0.2305531312216223
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BRME1,Break repair meiotic recombinase recruitment factor 1,20603,44,0.81 [0.37-1.76],0.5927606599559476
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BRSK2,Serine/threonine-protein kinase BRSK2,21225,45,0.73 [0.33-1.60],0.4286150499742224
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BSG,Basigin,24755,49,2.25 [0.59-8.61],0.2355650257626667
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BSND,Barttin,20504,44,0.79 [0.31-2.02],0.6239462105448506
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,24738,48,1.15 [0.64-2.08],0.6338695168999375
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,24738,48,0.94 [0.56-1.57],0.8074377103017328
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BTC,Probetacellulin,23919,48,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BTD,Biotinidase,21281,43,0.55 [0.15-2.08],0.3824117301469982
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BTLA,B- and T-lymphocyte attenuator,20504,44,0.60 [0.37-0.98],0.0428043502850676
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BTN1A1,Butyrophilin subfamily 1 member A1,21104,45,1.44 [0.87-2.36],0.1529319908635739
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,24599,50,2.00 [0.76-5.30],0.1616519010414804
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,24494,49,1.15 [0.58-2.29],0.6944784803069499
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BTNL10,Butyrophilin-like protein 10,20504,44,0.36 [0.13-1.03],0.0560851967487216
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,23928,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1GALT1C1,C1GALT1-specific chaperone 1,20593,42,1.49 [0.68-3.29],0.3227426999893552
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,24672,48,2.21 [0.75-6.49],0.1507817065943479
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",21225,45,0.69 [0.37-1.29],0.242192094701504
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1QL2,Complement C1q-like protein 2,20649,43,1.13 [0.59-2.15],0.7114705650312525
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,24561,49,1.83 [1.10-3.06],0.0200033897242887
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,20778,43,0.92 [0.42-2.01],0.8260894991178838
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,21225,45,0.67 [0.25-1.81],0.4346464670658814
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,20739,43,1.34 [0.70-2.57],0.3722750739688851
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1R,Complement C1r subcomponent,21281,43,0.28 [0.04-1.85],0.1840501983957712
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,21245,43,1.02 [0.23-4.46],0.9789842407666728
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1S,Complement C1s subcomponent,21281,43,0.32 [0.08-1.24],0.0991213846143977
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C2,Complement C2,24532,49,0.69 [0.37-1.30],0.2544132073761278
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C2CD2L,Phospholipid transfer protein C2CD2L,23881,49,0.82 [0.44-1.53],0.540994265010673
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C2orf69,UPF0565 protein C2orf69,20673,44,0.69 [0.37-1.29],0.2440334443680591
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C3,Complement C3,20218,38,0.80 [0.37-1.71],0.5575820486485761
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,24552,49,1.31 [0.70-2.44],0.3935405372377987
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C5,Complement C5,21281,43,1.44 [0.24-8.42],0.6887571333809102
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,20793,41,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,21200,44,0.91 [0.26-3.24],0.8898139242152598
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C8B,Complement component C8 beta chain,21281,43,1.01 [0.39-2.62],0.9798060336726222
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,21262,44,1.34 [0.76-2.37],0.3118766344863874
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C9orf40,Uncharacterized protein C9orf40,21165,44,1.07 [0.76-1.50],0.712753496273173
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA1,Carbonic anhydrase 1,23929,47,1.19 [0.79-1.79],0.4123632659897608
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA11,Carbonic anhydrase-related protein 11,23919,48,0.86 [0.35-2.12],0.7459464030287819
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,24384,48,1.27 [0.60-2.72],0.5308204621357129
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA13,Carbonic anhydrase 13,24221,48,0.97 [0.76-1.23],0.7807390683468464
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA14,Carbonic anhydrase 14,24723,49,1.39 [0.70-2.75],0.3438689608132657
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA2,Carbonic anhydrase 2,24422,47,1.02 [0.71-1.46],0.9045556957905992
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA3,Carbonic anhydrase 3,24756,50,0.96 [0.64-1.43],0.8225855630897972
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA4,Carbonic anhydrase 4,24798,50,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA5A,"Carbonic anhydrase 5A, mitochondrial",24075,50,0.87 [0.66-1.16],0.3401932603815711
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,24416,47,0.89 [0.61-1.31],0.55824798080772
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA7,Carbonic anhydrase 7,20859,45,1.66 [0.91-3.02],0.0996112044649819
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA8,Carbonic anhydrase-related protein,20649,43,1.15 [0.42-3.14],0.7826527080668906
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,24723,49,0.82 [0.44-1.52],0.5344718370224217
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CABP2,Calcium-binding protein 2,20673,44,0.68 [0.41-1.13],0.140882282648394
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,20603,44,0.67 [0.25-1.84],0.438502978928377
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,20603,44,0.51 [0.27-0.94],0.0308613576842511
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,21225,45,0.84 [0.60-1.17],0.2987121899140815
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CACYBP,Calcyclin-binding protein,20732,43,0.98 [0.74-1.30],0.8737029021210507
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CADPS,Calcium-dependent secretion activator 1,20673,44,1.09 [0.59-2.04],0.7750031904434612
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CALB1,Calbindin,24384,48,2.17 [1.22-3.85],0.0085751371868626
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CALB2,Calretinin,23928,49,0.57 [0.23-1.40],0.2186357662434542
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CALCA,Calcitonin,24297,45,1.10 [0.78-1.56],0.5734653006684428
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CALCB,Calcitonin gene-related peptide 2,21200,44,0.71 [0.31-1.64],0.4253120289020267
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,24653,49,1.00 [0.79-1.28],0.9839350489626586
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,20670,44,0.80 [0.54-1.18],0.2593711713514893
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CALY,Neuron-specific vesicular protein calcyon,20593,42,0.69 [0.27-1.74],0.4291779513962789
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,23919,48,0.63 [0.34-1.17],0.1453331645434284
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,20673,44,0.82 [0.46-1.48],0.5115936079130454
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,21225,45,0.96 [0.74-1.25],0.7593201324896925
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,24446,49,1.26 [0.35-4.53],0.7205170682168653
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,24351,48,1.34 [0.90-1.99],0.1561957805095749
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CAPN3,Calpain-3,21142,45,0.79 [0.34-1.82],0.5796712780537501
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CAPS,Calcyphosin,21200,44,0.77 [0.48-1.25],0.2992295918619195
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CARHSP1,Calcium-regulated heat-stable protein 1,23928,49,0.86 [0.53-1.41],0.5557811653430665
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASC3,Protein CASC3,20673,44,0.84 [0.41-1.72],0.6293179312518816
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASP1,Caspase-1,23928,49,1.14 [0.81-1.61],0.4468577500924412
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASP10,Caspase-10,23928,49,0.86 [0.61-1.21],0.3757768445811168
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASP2,Caspase-2,24494,49,0.81 [0.55-1.18],0.2666050028941058
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASP3,Caspase-3,24798,50,0.95 [0.72-1.25],0.7073633355744327
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASP4,Caspase-4,20859,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASP7,Caspase-7,21200,44,0.89 [0.63-1.25],0.4994479213203961
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASP8,Caspase-8,24660,49,0.82 [0.54-1.23],0.3352906827492803
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASP9,Caspase-9,20649,43,0.77 [0.47-1.26],0.3025834666965011
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASQ2,Calsequestrin-2,20593,42,0.40 [0.16-1.00],0.0507128270643211
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CAT,Catalase,20937,44,1.18 [0.72-1.93],0.517978268875865
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CBLIF,Cobalamin binding intrinsic factor,24487,49,1.02 [0.70-1.48],0.9115469786588056
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CBLN1,Cerebellin-1,20603,44,1.10 [0.86-1.41],0.4396699107753441
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CBLN4,Cerebellin-4,24723,49,1.65 [0.90-3.00],0.1026146299601063
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CBS,Cystathionine beta-synthase,20670,44,0.78 [0.42-1.44],0.425577403412383
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CBX2,Chromobox protein homolog 2,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,24344,45,0.99 [0.69-1.40],0.9344300017991128
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCAR2,Cell cycle and apoptosis regulator protein 2,21200,44,1.15 [0.74-1.77],0.5358092425416657
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCDC134,Coiled-coil domain-containing protein 134,21142,45,0.97 [0.54-1.73],0.9118544814342012
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCDC28A,Coiled-coil domain-containing protein 28A,20673,44,0.55 [0.21-1.47],0.2330098866486749
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,21225,45,1.07 [0.76-1.50],0.7057460538600178
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCDC80,Coiled-coil domain-containing protein 80,24515,49,1.51 [0.70-3.25],0.2920422114343921
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,20670,44,0.93 [0.57-1.51],0.764312104379242
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL11,Eotaxin,24803,49,1.13 [0.59-2.18],0.706078865232254
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL13,C-C motif chemokine 13,24763,49,1.22 [0.85-1.74],0.2864007989977205
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,24400,48,1.41 [0.80-2.47],0.2309489387689158
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,24798,50,0.93 [0.51-1.70],0.8218586559775634
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL16,C-C motif chemokine 16,24798,50,0.93 [0.57-1.50],0.7574269964499641
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL17,C-C motif chemokine 17,24435,50,1.05 [0.80-1.39],0.7045649851011428
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL18,C-C motif chemokine 18,24137,48,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL19,C-C motif chemokine 19,24738,48,0.91 [0.71-1.17],0.4613277313635178
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL2,C-C motif chemokine 2,24303,45,1.17 [0.71-1.91],0.5370348238578777
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL20,C-C motif chemokine 20,24803,49,0.93 [0.68-1.27],0.6390060436524077
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,24599,50,1.01 [0.74-1.39],0.937625702151002
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,24208,48,1.13 [0.69-1.86],0.6240729781859528
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL23,C-C motif chemokine 23,24599,50,0.98 [0.53-1.82],0.951731636061394
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL24,C-C motif chemokine 24,24564,50,1.22 [0.91-1.62],0.1864299196643137
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL25,C-C motif chemokine 25,24803,49,1.22 [0.74-2.01],0.4450640333652569
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL26,C-C motif chemokine 26,24494,49,0.97 [0.73-1.29],0.8472892164765682
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL27,C-C motif chemokine 27,24515,49,1.09 [0.72-1.65],0.6746713210203727
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL28,C-C motif chemokine 28,24421,49,1.26 [0.84-1.90],0.2641991334215006
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,24494,49,1.09 [0.70-1.72],0.6961254097593873
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,24511,50,1.24 [0.93-1.67],0.1489046914462728
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL5,C-C motif chemokine 5,24561,49,1.08 [0.85-1.38],0.5366627189460107
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,24494,49,1.16 [0.79-1.71],0.4538212332989351
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL8,C-C motif chemokine 8,24692,49,1.50 [0.99-2.29],0.0578114311820088
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,24350,48,0.81 [0.58-1.11],0.1902930647575847
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCN2,CCN family member 2,24497,50,0.94 [0.61-1.44],0.7793365667708305
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,24757,50,1.33 [0.62-2.86],0.4607514432481753
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCN4,CCN family member 4,24723,49,1.78 [1.02-3.11],0.043062697643858
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCN5,CCN family member 5,24493,47,1.73 [0.93-3.21],0.0836411513731626
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,20859,45,0.89 [0.43-1.85],0.7600703054042117
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCNE1,G1/S-specific cyclin-E1,20649,43,0.92 [0.66-1.28],0.6237012145184873
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCS,Copper chaperone for superoxide dismutase,24344,45,0.68 [0.39-1.18],0.1705566151107244
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCT5,T-complex protein 1 subunit epsilon,23919,48,0.83 [0.45-1.52],0.544859193779936
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD101,Immunoglobulin superfamily member 2,21165,44,0.95 [0.49-1.85],0.8758099384834328
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD109,CD109 antigen,24493,47,0.48 [0.24-0.97],0.0404025997393023
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,23951,47,1.14 [0.61-2.13],0.6808095038412576
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,24803,49,1.76 [1.04-2.99],0.0360710385345115
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,24561,49,1.23 [0.69-2.19],0.4830947277728529
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD164,Sialomucin core protein 24,24493,47,1.54 [0.92-2.57],0.1009676530813387
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD164L2,CD164 sialomucin-like 2 protein,20673,44,0.64 [0.27-1.48],0.2970770099701612
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,24458,47,0.94 [0.77-1.14],0.5171106636854617
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,24552,49,2.45 [0.80-7.53],0.1169654771391069
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD2,T-cell surface antigen CD2,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,24494,49,1.77 [0.70-4.50],0.2292507230851302
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,24413,49,2.17 [1.10-4.27],0.0246177173037757
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD207,C-type lectin domain family 4 member K,23968,47,2.19 [1.13-4.25],0.0205223035526929
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD209,CD209 antigen,24541,50,1.05 [0.55-2.00],0.887808740142051
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,24803,49,1.61 [0.88-2.93],0.1213900501756572
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD226,CD226 antigen,20649,43,0.97 [0.48-1.96],0.9251040896248276
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD244,Natural killer cell receptor 2B4,24803,49,1.45 [0.58-3.60],0.4294226136839879
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD248,Endosialin,21249,44,1.35 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,24552,49,1.13 [0.58-2.19],0.7180748348810448
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,24344,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD276,CD276 antigen,24478,49,1.24 [0.59-2.59],0.5662101832932833
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,23919,48,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD2AP,CD2-associated protein,24515,49,0.90 [0.61-1.35],0.6192722102435381
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,20778,43,1.71 [0.64-4.58],0.2862067670360082
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,24738,48,1.62 [0.75-3.49],0.2172587534018381
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,24648,49,2.00 [1.11-3.61],0.0208505054222673
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,24723,49,1.48 [0.89-2.46],0.128261798372616
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD300LG,CMRF35-like molecule 9,24493,47,1.22 [0.62-2.41],0.5676726595051179
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,24384,48,1.89 [1.04-3.41],0.0352814138681599
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD33,Myeloid cell surface antigen CD33,24552,49,1.32 [0.94-1.85],0.1140847280225478
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD34,Hematopoietic progenitor cell antigen CD34,24643,48,1.47 [0.52-4.21],0.4680976404722011
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD36,Platelet glycoprotein 4,20649,43,0.82 [0.41-1.61],0.5579934721417559
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,24384,48,1.44 [0.72-2.86],0.3022196262107541
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD3D,T-cell surface glycoprotein CD3 delta chain,20603,44,1.26 [0.63-2.53],0.515041258113506
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD3E,T-cell surface glycoprotein CD3 epsilon chain,20859,45,1.47 [0.90-2.38],0.1203912333574469
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD3G,T-cell surface glycoprotein CD3 gamma chain,20649,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,24450,49,0.75 [0.29-1.92],0.5443481335862782
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD40,Tumor necrosis factor receptor superfamily member 5,24476,50,0.95 [0.57-1.58],0.8468594471600943
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD40LG,CD40 ligand,24803,49,1.02 [0.74-1.41],0.9080524865131452
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,24315,48,1.63 [0.73-3.63],0.2366344268796398
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,24564,50,2.16 [0.92-5.03],0.0757647136810141
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,24692,49,1.92 [0.94-3.92],0.0725903772638219
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD55,Complement decay-accelerating factor,23628,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD58,Lymphocyte function-associated antigen 3,24427,49,1.50 [0.35-6.47],0.5852680144628393
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,23580,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,21170,42,0.67 [0.36-1.28],0.2281457418641993
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,24755,49,1.41 [0.88-2.24],0.1489658294994311
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD63,CD63 antigen,24303,45,1.04 [0.63-1.74],0.8724491620867351
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD69,Early activation antigen CD69,24382,49,0.95 [0.71-1.26],0.7064264839446205
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,20615,43,1.10 [0.56-2.14],0.7830897376639004
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,24494,49,0.82 [0.46-1.46],0.5041719688906137
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,20778,43,1.23 [0.60-2.55],0.5695576992789912
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,24738,48,1.89 [0.93-3.84],0.076886267513473
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,24803,49,1.76 [1.00-3.10],0.0517467836287969
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,21256,43,2.24 [1.03-4.84],0.041109603767359
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD82,CD82 antigen,20859,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,24494,49,1.01 [0.46-2.22],0.9795634977783696
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD84,SLAM family member 5,24494,49,0.65 [0.29-1.47],0.3029326981464786
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,21165,44,1.78 [0.66-4.79],0.255614058702142
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,24738,48,1.16 [0.71-1.89],0.551599880004277
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,23530,48,1.09 [0.47-2.54],0.8487156149295948
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD99,CD99 antigen,24493,47,1.07 [0.32-3.54],0.9094061890490056
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD99L2,CD99 antigen-like protein 2,24493,47,0.80 [0.27-2.34],0.683460566230885
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDA,Cytidine deaminase,21222,43,1.42 [0.83-2.42],0.2014469731070587
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDAN1,Codanin-1,21200,44,1.33 [0.45-3.92],0.6108866615385435
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDC123,Cell division cycle protein 123 homolog,20504,44,0.98 [0.63-1.54],0.9437999758293836
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDC25A,M-phase inducer phosphatase 1,20504,44,1.14 [0.60-2.16],0.6879594833686149
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDC26,Anaphase-promoting complex subunit CDC26,21129,44,0.91 [0.60-1.37],0.6533394149199765
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDC27,Cell division cycle protein 27 homolog,23919,48,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDC37,Hsp90 co-chaperone Cdc37,24552,49,0.94 [0.70-1.28],0.7079448368698011
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDC42BPB,Serine/threonine-protein kinase MRCK beta,21165,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,24344,45,1.43 [0.87-2.33],0.1565795599811401
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH1,Cadherin-1,23643,47,1.16 [0.64-2.10],0.6239120769394111
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH15,Cadherin-15,24691,48,1.11 [0.73-1.68],0.6281263393535402
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH17,Cadherin-17,24515,49,1.07 [0.74-1.55],0.7122550860704175
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH2,Cadherin-2,24515,49,1.50 [0.74-3.04],0.2600610961381246
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH22,Cadherin-22,20859,45,1.05 [0.39-2.80],0.928972812392566
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH23,Cadherin-23,21200,44,1.43 [0.55-3.72],0.4671897739012297
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,24738,48,1.49 [0.73-3.04],0.2757439981802202
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH4,Cadherin-4,20603,44,0.92 [0.49-1.75],0.8028385615595726
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,24798,50,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH6,Cadherin-6,24515,49,0.94 [0.48-1.83],0.84711648587136
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDHR1,Cadherin-related family member 1,23928,49,0.73 [0.37-1.42],0.3513279840343124
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDHR2,Cadherin-related family member 2,24384,48,0.95 [0.71-1.28],0.740255487616009
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDHR5,Cadherin-related family member 5,24515,49,1.00 [0.52-1.94],0.9936771029408784
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDK1,Cyclin-dependent kinase 1,20504,44,0.62 [0.28-1.34],0.2197800377242391
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,21225,45,0.82 [0.49-1.37],0.4548798844267705
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDKL5,Cyclin-dependent kinase-like 5,20603,44,0.69 [0.35-1.34],0.2703906082293442
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDKN1A,Cyclin-dependent kinase inhibitor 1,24384,48,0.89 [0.63-1.24],0.4850926132418046
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,24384,48,1.01 [0.77-1.32],0.9505287006822016
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDNF,Cerebral dopamine neurotrophic factor,24384,48,1.39 [0.68-2.83],0.3696258879417113
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,24523,50,0.76 [0.30-1.93],0.5655994711938251
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDSN,Corneodesmosin,24722,49,1.30 [0.72-2.35],0.3895828858827426
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,24514,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,21165,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,20859,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,21165,44,0.40 [0.20-0.81],0.0103677566115003
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,20859,45,1.21 [0.69-2.14],0.5081511306378843
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,24494,49,0.92 [0.68-1.25],0.6077281659660768
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,23919,48,0.99 [0.58-1.68],0.9633602937738052
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,23570,48,0.84 [0.55-1.31],0.4512582063037831
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,21249,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,24075,50,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEBPA,CCAAT/enhancer-binding protein alpha,20649,43,1.06 [0.54-2.09],0.867647162472511
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEBPB,CCAAT/enhancer-binding protein beta,24075,50,1.26 [0.69-2.29],0.4521689207287581
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CELA2A,Chymotrypsin-like elastase family member 2A,21249,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CELA3A,Chymotrypsin-like elastase family member 3A,24753,50,0.98 [0.63-1.53],0.9344969204600444
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,20778,43,0.82 [0.29-2.35],0.7161967605760334
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEMIP2,Cell surface hyaluronidase,20649,43,0.70 [0.24-2.03],0.5102230680644069
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEND1,Cell cycle exit and neuronal differentiation protein 1,20603,44,0.77 [0.42-1.41],0.3919370922885152
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CENPF,Centromere protein F,20859,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CENPJ,Centromere protein J,20859,45,1.15 [0.81-1.63],0.4286308447333983
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEP112,Centrosomal protein of 112 kDa,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEP152,Centrosomal protein of 152 kDa,20504,44,1.07 [0.56-2.05],0.8373247557722256
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEP164,Centrosomal protein of 164 kDa,24058,48,0.90 [0.57-1.42],0.6479123615829532
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEP170,Centrosomal protein of 170 kDa,20670,44,0.83 [0.56-1.24],0.3660236767150077
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEP20,Centrosomal protein 20,23919,48,1.14 [0.81-1.60],0.4478084655548677
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEP290,Centrosomal protein of 290 kDa,20859,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEP350,Centrosome-associated protein 350,20504,44,0.92 [0.41-2.06],0.8427687627419639
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEP43,Centrosomal protein 43,23882,50,1.07 [0.75-1.54],0.7043181028448566
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEP85,Centrosomal protein of 85 kDa,23919,48,0.82 [0.54-1.25],0.3593592897430889
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CERT,Ceramide transfer protein,23928,49,0.82 [0.54-1.25],0.3637530850490874
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,24537,49,1.08 [0.79-1.48],0.6150729740057835
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CES2,Cocaine esterase,24384,48,0.97 [0.61-1.55],0.9008080063716442
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,24384,48,0.99 [0.69-1.42],0.9716601018344584
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CETN2,Centrin-2,23928,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CETN3,Centrin-3,21165,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CFB,Complement factor B,20888,40,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CFC1,Cryptic protein,23919,48,1.23 [0.78-1.93],0.3764316033237711
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CFD,Complement factor D,21281,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CFH,Complement factor H,20058,38,0.66 [0.17-2.51],0.5433867620600601
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CFHR2,Complement factor H-related protein 2,21128,42,0.72 [0.46-1.13],0.1527786850692461
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CFHR4,Complement factor H-related protein 4,21242,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,20994,44,0.78 [0.40-1.55],0.4871521724661813
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CFI,Complement factor I,21281,43,0.88 [0.21-3.75],0.8600760434616606
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CFP,Properdin,21281,43,0.63 [0.16-2.49],0.509308751411562
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,24493,47,1.08 [0.86-1.35],0.5049325959539201
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,21262,44,1.37 [1.00-1.86],0.0468768067678731
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CGN,Cingulin,20673,44,1.01 [0.50-2.05],0.9752048461774452
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CGREF1,Cell growth regulator with EF hand domain protein 1,24515,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,23919,48,0.79 [0.51-1.25],0.3182683251097855
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,20778,43,0.84 [0.47-1.50],0.5622894047114859
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",21200,44,0.97 [0.48-1.99],0.9427325801658276
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,21142,45,0.89 [0.31-2.52],0.8196547507472289
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHEK2,Serine/threonine-protein kinase Chk2,24075,50,1.13 [0.56-2.30],0.734250966659945
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,21249,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHGB,Secretogranin-1,24649,47,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHI3L1,Chitinase-3-like protein 1,23909,49,1.22 [0.89-1.69],0.2172454540074153
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHIT1,Chitotriosidase-1,24589,48,0.99 [0.87-1.12],0.845668745539592
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHL1,Neural cell adhesion molecule L1-like protein,24518,49,1.01 [0.45-2.28],0.9845186403101036
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHM,Rab proteins geranylgeranyltransferase component A 1,20673,44,0.79 [0.48-1.30],0.3579172695252302
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHMP1A,Charged multivesicular body protein 1a,24344,45,0.94 [0.67-1.31],0.7041703590138808
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHMP6,Charged multivesicular body protein 6,21256,43,0.97 [0.58-1.62],0.8972990859209551
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHP1,Calcineurin B homologous protein 1,20603,44,0.90 [0.59-1.38],0.6391853651867672
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHRDL1,Chordin-like protein 1,24564,50,1.55 [0.69-3.49],0.2881802425399016
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHRDL2,Chordin-like protein 2,24515,49,1.16 [0.75-1.81],0.5006015881858153
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHRM1,Muscarinic acetylcholine receptor M1,20673,44,0.61 [0.24-1.55],0.3021932615176766
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CIAPIN1,Anamorsin,24552,49,0.98 [0.66-1.46],0.9330262830240516
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CILP,Cartilage intermediate layer protein 1,21249,44,0.65 [0.40-1.05],0.0798078398716069
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CINP,Cyclin-dependent kinase 2-interacting protein,20859,45,1.58 [1.06-2.37],0.0261651843929984
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CIRBP,Cold-inducible RNA-binding protein,21165,44,0.90 [0.67-1.21],0.4837533663792835
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,20673,44,1.13 [0.63-2.00],0.687920396477778
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,24667,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,21249,44,1.31 [0.80-2.13],0.2809113247133118
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",24380,49,0.90 [0.64-1.26],0.5283652564660002
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLASP1,CLIP-associating protein 1,20504,44,0.75 [0.47-1.18],0.215977809814322
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLC,Galectin-10,24480,49,0.87 [0.59-1.29],0.4826837308529015
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC10A,C-type lectin domain family 10 member A,24344,45,1.48 [0.71-3.08],0.2981532228804132
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,24446,47,1.69 [0.97-2.93],0.0616261767105909
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,20649,43,1.37 [0.36-5.28],0.6465365112977449
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,24493,47,1.22 [0.53-2.82],0.6392387690387147
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,24075,50,1.15 [0.53-2.51],0.7248277047129075
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC1B,C-type lectin domain family 1 member B,24738,48,0.96 [0.74-1.26],0.785615925772734
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC2L,C-type lectin domain family 2 member L,20673,44,0.62 [0.29-1.30],0.2018965687959936
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC3B,Tetranectin,20793,39,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC4A,C-type lectin domain family 4 member A,24494,49,0.73 [0.37-1.47],0.3817724379144219
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,24494,49,0.71 [0.41-1.21],0.2082004593144324
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC4D,C-type lectin domain family 4 member D,24494,49,0.74 [0.48-1.13],0.1647213050701812
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,24494,49,1.26 [0.59-2.67],0.550722305763677
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC4M,C-type lectin domain family 4 member M,21214,44,1.21 [0.67-2.19],0.5335018118304208
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC5A,C-type lectin domain family 5 member A,24425,49,2.49 [1.12-5.56],0.025857669658244
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,23919,48,1.05 [0.60-1.84],0.8627657467300653
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC7A,C-type lectin domain family 7 member A,24803,49,1.78 [0.99-3.20],0.0551729282139426
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLGN,Calmegin,20673,44,0.89 [0.47-1.69],0.7180241884809542
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLIC5,Chloride intracellular channel protein 5,20673,44,1.31 [0.61-2.85],0.4899762594096678
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLINT1,Clathrin interactor 1,20504,44,1.43 [1.00-2.05],0.0503913120607922
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLIP2,CAP-Gly domain-containing linker protein 2,24494,49,0.92 [0.74-1.15],0.4608545185041501
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,24723,49,3.63 [1.32-10.03],0.0127790576555941
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLNS1A,Methylosome subunit pICln,20673,44,0.95 [0.40-2.23],0.9032316631173662
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",24297,45,0.94 [0.71-1.24],0.6526626077868631
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLPS,Colipase,24455,47,1.16 [0.80-1.68],0.4262064063452254
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLSPN,Claspin,23881,49,0.74 [0.31-1.74],0.487079631957267
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLSTN1,Calsyntenin-1,23928,49,1.02 [0.62-1.65],0.94987423464399
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,24803,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,21200,44,0.95 [0.36-2.48],0.9178043915369962
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLTA,Clathrin light chain A,24075,50,0.67 [0.37-1.22],0.1950429962234929
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLU,Clusterin,21281,43,0.84 [0.29-2.45],0.7520202993733915
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLUL1,Clusterin-like protein 1,24476,49,1.01 [0.59-1.73],0.9756877487690464
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CMC1,COX assembly mitochondrial protein homolog,21256,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CMIP,C-Maf-inducing protein,21142,45,0.95 [0.67-1.35],0.7831860489981364
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,24561,49,1.12 [0.63-1.99],0.6918893880291022
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNGB3,Cyclic nucleotide-gated cation channel beta-3,20603,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",20632,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNPY2,Protein canopy homolog 2,24075,50,0.85 [0.53-1.38],0.516693955618273
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNPY4,Protein canopy homolog 4,24384,48,0.94 [0.67-1.31],0.7113859078942226
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNST,Consortin,24515,49,0.97 [0.77-1.22],0.7929371041281184
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNTF,Ciliary neurotrophic factor,20603,44,1.08 [0.46-2.51],0.8578597152500481
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNTN1,Contactin-1,24798,50,0.97 [0.40-2.34],0.9479476663766184
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNTN2,Contactin-2,24723,49,0.67 [0.38-1.20],0.1781482490751262
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,24493,47,0.64 [0.31-1.33],0.2323136137472549
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNTN4,Contactin-4,24493,47,0.96 [0.32-2.87],0.9475175206764408
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNTN5,Contactin-5,24571,47,1.21 [0.62-2.38],0.5788478099390041
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,24494,49,0.90 [0.49-1.65],0.7229237942055526
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNTNAP4,Contactin-associated protein-like 4,20673,44,0.93 [0.69-1.25],0.6272525578236063
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,21256,43,1.37 [0.74-2.53],0.3154922733040941
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL15A1,Collagen alpha-1(XV) chain,21249,44,1.33 [0.44-4.05],0.610277233629811
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,24576,49,2.13 [0.70-6.48],0.1845879508964556
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,24798,50,1.02 [0.38-2.76],0.9705562094469736
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL24A1,Collagen alpha-1(XXIV) chain,21165,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL28A1,Collagen alpha-1(XXVIII) chain,20673,44,0.82 [0.55-1.23],0.3400788921213025
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL2A1,Collagen alpha-1(II) chain,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL3A1,Collagen alpha-1(III) chain,21249,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,24515,49,0.97 [0.50-1.86],0.9206554201690292
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL4A4,Collagen alpha-4(IV) chain,20824,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,20778,43,1.48 [0.75-2.93],0.260079800775898
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,24798,50,1.93 [0.94-3.97],0.0749538002661606
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL9A1,Collagen alpha-1(IX) chain,24494,49,0.52 [0.28-0.98],0.0441752507192662
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,20859,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,24478,49,1.62 [0.59-4.46],0.352596145046989
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COMMD1,COMM domain-containing protein 1,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COMMD9,COMM domain-containing protein 9,21142,45,1.21 [0.63-2.32],0.5738440594900003
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COMP,Cartilage oligomeric matrix protein,24221,48,1.69 [0.79-3.60],0.1744614954871158
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COMT,Catechol O-methyltransferase,23801,50,0.98 [0.73-1.31],0.8755835301653876
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COPB2,Coatomer subunit beta',20593,42,0.75 [0.37-1.55],0.4384110965759662
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COPE,Coatomer subunit epsilon,23928,49,0.70 [0.36-1.37],0.3014808124386535
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",20670,44,0.68 [0.33-1.43],0.3128430661720413
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CORO1A,Coronin-1A,23995,49,1.14 [0.88-1.47],0.326771029945512
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CORO6,Coronin-6,20603,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",24384,48,0.93 [0.64-1.35],0.6909871338556728
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COX6B1,Cytochrome c oxidase subunit 6B1,21256,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPA1,Carboxypeptidase A1,24798,50,1.01 [0.66-1.54],0.9586503400203444
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPA2,Carboxypeptidase A2,24649,48,1.14 [0.77-1.68],0.5073786998436366
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPA4,Carboxypeptidase A4,20364,42,1.70 [0.84-3.47],0.1416342566924343
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPB1,Carboxypeptidase B,24798,50,1.04 [0.67-1.60],0.867640502070294
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPB2,Carboxypeptidase B2,21239,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPE,Carboxypeptidase E,24545,49,0.99 [0.52-1.88],0.9646010792910016
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPLX2,Complexin-2,20504,44,0.70 [0.25-1.95],0.4914702802587043
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPM,Carboxypeptidase M,24633,47,0.84 [0.40-1.80],0.6608768200979334
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",20649,43,0.53 [0.17-1.66],0.2781657463964301
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPPED1,Serine/threonine-protein phosphatase CPPED1,24738,48,0.77 [0.53-1.13],0.1846158692777179
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPQ,Carboxypeptidase Q,21213,44,0.79 [0.35-1.78],0.5706693694402338
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPTP,Ceramide-1-phosphate transfer protein,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPVL,Probable serine carboxypeptidase CPVL,24681,49,1.51 [0.80-2.84],0.2003035790830091
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPXM1,Probable carboxypeptidase X1,24552,49,1.11 [0.77-1.61],0.5647400880022828
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPXM2,Inactive carboxypeptidase-like protein X2,21256,43,2.89 [1.04-8.04],0.0419964614227382
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,21177,44,1.16 [0.51-2.64],0.7207377456520805
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,24561,49,1.08 [0.62-1.88],0.7891605916826505
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,23919,48,1.03 [0.77-1.38],0.8270619291931589
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRADD,Death domain-containing protein CRADD,24297,45,0.92 [0.65-1.30],0.6479865369456519
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CREB3,Cyclic AMP-responsive element-binding protein 3,20504,44,0.56 [0.29-1.08],0.0848877020680744
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CREBZF,CREB/ATF bZIP transcription factor,20504,44,1.03 [0.35-3.06],0.9526000884549906
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,24150,49,1.10 [0.56-2.15],0.781495105384096
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRELD1,Protein disulfide isomerase CRELD1,20778,43,1.21 [0.56-2.64],0.6257003626818176
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRELD2,Protein disulfide isomerase CRELD2,24564,50,0.90 [0.56-1.46],0.678839864367177
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,23878,48,0.93 [0.69-1.25],0.6226675688045684
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRHBP,Corticotropin-releasing factor-binding protein,24478,49,0.84 [0.34-2.05],0.6948922152954773
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRHR1,Corticotropin-releasing factor receptor 1,24075,50,1.11 [0.78-1.59],0.5695143711106129
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,24599,50,1.32 [0.38-4.60],0.6676426695404679
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRIP2,Cysteine-rich protein 2,24344,45,0.80 [0.38-1.69],0.5668175541330541
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRISP2,Cysteine-rich secretory protein 2,24723,49,0.98 [0.67-1.44],0.9292400982603743
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,21056,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRKL,Crk-like protein,24513,50,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,24599,50,0.72 [0.27-1.90],0.5087391768350393
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRNN,Cornulin,23763,47,1.52 [1.05-2.21],0.0254926580519413
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRTAC1,Cartilage acidic protein 1,24798,50,1.23 [0.53-2.83],0.6306907946700566
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,24344,45,1.29 [0.76-2.20],0.3414193927763792
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRTAP,Cartilage-associated protein,20673,44,0.71 [0.36-1.40],0.3228868803805307
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRX,Cone-rod homeobox protein,24075,50,1.17 [0.97-1.41],0.0959845762974092
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRYBB1,Beta-crystallin B1,21256,43,0.93 [0.60-1.45],0.7507125658363607
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRYBB2,Beta-crystallin B2,21200,44,1.03 [0.63-1.67],0.9182589202255366
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRYGD,Gamma-crystallin D,21200,44,0.73 [0.54-0.99],0.0404391409425117
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRYM,Ketimine reductase mu-crystallin,20603,44,0.87 [0.57-1.33],0.5195680823706994
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRYZL1,Quinone oxidoreductase-like protein 1,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSDE1,Cold shock domain-containing protein E1,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,24599,50,1.73 [0.68-4.40],0.2472781023609622
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,21262,44,1.72 [0.97-3.07],0.0636795341298708
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSF2,Granulocyte-macrophage colony-stimulating factor,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,24344,45,1.10 [0.70-1.75],0.6782341007123027
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,20649,43,1.12 [0.57-2.21],0.7321445174657331
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSF3,Granulocyte colony-stimulating factor,24058,48,0.96 [0.56-1.63],0.8741364740058806
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSF3R,Granulocyte colony-stimulating factor receptor,20649,43,0.67 [0.23-1.94],0.4587931538064693
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSH1,Chorionic somatomammotropin hormone 1,21262,44,1.24 [0.66-2.32],0.499151537211127
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSNK1D,Casein kinase I isoform delta,20649,43,0.77 [0.47-1.26],0.2969097963192817
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSNK2A1,Casein kinase II subunit alpha,21225,45,0.95 [0.51-1.79],0.8779776411419423
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,21249,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSPG5,Chondroitin sulfate proteoglycan 5,20603,44,1.39 [0.88-2.22],0.161399853846387
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSRP3,Cysteine and glycine-rich protein 3,20593,42,0.80 [0.56-1.15],0.2268196744697114
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CST1,Cystatin-SN,18406,33,1.17 [0.83-1.64],0.3673888329768562
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,24520,49,2.28 [0.97-5.35],0.0588034507370333
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CST5,Cystatin-D,24056,43,1.46 [0.90-2.36],0.1216878092951887
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CST6,Cystatin-M,23884,48,1.22 [0.72-2.09],0.4630314341224872
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CST7,Cystatin-F,24511,50,0.98 [0.74-1.28],0.863597436903905
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,24157,48,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTAG1A_CTAG1B,Cancer/testis antigen 1,20813,45,1.12 [0.66-1.91],0.6792887896206885
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTBS,Di-N-acetylchitobiase,20968,44,1.38 [0.46-4.12],0.5656556311432512
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTF1,Cardiotrophin-1,24075,50,1.00 [0.63-1.60],0.994440158985276
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTHRC1,Collagen triple helix repeat-containing protein 1,21249,44,0.51 [0.18-1.39],0.1866337923042994
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTLA4,Cytotoxic T-lymphocyte protein 4,21249,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTNNA1,Catenin alpha-1,20603,44,1.88 [1.20-2.94],0.0057280350821848
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTRB1,Chymotrypsinogen B,24493,47,0.88 [0.54-1.43],0.6087798388110766
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTRC,Chymotrypsin-C,24480,50,0.94 [0.63-1.42],0.7822332027131553
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTRL,Chymotrypsin-like protease CTRL-1,21200,44,0.62 [0.41-0.94],0.0255106485747484
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,24487,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSC,Dipeptidyl peptidase 1,24428,50,0.72 [0.40-1.29],0.2643452431678877
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,22837,46,1.21 [0.64-2.27],0.5546501460215232
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSE,Cathepsin E,20778,43,0.96 [0.55-1.68],0.8854573255989775
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSF,Cathepsin F,24552,49,1.10 [0.59-2.05],0.7623116643394237
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,24008,50,1.08 [0.76-1.52],0.66631331363849
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,24515,49,2.19 [0.84-5.71],0.1098381506962324
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,24803,49,1.05 [0.46-2.41],0.9006739039485891
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,19356,36,0.39 [0.10-1.53],0.1766794055590084
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,24649,49,1.02 [0.55-1.90],0.9407642650156086
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,24469,49,0.92 [0.41-2.09],0.847383653211943
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CUZD1,CUB and zona pellucida-like domain-containing protein 1,20673,44,1.23 [0.62-2.43],0.5462618639402965
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,21048,44,1.10 [0.74-1.64],0.6424649017448973
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CX3CL1,Fractalkine,24344,45,1.35 [0.62-2.94],0.4525801944317928
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,24494,49,1.07 [0.66-1.76],0.7762844261261078
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL1,Growth-regulated alpha protein,24429,50,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,24599,50,1.33 [0.96-1.84],0.0843199851113109
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,24738,48,1.03 [0.74-1.43],0.8681005672433225
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL12,Stromal cell-derived factor 1,24058,48,1.17 [0.62-2.19],0.6271066666536129
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,24738,48,0.78 [0.47-1.29],0.3303344822304889
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL14,C-X-C motif chemokine 14,24058,48,1.17 [0.83-1.64],0.3820716316987975
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL16,C-X-C motif chemokine 16,24748,50,0.65 [0.22-1.94],0.4381797407204199
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,24803,49,0.93 [0.50-1.73],0.817678652791062
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL3,C-X-C motif chemokine 3,24476,50,0.93 [0.72-1.20],0.5817791141359394
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL5,C-X-C motif chemokine 5,24430,49,1.06 [0.85-1.32],0.6261311887295449
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL6,C-X-C motif chemokine 6,24803,49,1.22 [0.88-1.69],0.2244877104775725
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,24311,48,1.16 [0.82-1.64],0.4085372528971993
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,24599,50,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CYB5A,Cytochrome b5,20504,44,0.86 [0.55-1.35],0.5235276308759542
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,20911,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",20593,42,1.11 [0.82-1.50],0.4891896716601143
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CYTH3,Cytohesin-3,20504,44,0.95 [0.64-1.41],0.7957666728651637
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CYTL1,Cytokine-like protein 1,21249,44,2.01 [0.64-6.33],0.2315105252992909
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DAAM1,Disheveled-associated activator of morphogenesis 1,20778,43,0.95 [0.66-1.36],0.7675600257125466
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DAB2,Disabled homolog 2,24723,49,1.01 [0.81-1.26],0.9422932638819396
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DAG1,Dystroglycan,24599,50,0.83 [0.49-1.39],0.4704121038325831
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DAND5,DAN domain family member 5,20649,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DAPK2,Death-associated protein kinase 2,20649,43,1.19 [0.75-1.88],0.4685454544252457
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,24494,49,1.00 [0.81-1.23],0.9972864854216998
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DARS1,"Aspartate--tRNA ligase, cytoplasmic",24297,45,0.84 [0.58-1.20],0.3262837594731155
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DBH,Dopamine beta-hydroxylase,21228,44,0.93 [0.73-1.19],0.5667668441434508
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DBI,Acyl-CoA-binding protein,24376,46,1.00 [0.73-1.39],0.9848672178307154
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DBN1,Drebrin,20649,43,0.68 [0.37-1.24],0.2092919233917017
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DBNL,Drebrin-like protein,24599,50,0.95 [0.73-1.24],0.7158019444366457
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",24552,49,0.64 [0.31-1.29],0.2119490996749735
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCC,Netrin receptor DCC,20673,44,1.14 [0.36-3.58],0.8287281524685861
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCDC2C,Doublecortin domain-containing protein 2C,20504,44,0.77 [0.46-1.29],0.3220971793058497
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCLRE1C,Protein artemis,20504,44,0.52 [0.19-1.41],0.1974480845702459
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCN,Decorin,24075,50,0.80 [0.24-2.62],0.7104745323812511
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCTD,Deoxycytidylate deaminase,20778,43,0.95 [0.70-1.30],0.7645676856706916
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCTN1,Dynactin subunit 1,24723,49,0.96 [0.65-1.41],0.8431256863448764
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCTN2,Dynactin subunit 2,24384,48,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCTN6,Dynactin subunit 6,23928,49,0.77 [0.51-1.16],0.2124067967469425
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,24515,49,1.33 [0.60-2.98],0.4811151362657676
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCUN1D1,DCN1-like protein 1,20603,44,0.76 [0.48-1.21],0.2540730843889812
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCUN1D2,DCN1-like protein 2,20504,44,0.94 [0.64-1.37],0.7514105244749881
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCXR,L-xylulose reductase,24552,49,0.90 [0.57-1.42],0.6602043315111363
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDA1,DET1- and DDB1-associated protein 1,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",24384,48,0.94 [0.52-1.68],0.82576862819196
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDC,Aromatic-L-amino-acid decarboxylase,24487,49,1.19 [0.70-2.00],0.5221130708042959
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDHD2,Phospholipase DDHD2,21225,45,0.91 [0.59-1.40],0.6698818133897728
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDI2,Protein DDI1 homolog 2,20778,43,0.90 [0.62-1.31],0.5723988502116166
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,24738,48,1.92 [0.67-5.53],0.2252789425490288
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDT,D-dopachrome decarboxylase,21249,44,0.84 [0.38-1.88],0.6771587448930034
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDX1,ATP-dependent RNA helicase DDX1,21165,44,0.85 [0.46-1.57],0.6141681444799807
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDX25,ATP-dependent RNA helicase DDX25,20673,44,0.77 [0.32-1.83],0.5484421269149768
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDX39A,ATP-dependent RNA helicase DDX39A,20649,43,0.46 [0.11-1.97],0.2946917762390965
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDX4,Probable ATP-dependent RNA helicase DDX4,20649,43,1.06 [0.65-1.72],0.8155217369855455
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDX53,Probable ATP-dependent RNA helicase DDX53,20673,44,0.87 [0.39-1.95],0.7332864903492401
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,23919,48,0.97 [0.62-1.51],0.8823218339222694
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",24494,49,0.88 [0.67-1.14],0.3307364501634748
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,23980,48,1.62 [1.13-2.33],0.0088518350246509
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DEFB103A_DEFB103B,Beta-defensin 103,20503,42,0.69 [0.29-1.64],0.4005648997641163
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DEFB104A_DEFB104B,Beta-defensin 104,20603,44,1.07 [0.67-1.70],0.7893193854098398
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DEFB116,Beta-defensin 116,20603,44,0.91 [0.61-1.38],0.6707001900360932
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DEFB118,Beta-defensin 118,20603,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DEFB4A_DEFB4B,Beta-defensin 4A,24125,47,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DENND2B,DENN domain-containing protein 2B,20593,42,0.51 [0.21-1.23],0.1356447878311525
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DENR,Density-regulated protein,20649,43,0.74 [0.42-1.30],0.2951536561122894
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,24803,49,0.80 [0.54-1.17],0.2440150066240139
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,20603,44,1.30 [0.78-2.16],0.3160360414538073
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DGKA,Diacylglycerol kinase alpha,20649,43,0.88 [0.51-1.53],0.655274780767354
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DGKZ,Diacylglycerol kinase zeta,24058,48,1.01 [0.50-2.06],0.970742647593197
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DHODH,Dihydroorotate dehydrogenase,20593,42,0.74 [0.36-1.51],0.4073785427735044
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,21142,45,1.38 [0.81-2.35],0.2408280904719434
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,21200,44,0.88 [0.47-1.66],0.6976910559944882
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DIABLO,"Diablo homolog, mitochondrial",24425,49,0.97 [0.77-1.22],0.7815670176815999
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DIPK1C,Divergent protein kinase domain 1C,20673,44,1.67 [1.05-2.65],0.0307163090112116
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DIPK2B,Divergent protein kinase domain 2B,20778,43,0.90 [0.32-2.52],0.8387651163275113
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DKK1,Dickkopf-related protein 1,24738,48,1.18 [0.77-1.82],0.4464914833143915
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DKK3,Dickkopf-related protein 3,24798,50,1.67 [0.71-3.93],0.2394455596782971
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DKK4,Dickkopf-related protein 4,24301,45,1.14 [0.65-2.00],0.6456158192005998
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DKKL1,Dickkopf-like protein 1,24384,48,0.92 [0.70-1.23],0.5905147976283811
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DLG4,Disks large homolog 4,21200,44,0.74 [0.48-1.14],0.1703417407210794
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DLGAP5,Disks large-associated protein 5,21225,45,0.72 [0.35-1.50],0.3851546796012427
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DLK1,Protein delta homolog 1,24798,50,1.29 [0.83-2.01],0.2659189160026856
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,24552,49,1.47 [0.61-3.55],0.3917431272720451
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DLL4,Delta-like protein 4,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DMD,Dystrophin,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DMP1,Dentin matrix acidic phosphoprotein 1,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJA1,DnaJ homolog subfamily A member 1,20504,44,1.03 [0.56-1.90],0.9263098311467012
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJA2,DnaJ homolog subfamily A member 2,24715,49,0.94 [0.69-1.27],0.6932324663735907
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJA4,DnaJ homolog subfamily A member 4,21200,44,0.90 [0.60-1.34],0.5951433722122631
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJB1,DnaJ homolog subfamily B member 1,24384,48,0.88 [0.66-1.18],0.3996075452563727
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJB14,DnaJ homolog subfamily B member 14,21165,44,1.05 [0.68-1.61],0.8342775208960924
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJB2,DnaJ homolog subfamily B member 2,20778,43,0.97 [0.57-1.66],0.914426100214798
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJB6,DnaJ homolog subfamily B member 6,20580,43,0.96 [0.68-1.36],0.8254871668254727
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJB8,DnaJ homolog subfamily B member 8,24075,50,0.97 [0.61-1.52],0.8826450090236719
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJC21,DnaJ homolog subfamily C member 21,21200,44,0.72 [0.33-1.58],0.4180212093590756
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJC6,Putative tyrosine-protein phosphatase auxilin,20670,44,0.80 [0.56-1.14],0.2199548191035066
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJC9,DnaJ homolog subfamily C member 9,21165,44,0.88 [0.61-1.28],0.5084297299719889
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNER,Delta and Notch-like epidermal growth factor-related receptor,24443,50,1.23 [0.47-3.24],0.6699626877503844
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNLZ,DNL-type zinc finger protein,20603,44,0.84 [0.57-1.24],0.3731045510748282
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNM1,Dynamin-1,21165,44,0.91 [0.71-1.17],0.4597961531067751
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNM3,Dynamin-3,21225,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,24344,45,0.90 [0.58-1.38],0.6265960903944547
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNPEP,Aspartyl aminopeptidase,21200,44,0.76 [0.49-1.18],0.218869385428617
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,24548,50,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DOC2B,Double C2-like domain-containing protein beta,20673,44,1.61 [0.99-2.63],0.0556112075278297
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DOCK9,Dedicator of cytokinesis protein 9,20603,44,1.04 [0.82-1.31],0.737193293480086
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DOK1,Docking protein 1,21200,44,0.97 [0.79-1.20],0.7906579268693056
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DOK2,Docking protein 2,24515,49,0.99 [0.80-1.21],0.8936881228416165
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DPEP1,Dipeptidase 1,24297,45,1.38 [0.79-2.42],0.2610938355932157
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,24384,48,0.64 [0.26-1.59],0.3373029684579667
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,24494,49,1.16 [0.57-2.38],0.6850288297984768
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,23992,48,1.27 [0.53-3.00],0.5931920868495095
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DPP6,Dipeptidyl aminopeptidase-like protein 6,24384,48,1.56 [0.73-3.33],0.2519767451575022
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DPP7,Dipeptidyl peptidase 2,24310,48,0.96 [0.63-1.46],0.8437434480204868
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,24798,50,2.09 [0.77-5.65],0.1460159777863519
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,24657,48,1.03 [0.68-1.56],0.8947012560217023
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DRAXIN,Draxin,24344,45,1.61 [0.88-2.95],0.1207480430497246
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DRG2,Developmentally-regulated GTP-binding protein 2,24384,48,0.85 [0.54-1.34],0.4855736765637195
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,24196,47,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,21225,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DSG2,Desmoglein-2,24493,47,3.21 [1.28-8.05],0.0131784791684442
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DSG3,Desmoglein-3,24651,48,1.21 [0.59-2.48],0.609750591364004
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DSG4,Desmoglein-4,24294,48,1.09 [0.65-1.83],0.7518365845852224
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DTD1,D-aminoacyl-tRNA deacylase 1,20778,43,0.96 [0.69-1.34],0.8049300079523889
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,21106,45,1.05 [0.57-1.94],0.8754835596982876
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DTX2,Probable E3 ubiquitin-protein ligase DTX2,20673,44,0.81 [0.49-1.34],0.4149352913057339
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,24384,48,3.04 [1.36-6.83],0.007006724429405
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DTYMK,Thymidylate kinase,21256,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DUOX2,Dual oxidase 2,24075,50,0.86 [0.58-1.29],0.4717785340980993
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DUSP13,Dual specificity protein phosphatase 13 isoform A,21142,45,1.26 [0.69-2.31],0.453355934411796
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DUSP29,Dual specificity phosphatase 29,20673,44,1.05 [0.69-1.59],0.8154160603016907
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DUSP3,Dual specificity protein phosphatase 3,23928,49,0.90 [0.65-1.24],0.5261473930385934
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",21165,44,0.84 [0.63-1.12],0.2436594521061945
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,21200,44,0.81 [0.42-1.54],0.5172635009084476
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,21142,45,1.17 [0.72-1.91],0.5229294655369351
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DYNLT1,Dynein light chain Tctex-type 1,20673,44,0.73 [0.48-1.11],0.1438219320430528
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DYNLT3,Dynein light chain Tctex-type 3,21142,45,0.65 [0.33-1.29],0.2146109851984612
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,24344,45,0.85 [0.65-1.13],0.2749493201789559
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,24691,49,1.68 [0.78-3.63],0.1862519882605255
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ECE1,Endothelin-converting enzyme 1,23928,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",21256,43,0.74 [0.48-1.14],0.1673752526032368
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ECHS1,"Enoyl-CoA hydratase, mitochondrial",20670,44,0.82 [0.60-1.12],0.2123658292886856
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ECI2,Enoyl-CoA delta isomerase 2,20593,42,1.14 [0.78-1.66],0.5111350377027506
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ECM1,Extracellular matrix protein 1,20679,40,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ECSCR,Endothelial cell-specific chemotaxis regulator,20603,44,1.29 [0.84-1.98],0.2537495749194545
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,24723,49,1.22 [0.58-2.55],0.5999478660281194
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EDAR,Tumor necrosis factor receptor superfamily member EDAR,24494,49,0.89 [0.68-1.18],0.42211806076614
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EDDM3B,Epididymal secretory protein E3-beta,21142,45,1.01 [0.73-1.40],0.939770849510424
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,20593,42,0.44 [0.15-1.24],0.1185129580702348
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EDF1,Endothelial differentiation-related factor 1,21225,45,1.10 [0.77-1.58],0.592256199006443
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,24075,50,0.73 [0.35-1.51],0.3922308530987626
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,20670,44,0.93 [0.33-2.61],0.8847150113425488
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EDNRB,Endothelin receptor type B,20649,43,0.48 [0.19-1.17],0.1051109906034889
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EEF1D,Elongation factor 1-delta,21256,43,0.98 [0.71-1.34],0.895859058250367
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,21165,44,1.06 [0.36-3.10],0.916471718403882
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EFCAB2,Dynein regulatory complex protein 8,20859,45,0.74 [0.31-1.73],0.4822235701341989
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,24512,49,2.58 [1.20-5.54],0.0147681245592199
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EFHD1,EF-hand domain-containing protein D1,21225,45,1.40 [0.67-2.90],0.3688964162581319
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,24448,46,1.29 [0.48-3.49],0.6118240692992453
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,24303,45,1.88 [0.75-4.72],0.179326539338511
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EFNB2,Ephrin-B2,20673,44,1.23 [0.86-1.77],0.2590638577144624
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EGF,Pro-epidermal growth factor,24437,49,1.00 [0.78-1.27],0.9749247913654092
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,23919,48,1.32 [0.72-2.43],0.3729122172409873
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EGFLAM,Pikachurin,21165,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,24798,50,1.01 [0.21-4.78],0.9898597310367306
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,24494,49,0.79 [0.46-1.35],0.3857826926265464
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EHBP1,EH domain-binding protein 1,21256,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EHD3,EH domain-containing protein 3,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",21200,44,0.75 [0.41-1.37],0.3501663545070879
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",21103,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,20593,42,0.88 [0.63-1.22],0.4481849322906086
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF4B,Eukaryotic translation initiation factor 4B,24344,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF4E,Eukaryotic translation initiation factor 4E,20649,43,0.94 [0.67-1.30],0.6882151127845628
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,24515,49,1.05 [0.72-1.53],0.8043049714692396
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,24803,49,0.97 [0.76-1.25],0.8188559363754928
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,21225,45,0.73 [0.46-1.16],0.1842676698020534
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF5,Eukaryotic translation initiation factor 5,20593,42,1.35 [0.79-2.30],0.2717248102479412
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF5A,Eukaryotic translation initiation factor 5A-1,24058,48,1.03 [0.44-2.40],0.9422028665249764
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ELAC1,Zinc phosphodiesterase ELAC protein 1,21225,45,0.98 [0.71-1.37],0.9208425472622764
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ELAVL4,ELAV-like protein 4,20603,44,0.74 [0.50-1.09],0.1300488013632959
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ELN,Elastin,21256,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,24384,48,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ELOB,Elongin-B,20593,42,0.51 [0.20-1.28],0.1495836632715948
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENAH,Protein enabled homolog,24058,48,0.89 [0.52-1.55],0.6883211352094536
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENDOU,Poly(U)-specific endoribonuclease,19645,41,1.05 [0.62-1.78],0.8563578428579002
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,24798,50,1.60 [0.37-6.79],0.5274983310055563
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENO1,Alpha-enolase,24483,48,0.92 [0.66-1.26],0.5915250776008163
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENO2,Gamma-enolase,24738,48,0.87 [0.59-1.29],0.4864409402821325
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENO3,Beta-enolase,20670,44,0.77 [0.47-1.27],0.3118703250506667
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENOPH1,Enolase-phosphatase E1,21142,45,1.35 [1.03-1.78],0.0297530813602891
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,20593,42,0.47 [0.15-1.50],0.2011575855644743
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENPEP,Glutamyl aminopeptidase,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,24798,50,1.42 [0.69-2.94],0.3402858790540048
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,24599,50,1.09 [0.62-1.91],0.764366045656277
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,23784,49,0.98 [0.73-1.32],0.9111063948265368
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENSA,Alpha-endosulfine,21142,45,0.86 [0.49-1.51],0.5961859028273571
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,23919,48,0.88 [0.49-1.59],0.6788982239262238
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,24075,50,0.82 [0.25-2.63],0.7361867918028469
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,24075,50,0.76 [0.32-1.79],0.530583103623798
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,20670,44,1.24 [0.80-1.92],0.3278008715639814
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EP300,Histone acetyltransferase p300,20649,43,1.31 [0.54-3.14],0.5493302894350138
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPB41L5,Band 4.1-like protein 5,20673,44,1.21 [0.85-1.73],0.29856489817636
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPCAM,Epithelial cell adhesion molecule,24483,50,1.19 [0.93-1.53],0.1732855751633271
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPGN,Epigen,21142,45,0.76 [0.35-1.64],0.4797590467248964
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPHA1,Ephrin type-A receptor 1,24548,50,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPHA10,Ephrin type-A receptor 10,23928,49,1.03 [0.70-1.51],0.8789117924101566
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,23626,45,1.83 [0.79-4.26],0.161158168611356
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,20778,43,1.23 [0.44-3.49],0.6940536488915675
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,24798,50,3.16 [1.31-7.60],0.0102791316727666
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,24297,45,1.10 [0.46-2.65],0.8317709874371587
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPHX2,Bifunctional epoxide hydrolase 2,24075,50,0.74 [0.46-1.20],0.228236406363756
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPN1,Epsin-1,20859,45,0.84 [0.40-1.76],0.6491054264584435
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,24494,49,0.86 [0.60-1.25],0.4349367564483533
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPPK1,Epiplakin,20670,44,0.78 [0.50-1.19],0.2449151684921348
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,24689,48,0.97 [0.41-2.30],0.9365343616137884
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,24552,49,0.83 [0.31-2.19],0.7033702326158467
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERBB3,Receptor tyrosine-protein kinase erbB-3,24384,50,0.86 [0.24-3.08],0.8206483587733084
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERBB4,Receptor tyrosine-protein kinase erbB-4,24552,49,0.86 [0.29-2.49],0.7748860391792755
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERBIN,Erbin,24384,48,0.95 [0.74-1.21],0.6580201159684392
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERC2,ERC protein 2,20673,44,0.91 [0.60-1.39],0.667881897906702
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERCC1,DNA excision repair protein ERCC-1,20504,44,0.97 [0.40-2.36],0.9437340636336676
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EREG,Proepiregulin,24297,45,0.92 [0.66-1.30],0.6537028922594471
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,20859,45,0.81 [0.34-1.94],0.6424411554023057
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERMAP,Erythroid membrane-associated protein,20649,43,0.98 [0.52-1.86],0.9477880007952232
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,21142,45,1.47 [0.78-2.76],0.229116813361388
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERP29,Endoplasmic reticulum resident protein 29,20778,43,0.96 [0.75-1.23],0.7672786050809075
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERP44,Endoplasmic reticulum resident protein 44,24350,48,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,20593,42,0.61 [0.28-1.33],0.214232491831284
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ESAM,Endothelial cell-selective adhesion molecule,24798,50,1.47 [0.68-3.16],0.3276827590645166
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ESM1,Endothelial cell-specific molecule 1,24478,49,1.48 [0.71-3.12],0.2974366101601876
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ESPL1,Separin,20504,44,0.76 [0.40-1.44],0.3946760296528063
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ESR1,Estrogen receptor,20649,43,0.86 [0.50-1.47],0.5833218863738243
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ESYT2,Extended synaptotagmin-2,21200,44,0.94 [0.66-1.34],0.7390620030796746
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EVI2B,Protein EVI2B,20504,44,0.67 [0.27-1.64],0.3809400410614575
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EVI5,Ecotropic viral integration site 5 protein homolog,20649,43,0.92 [0.67-1.28],0.6401300430162062
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EVPL,Envoplakin,20859,45,0.71 [0.27-1.87],0.4874628683066933
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EXOSC10,Exosome component 10,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EXTL1,Exostosin-like 1,20593,42,0.67 [0.31-1.43],0.2951163122062854
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,24738,48,0.68 [0.23-2.01],0.4863606041104791
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F10,Coagulation factor X,21262,44,1.26 [0.51-3.12],0.6207353763463863
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F11,Coagulation factor XI,20972,42,0.99 [0.38-2.53],0.9767726248836146
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F11R,Junctional adhesion molecule A,24493,47,0.79 [0.49-1.26],0.3150501515916978
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F12,Coagulation factor XII,21281,43,1.36 [0.65-2.83],0.4133760370649081
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F13B,Coagulation factor XIII B chain,21170,42,0.75 [0.24-2.31],0.6127459017482838
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F2,Prothrombin,21281,43,1.09 [0.16-7.53],0.9268688172667344
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F2R,Proteinase-activated receptor 1,24564,50,0.82 [0.53-1.26],0.3672771195312022
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,24567,49,2.59 [1.06-6.34],0.0377363306398602
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F7,Coagulation factor VII,24521,49,1.18 [0.50-2.78],0.7002548269599932
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F9,Coagulation factor IX,24532,49,0.31 [0.09-1.12],0.0728985748564338
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",24478,49,1.14 [0.88-1.49],0.3242113787720307
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FABP2,"Fatty acid-binding protein, intestinal",24515,49,1.29 [0.95-1.76],0.105241810218475
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FABP3,"Fatty acid-binding protein, heart",21256,43,1.23 [0.67-2.25],0.5120616800790422
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",24798,50,0.95 [0.59-1.52],0.8158467588545948
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FABP5,Fatty acid-binding protein 5,24671,48,1.04 [0.72-1.50],0.8281090306510047
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FABP6,Gastrotropin,24042,50,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FABP9,Fatty acid-binding protein 9,24494,49,0.73 [0.45-1.16],0.1762653662990164
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FADD,FAS-associated death domain protein,24515,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAM13A,Protein FAM13A,21165,44,0.75 [0.48-1.17],0.2092204202288224
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAM171A2,Protein FAM171A2,21225,45,1.13 [0.97-1.32],0.1289754351665958
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAM171B,Protein FAM171B,21142,45,0.81 [0.27-2.45],0.7133978955156466
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAM172A,Cotranscriptional regulator FAM172A,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAM20A,Pseudokinase FAM20A,21256,43,1.00 [0.35-2.85],0.9925558536136766
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAM3B,Protein FAM3B,24384,48,1.14 [0.54-2.40],0.7374318813759191
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,24487,49,1.79 [0.76-4.21],0.1849019223927782
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAM3D,Protein FAM3D,21165,44,1.11 [0.79-1.55],0.5603046010222534
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAP,Prolyl endopeptidase FAP,24798,50,1.53 [0.61-3.85],0.3637690891458176
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FARSA,Phenylalanine--tRNA ligase alpha subunit,20673,44,0.57 [0.34-0.97],0.0366400904035661
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,24708,50,1.39 [0.81-2.40],0.2354488389438679
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FASLG,Tumor necrosis factor ligand superfamily member 6,24803,49,2.13 [1.10-4.15],0.0257988907063827
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,21249,44,2.63 [1.05-6.57],0.0390048503526499
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FBN2,Fibrillin-2,20673,44,0.86 [0.53-1.39],0.5326098674631095
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FBP1,"Fructose-1,6-bisphosphatase 1",24515,49,1.24 [0.90-1.72],0.1859335569972253
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,21256,43,1.22 [0.81-1.82],0.3386811167026898
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCAR,Immunoglobulin alpha Fc receptor,24494,49,1.25 [0.73-2.13],0.4155338972223056
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,21225,45,1.46 [0.48-4.44],0.5005135492975141
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,24493,47,1.70 [1.04-2.78],0.0332801085307053
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,24366,48,1.06 [0.69-1.65],0.7827746203396475
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,23919,48,0.88 [0.56-1.39],0.5867642525814903
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,24481,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCN1,Ficolin-1,21228,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,24362,48,0.81 [0.45-1.45],0.4712383515597527
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,24515,49,2.05 [1.19-3.52],0.009360962039172
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,24695,48,1.56 [0.94-2.59],0.0855962840870644
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,24058,48,0.97 [0.60-1.58],0.9090451438352516
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,24493,47,1.15 [0.73-1.80],0.5551601914485034
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCRL6,Fc receptor-like protein 6,24494,49,0.72 [0.50-1.04],0.0790326721637508
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,23919,48,0.72 [0.43-1.18],0.1897730390994725
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FDX1,"Adrenodoxin, mitochondrial",20593,42,0.80 [0.47-1.36],0.403704867219558
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FDX2,"Ferredoxin-2, mitochondrial",20593,42,0.49 [0.25-0.93],0.0297348847755191
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,23919,48,0.97 [0.64-1.45],0.8635141285076487
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FES,Tyrosine-protein kinase Fes/Fps,23919,48,1.03 [0.61-1.75],0.903088745070748
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,24532,49,0.86 [0.43-1.73],0.679246496063033
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGA,Fibrinogen alpha chain,20783,40,1.03 [0.38-2.73],0.9596749922630414
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",21225,45,1.00 [0.70-1.42],0.9991155781595684
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF12,Fibroblast growth factor 12,20649,43,1.37 [0.96-1.96],0.0856946677523184
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF16,Fibroblast growth factor 16,20649,43,1.06 [0.59-1.92],0.8371764890771932
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF19,Fibroblast growth factor 19,24599,50,0.89 [0.64-1.23],0.4723487922330469
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,24494,49,0.78 [0.52-1.15],0.2087043755983267
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF20,Fibroblast growth factor 20,20649,43,1.11 [0.61-2.03],0.7247658546501485
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF21,Fibroblast growth factor 21,24691,49,0.99 [0.80-1.23],0.9401375391306164
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF23,Fibroblast growth factor 23,24685,49,1.02 [0.66-1.58],0.9116100269102004
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF3,Fibroblast growth factor 3,20649,43,1.69 [1.54-1.87],1.914729820552782e-26
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF5,Fibroblast growth factor 5,24058,48,1.72 [0.92-3.20],0.0903913319512226
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF6,Fibroblast growth factor 6,20649,43,0.67 [0.27-1.65],0.3817806285769384
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF7,Fibroblast growth factor 7,20504,44,1.00 [0.70-1.43],0.9964493912122668
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF9,Fibroblast growth factor 9,20461,44,1.36 [0.65-2.84],0.4074007816059809
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,24552,49,1.01 [0.46-2.24],0.9762591153034736
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,21249,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGFBP3,Fibroblast growth factor-binding protein 3,21200,44,1.53 [0.71-3.31],0.2810524825025239
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,24552,49,1.82 [0.61-5.44],0.2868680534826883
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGFR4,Fibroblast growth factor receptor 4,20778,43,0.98 [0.56-1.71],0.948988310439624
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGL1,Fibrinogen-like protein 1,21262,44,1.06 [0.69-1.65],0.7813678954731662
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGR,Tyrosine-protein kinase Fgr,23928,49,0.93 [0.59-1.47],0.7452158834654985
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FH,"Fumarate hydratase, mitochondrial",20603,44,0.93 [0.64-1.36],0.7206986441002645
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FHIP2A,FHF complex subunit HOOK interacting protein 2A,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FHIT,Bis(5'-adenosyl)-triphosphatase,23928,49,0.89 [0.63-1.26],0.5249718688974894
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FIS1,Mitochondrial fission 1 protein,24460,50,0.86 [0.62-1.19],0.3663625136075235
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,21225,45,0.95 [0.71-1.26],0.712971066997719
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,24605,48,0.89 [0.70-1.12],0.3116261580541219
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,24344,45,0.92 [0.51-1.66],0.7765109777974838
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,24344,45,1.03 [0.78-1.35],0.8594286614323182
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,23881,49,0.73 [0.39-1.37],0.3305941467533628
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FKBPL,FK506-binding protein-like,21165,44,0.96 [0.59-1.56],0.8745800264010554
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FLI1,Friend leukemia integration 1 transcription factor,23919,48,1.00 [0.79-1.26],0.985748848624285
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,24344,45,1.32 [0.52-3.34],0.5633894855474438
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FLT1,Vascular endothelial growth factor receptor 1,24343,48,1.96 [0.91-4.21],0.0835137443695341
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FLT3,Receptor-type tyrosine-protein kinase FLT3,23919,48,1.43 [0.73-2.79],0.2947926660346274
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,24803,49,0.86 [0.40-1.82],0.6870088490881293
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FLT4,Vascular endothelial growth factor receptor 3,24552,49,0.97 [0.46-2.02],0.9330663357380744
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FMNL1,Formin-like protein 1,23928,49,1.13 [0.81-1.59],0.4676946070053892
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FMR1,Synaptic functional regulator FMR1,23919,48,0.86 [0.41-1.79],0.6860740614324499
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FN1,Fibronectin,21281,43,0.71 [0.24-2.12],0.5421276851596228
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FNDC1,Fibronectin type III domain-containing protein 1,21200,44,1.15 [0.62-2.16],0.6570548299230273
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,21142,45,1.61 [0.90-2.88],0.1074530702817678
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FOLH1,Glutamate carboxypeptidase 2,20649,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,24433,49,2.11 [0.91-4.90],0.0818336731671414
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,24738,48,3.01 [1.35-6.68],0.0069287299455397
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FOLR3,Folate receptor gamma,24475,49,1.00 [0.87-1.14],0.9632292062928756
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FOS,Proto-oncogene c-Fos,20461,44,0.79 [0.35-1.78],0.5689414657037289
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FOSB,Protein fosB,23928,49,0.74 [0.35-1.57],0.4263312261199746
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,20649,43,0.88 [0.45-1.72],0.7030186106598466
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,24494,49,0.84 [0.62-1.13],0.2496816110203623
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FOXO3,Forkhead box protein O3,23919,48,0.95 [0.73-1.24],0.7296582897746406
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FRMD4B,FERM domain-containing protein 4B,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FRMD7,FERM domain-containing protein 7,20673,44,0.90 [0.37-2.19],0.8223164172953757
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FRZB,Secreted frizzled-related protein 3,24268,45,0.92 [0.34-2.50],0.8743539185070784
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FST,Follistatin,24564,50,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,20670,44,1.97 [0.58-6.65],0.2772559016885546
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,24444,50,1.72 [0.76-3.89],0.1918935710580053
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FTCD,Formimidoyltransferase-cyclodeaminase,21164,44,0.90 [0.63-1.27],0.537406164202828
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FUCA1,Tissue alpha-L-fucosidase,24629,50,0.82 [0.63-1.08],0.1563456187789226
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FUOM,Fucose mutarotase,20778,43,1.21 [0.77-1.89],0.41162018253735
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FURIN,Furin,24552,49,1.37 [0.65-2.90],0.4034543058258901
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,23881,48,0.64 [0.32-1.28],0.2038838947799889
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",20824,45,1.06 [0.68-1.63],0.8076090730201256
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,24738,48,1.43 [0.80-2.55],0.2216566305617145
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FUT8,"Alpha-(1,6)-fucosyltransferase",24344,45,0.86 [0.54-1.38],0.5401003788820429
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FXN,"Frataxin, mitochondrial",24723,49,0.94 [0.66-1.32],0.7067516631153393
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FXYD5,FXYD domain-containing ion transport regulator 5,24058,48,0.82 [0.54-1.24],0.3445858806316598
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FYB1,FYN-binding protein 1,24455,47,0.85 [0.64-1.13],0.2586110383246008
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FZD10,Frizzled-10,20673,44,0.84 [0.48-1.48],0.5485770823096341
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FZD8,Frizzled-8,20603,44,1.18 [0.65-2.15],0.578629916408911
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GABARAP,Gamma-aminobutyric acid receptor-associated protein,21142,45,1.07 [0.61-1.89],0.813131400471324
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,20859,45,0.98 [0.64-1.49],0.9119720689279344
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,20603,44,0.52 [0.27-0.99],0.0458495231459532
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GAD1,Glutamate decarboxylase 1,20504,44,1.15 [0.38-3.47],0.7996627075030787
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GAD2,Glutamate decarboxylase 2,20649,43,1.26 [0.79-2.02],0.3301330996467961
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,20859,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GAGE2A,G antigen 2A,20504,44,0.89 [0.53-1.48],0.6459797672926444
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,24599,50,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,24384,48,1.91 [0.81-4.49],0.1368171698948003
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,24723,49,1.71 [0.65-4.46],0.27487175334045
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,24058,48,1.14 [0.62-2.10],0.667223405836783
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,21256,43,0.89 [0.30-2.65],0.8397111839797095
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,24384,48,2.36 [0.75-7.43],0.1413599701060781
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GAMT,Guanidinoacetate N-methyltransferase,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,20334,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GART,Trifunctional purine biosynthetic protein adenosine-3,21225,45,1.01 [0.35-2.96],0.9848848518496348
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GAS2,Growth arrest-specific protein 2,20859,45,0.98 [0.57-1.68],0.950141104576166
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,24620,49,0.89 [0.34-2.35],0.8140330648086341
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GAST,Gastrin,21200,44,0.91 [0.69-1.20],0.5151095240362871
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,20504,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GBA,Lysosomal acid glucosylceramidase,20673,44,1.24 [0.76-2.03],0.3834458201934053
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,21161,44,1.26 [0.82-1.93],0.2899666296722417
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,24058,48,1.28 [0.87-1.89],0.2136854750193239
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GBP4,Guanylate-binding protein 4,23928,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GBP6,Guanylate-binding protein 6,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GC,Vitamin D-binding protein,21281,43,1.02 [0.34-3.06],0.9678189657126688
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GCC1,GRIP and coiled-coil domain-containing protein 1,21200,44,0.90 [0.69-1.18],0.4478329857604501
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GCG,Pro-glucagon,23919,48,0.98 [0.79-1.21],0.8379348782700228
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,20268,43,1.06 [0.60-1.87],0.8492761540517082
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GCLM,Glutamate--cysteine ligase regulatory subunit,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",24384,48,1.64 [0.80-3.37],0.1780605955970149
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,24798,50,1.01 [0.53-1.92],0.980252113828914
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,24515,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GDNF,Glial cell line-derived neurotrophic factor,23928,49,0.68 [0.34-1.36],0.2787334739697352
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GET3,ATPase GET3,21256,43,0.74 [0.40-1.36],0.3265801856022053
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GFAP,Glial fibrillary acidic protein,23885,48,1.63 [0.97-2.74],0.0675157413700532
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GFER,FAD-linked sulfhydryl oxidase ALR,23919,48,0.98 [0.66-1.45],0.9133282676406672
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,23919,48,0.91 [0.72-1.15],0.4385877640230534
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,24691,49,1.19 [0.46-3.05],0.7209266191520586
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GFRA2,GDNF family receptor alpha-2,24384,48,3.36 [1.29-8.74],0.013174972880137
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GFRA3,GDNF family receptor alpha-3,24263,45,1.47 [0.58-3.67],0.4153731700679453
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GFRAL,GDNF family receptor alpha-like,20591,41,0.99 [0.61-1.61],0.9668321934647224
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GGA1,ADP-ribosylation factor-binding protein GGA1,23928,49,0.95 [0.66-1.37],0.798368567271081
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GGACT,Gamma-glutamylaminecyclotransferase,21256,43,0.93 [0.62-1.41],0.7443948850157778
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GGCT,Gamma-glutamylcyclotransferase,21219,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,24043,48,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GGT1,Glutathione hydrolase 1 proenzyme,24448,46,0.91 [0.54-1.53],0.733764289908087
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,24344,45,2.22 [0.82-6.06],0.1184920849759566
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GH1,Somatotropin,24487,49,1.06 [0.94-1.21],0.3335404791073167
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GH2,Growth hormone variant,23919,48,1.06 [0.92-1.22],0.4092468676889518
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GHR,Growth hormone receptor,20778,43,0.58 [0.21-1.61],0.2984897856961852
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GHRHR,Growth hormone-releasing hormone receptor,23928,49,0.89 [0.54-1.46],0.6322480013240426
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GHRL,Appetite-regulating hormone,24515,49,1.17 [0.85-1.61],0.3420615347535863
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GID8,Glucose-induced degradation protein 8 homolog,21225,45,0.57 [0.19-1.71],0.3152148599671101
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GIGYF2,GRB10-interacting GYF protein 2,21225,45,0.88 [0.60-1.27],0.4860973964758867
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GIMAP7,GTPase IMAP family member 7,20778,43,1.37 [0.64-2.91],0.4186374005869339
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GIMAP8,GTPase IMAP family member 8,20504,44,1.23 [0.75-2.02],0.4139553623079387
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GIP,Gastric inhibitory polypeptide,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,21200,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GIPC3,PDZ domain-containing protein GIPC3,21165,44,0.89 [0.67-1.18],0.4218516437969294
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GIPR,Gastric inhibitory polypeptide receptor,20649,43,0.78 [0.37-1.64],0.5051519324742881
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GIT1,ARF GTPase-activating protein GIT1,20649,43,0.92 [0.67-1.25],0.5771691575408763
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GJA8,Gap junction alpha-8 protein,20504,44,1.52 [1.33-1.72],2.575365769232849e-10
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GKN1,Gastrokine-1,23464,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLA,Alpha-galactosidase A,20732,43,1.20 [0.56-2.54],0.6415753096588819
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLB1,Beta-galactosidase,24344,45,0.86 [0.46-1.59],0.6314613950630544
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLI2,Zinc finger protein GLI2,20649,43,0.82 [0.34-2.01],0.6669910769027994
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLO1,Lactoylglutathione lyase,24075,50,0.85 [0.55-1.32],0.4765963629238776
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLOD4,Glyoxalase domain-containing protein 4,24425,50,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLP1R,Glucagon-like peptide 1 receptor,20603,44,1.04 [0.50-2.18],0.913673917891906
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLRX,Glutaredoxin-1,24362,48,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",20778,43,0.94 [0.67-1.31],0.6999344897211996
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,23928,49,0.99 [0.59-1.68],0.9846074143770724
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,21142,45,1.20 [0.81-1.77],0.3605945300377963
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,20747,44,1.86 [1.31-2.65],0.000533151390312
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GMFG,Glia maturation factor gamma,21256,43,1.02 [0.68-1.52],0.9243892630565048
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GMPR,GMP reductase 1,24803,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GMPR2,GMP reductase 2,20778,43,0.93 [0.60-1.45],0.7587035742120479
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GNAS,Neuroendocrine secretory protein 55,21225,45,0.80 [0.55-1.15],0.2271196025084423
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,23919,48,0.70 [0.46-1.06],0.0906913323368526
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,20673,44,1.03 [0.60-1.75],0.9187754193146448
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GNLY,Granulysin,24493,47,1.06 [0.64-1.76],0.8263944503511277
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GNPDA1,Glucosamine-6-phosphate isomerase 1,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GNPDA2,Glucosamine-6-phosphate isomerase 2,20778,43,0.79 [0.35-1.79],0.5771487824703532
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GOLGA3,Golgin subfamily A member 3,21225,45,0.76 [0.51-1.12],0.1645303655126881
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,24738,48,0.92 [0.29-2.89],0.8819237787917699
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,24494,49,0.92 [0.72-1.17],0.4869577718772501
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GORASP2,Golgi reassembly-stacking protein 2,21165,44,0.69 [0.37-1.30],0.2495966970351474
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",21249,44,0.79 [0.39-1.59],0.5003451945784515
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GP1BA,Platelet glycoprotein Ib alpha chain,24370,48,0.96 [0.43-2.12],0.9149658091779582
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GP1BB,Platelet glycoprotein Ib beta chain,20593,42,0.79 [0.50-1.23],0.2907612398426727
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,23761,50,0.90 [0.66-1.23],0.5126579300200804
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GP5,Platelet glycoprotein V,20778,43,1.13 [0.49-2.60],0.776584952130892
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GP6,Platelet glycoprotein VI,24455,47,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPA33,Cell surface A33 antigen,24384,48,1.12 [0.93-1.35],0.2417615632557409
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPC1,Glypican-1,24723,49,1.06 [0.45-2.47],0.8940471251722389
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPC5,Glypican-5,24344,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPD1,Glycerol-3-phosphate dehydrogenase,21142,45,0.50 [0.27-0.92],0.0257860160436208
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPHA2,Glycoprotein hormone alpha-2,21165,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPI,Glucose-6-phosphate isomerase,21262,44,1.03 [0.57-1.88],0.9192737589668756
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,21165,44,1.12 [0.73-1.72],0.6091221922800949
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,23928,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPNMB,Transmembrane glycoprotein NMB,23858,48,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPR101,Probable G-protein coupled receptor 101,20603,44,1.11 [0.74-1.65],0.621477972557672
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPR158,Probable G-protein coupled receptor 158,21225,45,1.11 [0.53-2.32],0.7722480943926431
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPR15L,Protein GPR15L,21165,44,0.77 [0.50-1.20],0.2560819133825553
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPR37,Prosaposin receptor GPR37,24075,50,1.01 [0.66-1.54],0.958771485504282
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPRC5C,G-protein coupled receptor family C group 5 member C,21142,45,0.59 [0.31-1.12],0.1093731854600163
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GRAP2,GRB2-related adapter protein 2,24515,49,0.99 [0.81-1.20],0.9174254575479366
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,21256,43,0.90 [0.57-1.42],0.6439578763086723
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GRIK2,"Glutamate receptor ionotropic, kainate 2",21225,45,0.77 [0.35-1.70],0.5134545491241342
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",20603,44,0.77 [0.40-1.46],0.4185962875913054
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GRK5,G protein-coupled receptor kinase 5,24075,50,0.82 [0.48-1.41],0.4803255586686503
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,24373,46,2.29 [0.85-6.15],0.0994332841373114
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GRP,Gastrin-releasing peptide,20670,44,0.95 [0.54-1.67],0.8625337242823052
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",24384,48,0.77 [0.49-1.20],0.2477011325340287
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GRSF1,G-rich sequence factor 1,20387,44,0.92 [0.64-1.32],0.6468559530533251
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GSAP,Gamma-secretase-activating protein,23919,48,0.83 [0.57-1.20],0.3295206665292249
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GSN,Gelsolin,21176,44,1.26 [0.27-5.99],0.7673264284064878
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GSR,"Glutathione reductase, mitochondrial",21141,44,2.23 [0.63-7.96],0.2151292424583284
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GSTA1,Glutathione S-transferase A1,24480,49,0.92 [0.68-1.24],0.5691079265214403
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GSTA3,Glutathione S-transferase A3,23919,48,1.03 [0.74-1.43],0.8664732507363336
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GSTM4,Glutathione S-transferase Mu 4,20593,42,0.85 [0.53-1.37],0.5091728952602086
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GSTP1,Glutathione S-transferase P,23775,49,0.58 [0.38-0.87],0.0091767932286339
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GSTT2B,Glutathione S-transferase theta-2B,21200,44,1.01 [0.90-1.14],0.8324306864100505
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,20859,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GTPBP2,GTP-binding protein 2,20673,44,0.82 [0.56-1.18],0.2774992196852953
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GUCA2A,Guanylin,24374,47,1.64 [0.73-3.67],0.230508642117672
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GUCY2C,Heat-stable enterotoxin receptor,20859,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GUK1,Guanylate kinase,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,24587,50,1.04 [0.69-1.54],0.862138579916532
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GYS1,"Glycogen [starch] synthase, muscle",24075,50,0.93 [0.71-1.22],0.5949898549019808
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,24803,49,1.41 [0.71-2.79],0.3297742481252745
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GZMB,Granzyme B,24494,49,0.87 [0.59-1.31],0.5120812707088103
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,24075,50,1.18 [0.90-1.55],0.2293261751748746
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",H2AP,Huntingtin-interacting protein M,20504,44,0.95 [0.51-1.76],0.8607736886655251
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",20593,42,0.73 [0.40-1.36],0.3272705066882888
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",24660,49,0.89 [0.63-1.25],0.4996374606706104
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HAO1,Hydroxyacid oxidase 1,24723,49,0.98 [0.81-1.19],0.8420739291285172
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HARS1,"Histidine--tRNA ligase, cytoplasmic",24493,47,0.94 [0.68-1.31],0.718795213741118
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,24692,49,0.97 [0.63-1.49],0.8831544069170645
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,24493,47,1.89 [0.93-3.83],0.0789585569973762
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HBEGF,Proheparin-binding EGF-like growth factor,24660,49,1.14 [0.81-1.61],0.4494594641389765
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HBQ1,Hemoglobin subunit theta-1,24723,49,1.15 [0.79-1.68],0.4711465105271769
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HBZ,Hemoglobin subunit zeta,21256,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HCG22,Protein PBMUCL2,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HCLS1,Hematopoietic lineage cell-specific protein,24803,49,0.90 [0.58-1.41],0.6421015624178874
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HDAC8,Histone deacetylase 8,20649,43,1.00 [0.64-1.55],0.9847151604829362
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HDAC9,Histone deacetylase 9,20603,44,0.79 [0.46-1.37],0.4050595127102766
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HDDC2,5'-deoxynucleotidase HDDC2,21165,44,0.72 [0.36-1.41],0.3332904898439444
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HDGF,Hepatoma-derived growth factor,24693,49,1.00 [0.76-1.30],0.9857119022733524
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,21200,44,0.97 [0.62-1.52],0.9015067013422956
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HEBP1,Heme-binding protein 1,24075,50,0.91 [0.56-1.46],0.6856716844147468
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,20778,43,0.91 [0.31-2.72],0.8726236281148186
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HEPACAM2,HEPACAM family member 2,21200,44,1.65 [0.84-3.25],0.1498671652119558
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HEPH,Hephaestin,21256,43,1.00 [0.33-3.00],0.9979636244689444
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HEXIM1,Protein HEXIM1,24494,49,0.77 [0.56-1.06],0.1103401608789302
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,24803,49,1.06 [0.51-2.21],0.8777957561071719
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,21065,44,1.63 [0.56-4.70],0.3687131762942934
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,23919,48,0.87 [0.62-1.23],0.4403650241522225
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HHEX,Hematopoietically-expressed homeobox protein HHEX,21200,44,,
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HIF1A,Hypoxia-inducible factor 1-alpha,20649,43,1.29 [0.97-1.73],0.0830248458121833
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HIP1,Huntingtin-interacting protein 1,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,21166,44,1.25 [0.73-2.16],0.4142010252136403
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HJV,Hemojuvelin,21225,45,1.06 [0.57-1.97],0.8528451787308071
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HK2,Hexokinase-2,24075,50,1.15 [0.48-2.77],0.7543543301234134
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",21225,45,0.91 [0.38-2.16],0.8258725934101222
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",24411,49,1.45 [0.74-2.82],0.2775740131348452
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",24494,49,1.18 [0.47-2.93],0.7214812144853386
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HMBS,Porphobilinogen deaminase,24723,49,1.25 [0.71-2.20],0.4361293806600462
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HMCN2,Hemicentin-2,20736,43,1.00 [0.60-1.67],0.9916822465162894
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HMMR,Hyaluronan mediated motility receptor,20468,44,0.80 [0.40-1.59],0.5246779633150007
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,24239,48,1.41 [0.84-2.37],0.193477109390503
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,23928,49,0.73 [0.40-1.33],0.2997684648306632
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HNF1A,Hepatocyte nuclear factor 1-alpha,20673,44,0.94 [0.61-1.45],0.7792987914778793
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,24222,45,1.43 [0.81-2.52],0.2138896289800315
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,23989,50,0.95 [0.68-1.31],0.7396882464333582
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,21225,45,0.89 [0.49-1.62],0.7107195976575974
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HPCAL1,Hippocalcin-like protein 1,24803,49,0.98 [0.70-1.37],0.8887060005690487
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,23919,48,1.23 [0.63-2.39],0.5520570398975508
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HPSE,Heparanase,20970,44,1.17 [0.86-1.60],0.3180568007902328
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HRAS,GTPase Hras,20830,45,1.01 [0.76-1.34],0.969199255907841
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HRG,Histidine-rich glycoprotein,21170,42,0.97 [0.38-2.47],0.9482827383446324
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HS1BP3,HCLS1-binding protein 3,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,24384,48,1.43 [0.74-2.76],0.2926269174866315
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,24723,49,1.43 [0.74-2.78],0.290469257895031
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,20649,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSBP1,Heat shock factor-binding protein 1,20670,44,0.77 [0.56-1.04],0.0909452329880115
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,24494,49,0.72 [0.38-1.37],0.3201288347530322
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,21200,44,0.98 [0.62-1.56],0.9366191221519056
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSD17B3,Testosterone 17-beta-dehydrogenase 3,20593,42,1.32 [0.78-2.22],0.2963072993873766
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,20670,44,0.59 [0.31-1.14],0.115362300625352
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSP90B1,Endoplasmin,23824,49,0.93 [0.62-1.39],0.7183667074388553
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSPA1A,Heat shock 70 kDa protein 1A,24548,50,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSPA2,Heat shock-related 70 kDa protein 2,21142,45,0.72 [0.29-1.78],0.4775146494532462
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSPB1,Heat shock protein beta-1,24097,48,0.89 [0.62-1.27],0.5175429132443465
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSPB6,Heat shock protein beta-6,24723,49,1.07 [0.57-2.02],0.8241093284556095
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,24285,48,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HTR1A,5-hydroxytryptamine receptor 1A,20603,44,0.92 [0.60-1.39],0.6816176415666542
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HTR1B,5-hydroxytryptamine receptor 1B,20603,44,0.64 [0.29-1.40],0.2629626816734187
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HTRA2,"Serine protease HTRA2, mitochondrial",24552,49,0.97 [0.64-1.46],0.8745582708896944
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HYAL1,Hyaluronidase-1,24323,48,1.62 [0.55-4.75],0.378522647674104
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,24798,50,1.53 [0.48-4.88],0.4703671909437297
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ICA1,Islet cell autoantigen 1,24058,48,0.83 [0.60-1.16],0.2791934904356977
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,24370,48,1.62 [0.68-3.86],0.2751293358868076
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,24798,50,1.08 [0.49-2.39],0.8499642065796862
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,24798,50,2.28 [0.88-5.89],0.089183235176421
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ICAM4,Intercellular adhesion molecule 4,24494,49,0.91 [0.57-1.45],0.6936578465748388
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ICAM5,Intercellular adhesion molecule 5,24515,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,24384,48,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ID4,DNA-binding protein inhibitor ID-4,20859,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IDI2,Isopentenyl-diphosphate delta-isomerase 2,23928,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IDO1,"Indoleamine 2,3-dioxygenase 1",20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IDS,Iduronate 2-sulfatase,24803,49,1.23 [0.07-21.30],0.8890386457046189
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IDUA,Alpha-L-iduronidase,24723,49,0.89 [0.52-1.53],0.67454612504148
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,20684,41,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,20859,45,0.93 [0.53-1.65],0.812500674196684
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,20859,45,0.89 [0.89-0.89],0.0
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFNAR1,Interferon alpha/beta receptor 1,21165,44,0.68 [0.21-2.23],0.525497735765035
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFNG,Interferon gamma,24058,48,1.19 [0.96-1.48],0.1085183089578911
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,24599,50,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFNGR2,Interferon gamma receptor 2,24344,45,1.15 [0.70-1.90],0.5834607739792637
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,23928,49,1.26 [0.72-2.19],0.4147249547902937
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFNL2,Interferon lambda-2,20603,44,0.99 [0.62-1.57],0.9670303040390196
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,24494,49,0.87 [0.43-1.77],0.7022084608886118
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFNW1,Interferon omega-1,20593,42,0.44 [0.14-1.37],0.1568979070931116
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFT20,Intraflagellar transport protein 20 homolog,20673,44,0.59 [0.28-1.23],0.1583868758913106
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGBP1,Immunoglobulin-binding protein 1,21225,45,0.81 [0.51-1.31],0.395882462300385
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,20603,44,1.27 [0.80-2.01],0.3199211012564907
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,21249,44,0.71 [0.23-2.15],0.5409997196976802
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGF1R,Insulin-like growth factor 1 receptor,24384,48,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGF2R,Cation-independent mannose-6-phosphate receptor,24493,47,0.73 [0.24-2.20],0.5812629163016148
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGFBP1,Insulin-like growth factor-binding protein 1,24756,50,1.15 [0.94-1.41],0.165727891802226
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,24750,49,1.29 [0.85-1.94],0.2309426528989184
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,24561,49,0.72 [0.30-1.71],0.4551635315929069
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,24173,47,1.58 [0.86-2.90],0.1429070496248646
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGFBP6,Insulin-like growth factor-binding protein 6,24371,48,2.14 [1.04-4.38],0.0380589558652044
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,24798,50,1.62 [0.80-3.25],0.1784836894612699
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,24515,49,1.98 [0.99-3.98],0.0549945837041536
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGFL4,Insulin growth factor-like family member 4,20649,43,1.11 [0.80-1.54],0.5354097917193557
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGHMBP2,DNA-binding protein SMUBP-2,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGLC2,Immunoglobulin lambda constant 2,21249,42,0.24 [0.04-1.46],0.122146031556049
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGLON5,IgLON family member 5,20504,44,0.84 [0.56-1.25],0.3859035315255975
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGSF21,Immunoglobulin superfamily member 21,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,24384,48,1.33 [0.66-2.66],0.4233735551021883
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGSF8,Immunoglobulin superfamily member 8,24515,49,1.31 [0.58-2.98],0.515216387688072
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,21256,43,0.96 [0.67-1.38],0.8321365018907094
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IKBKG,NF-kappa-B essential modulator,24494,49,0.84 [0.64-1.11],0.2194283707104949
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IKZF2,Zinc finger protein Helios,23919,48,0.96 [0.73-1.27],0.7985740833397487
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,24058,48,1.08 [0.80-1.45],0.629142069479407
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL10RA,Interleukin-10 receptor subunit alpha,24058,48,0.88 [0.54-1.44],0.606465791026094
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,24599,50,1.71 [0.79-3.71],0.1771130111594078
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL11,Interleukin-11,24058,48,0.77 [0.48-1.24],0.2853175772472321
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,24384,48,1.22 [0.88-1.70],0.2354913663166922
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,24803,49,1.58 [1.00-2.52],0.0522912455465101
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,24058,48,1.63 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL12RB2,Interleukin-12 receptor subunit beta-2,20649,43,1.27 [0.69-2.34],0.4417066715593091
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL13,Interleukin-13,24058,48,0.60 [0.28-1.26],0.1774274654120188
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,24162,48,1.22 [0.38-3.91],0.7375123807322626
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL13RA2,Interleukin-13 receptor subunit alpha-2,20603,44,1.09 [0.40-2.97],0.8604190134715899
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL15,Interleukin-15,24494,49,0.77 [0.34-1.70],0.5121863552382582
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,24058,48,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,24803,49,1.11 [0.63-1.95],0.7263739954746645
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL17A,Interleukin-17A,24015,48,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL17C,Interleukin-17C,24058,48,1.41 [1.04-1.91],0.0276165602373479
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL17D,Interleukin-17D,24058,48,1.15 [0.56-2.34],0.7079954808965099
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL17F,Interleukin-17F,24058,48,1.18 [0.90-1.55],0.2244281078144779
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL17RA,Interleukin-17 receptor A,24493,47,1.02 [0.56-1.83],0.9601997534274492
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,24178,49,1.15 [0.72-1.84],0.5626973125449108
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,24387,49,0.97 [0.56-1.67],0.91150224679214
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,24561,49,2.27 [1.06-4.86],0.0357707816893657
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,24803,49,1.11 [0.52-2.40],0.7847776417946818
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL18RAP,Interleukin-18 receptor accessory protein,24188,44,0.84 [0.70-1.00],0.0534290333476834
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL19,Interleukin-19,23909,49,0.83 [0.56-1.24],0.3664610847768714
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL1A,Interleukin-1 alpha,24058,48,1.09 [0.71-1.66],0.6923124610468898
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL1B,Interleukin-1 beta,23940,47,0.92 [0.57-1.49],0.7248786543307291
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,24448,46,1.42 [0.44-4.58],0.5581815937319878
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL1R2,Interleukin-1 receptor type 2,24438,49,0.60 [0.17-2.17],0.4402658312520544
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,24493,47,1.14 [0.65-2.01],0.6457893266459305
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,24708,50,0.81 [0.50-1.31],0.3988484222139482
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL1RL2,Interleukin-1 receptor-like 2,24058,48,1.42 [0.74-2.72],0.2878688223501399
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,24423,50,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL2,Interleukin-2,24058,48,0.73 [0.33-1.65],0.45361331621515
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL20,Interleukin-20,24058,48,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL20RA,Interleukin-20 receptor subunit alpha,24058,48,0.94 [0.52-1.70],0.8383537817796276
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL20RB,Interleukin-20 receptor subunit beta,20649,43,0.81 [0.40-1.64],0.5528502395858719
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL21R,Interleukin-21 receptor,20649,43,1.47 [1.05-2.05],0.0236004310877205
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,21142,45,1.06 [0.70-1.60],0.786326592262903
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL22RA1,Interleukin-22 receptor subunit alpha-1,24058,48,0.74 [0.38-1.45],0.3793848249719326
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL24,Interleukin-24,24058,48,1.25 [0.79-1.96],0.3393017477452857
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL25,Interleukin-25,20428,44,1.13 [0.48-2.65],0.780248486232687
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,24336,49,1.97 [1.13-3.43],0.0168550626548492
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL2RB,Interleukin-2 receptor subunit beta,24058,48,1.18 [0.65-2.15],0.5820033220520342
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,21142,45,1.23 [0.65-2.32],0.5247231088691051
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL3,Interleukin-3,20504,44,0.86 [0.56-1.32],0.4877165252674499
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL31,Interleukin-31,20649,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL31RA,Interleukin-31 receptor subunit alpha,20579,43,1.14 [0.55-2.34],0.7272017176293839
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,24494,49,1.01 [0.55-1.87],0.9648910648200348
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL33,Interleukin-33,24058,48,1.10 [0.57-2.09],0.78194260001906
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL34,Interleukin-34,23891,49,0.77 [0.39-1.54],0.4657808805552175
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL36A,Interleukin-36 alpha,20649,43,0.90 [0.52-1.56],0.6966395832599166
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL36G,Interleukin-36 gamma,20583,42,1.00 [0.65-1.53],0.9991706349352252
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL3RA,Interleukin-3 receptor subunit alpha,24058,48,1.44 [0.68-3.06],0.3406882766881968
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL4,Interleukin-4,24058,48,1.00 [0.75-1.34],0.978160409267551
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,24494,49,0.84 [0.40-1.76],0.6506907038440385
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL5,Interleukin-5,24058,48,0.98 [0.82-1.18],0.8527404104308052
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,24494,49,0.75 [0.47-1.22],0.2477028830795313
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,24384,48,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,24323,48,1.36 [0.65-2.87],0.4156937796394407
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL6ST,Interleukin-6 receptor subunit beta,24515,49,1.52 [0.38-6.15],0.5537153977557516
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL7,Interleukin-7,24494,49,0.95 [0.64-1.40],0.8000870077005249
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL7R,Interleukin-7 receptor subunit alpha,24493,47,1.36 [0.82-2.24],0.2309549637872717
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL9,Interleukin-9,20859,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,23893,49,0.67 [0.42-1.07],0.090448180364683
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,21142,45,0.84 [0.42-1.66],0.6101252235295566
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IMPA1,Inositol monophosphatase 1,24344,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IMPACT,Protein IMPACT,21200,44,0.73 [0.43-1.22],0.2286710800076312
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IMPG1,Interphotoreceptor matrix proteoglycan 1,20603,44,0.66 [0.22-1.98],0.4577789846093453
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,23881,49,0.96 [0.54-1.68],0.8743402001949442
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INHBB,Inhibin beta B chain,20778,43,1.34 [0.76-2.35],0.3163320970306457
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INHBC,Inhibin beta C chain,24493,47,1.05 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INPP1,Inositol polyphosphate 1-phosphatase,24384,48,0.81 [0.50-1.31],0.3913199903627432
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",20670,44,0.75 [0.45-1.26],0.279455354957316
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",21225,45,1.59 [1.04-2.43],0.0338699955667425
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",24384,48,0.89 [0.68-1.15],0.3728273987081782
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,21200,44,1.01 [0.83-1.22],0.9353048151679286
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INSL4,Early placenta insulin-like peptide,21142,45,1.21 [0.78-1.87],0.3958275185016393
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INSL5,Insulin-like peptide INSL5,21165,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INSR,Insulin receptor,20649,43,2.94 [0.52-16.43],0.2204301340507934
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IPCEF1,Interactor protein for cytohesin exchange factors 1,24303,45,0.86 [0.63-1.17],0.323347394337668
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IQGAP2,Ras GTPase-activating-like protein IQGAP2,24384,48,0.76 [0.47-1.23],0.2654562660368125
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",24075,50,1.14 [0.88-1.47],0.3293297761645545
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IRAK1,Interleukin-1 receptor-associated kinase 1,24058,48,0.82 [0.56-1.19],0.293031206901994
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IRAK4,Interleukin-1 receptor-associated kinase 4,24494,49,0.95 [0.75-1.21],0.6986035259133172
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,23562,49,0.80 [0.40-1.59],0.5250156693945524
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ISM1,Isthmin-1,24494,49,0.85 [0.45-1.60],0.6138212098974272
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ISM2,Isthmin-2,21249,44,1.13 [0.62-2.07],0.6853743999387928
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IST1,IST1 homolog,21014,44,0.88 [0.66-1.18],0.3862720065801419
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,24494,49,1.02 [0.49-2.14],0.9590259014958672
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGA2,Integrin alpha-2,20778,43,1.40 [0.59-3.32],0.4423662484958467
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,24493,47,1.64 [0.59-4.60],0.3443771075799532
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,24494,49,0.72 [0.43-1.20],0.2066486867947162
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,20649,43,1.27 [0.63-2.59],0.5010911122037058
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGAM,Integrin alpha-M,24493,47,1.65 [0.75-3.63],0.2130825391553605
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGAV,Integrin alpha-V,24723,49,1.38 [0.29-6.50],0.6859447012751363
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGAX,Integrin alpha-X,20859,45,0.69 [0.40-1.20],0.1888257365923845
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGB1,Integrin beta-1,24439,49,2.25 [0.88-5.76],0.0911683863316547
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGB1BP1,Integrin beta-1-binding protein 1,23919,48,0.95 [0.51-1.80],0.8808444797803355
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGB1BP2,Integrin beta-1-binding protein 2,24075,50,0.97 [0.77-1.21],0.7698764006661738
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,24346,48,2.00 [0.95-4.20],0.0682187039002244
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGB5,Integrin beta-5,24552,49,0.92 [0.46-1.81],0.8028046317667387
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGB6,Integrin beta-6,24058,48,1.22 [0.54-2.73],0.6339611743789715
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,24723,49,1.59 [0.98-2.60],0.062367528860373
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,21249,44,2.34 [1.21-4.52],0.0111321866321116
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,21281,43,1.40 [0.34-5.78],0.6443168100763705
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,24561,49,1.11 [0.59-2.08],0.7389018401788381
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,21281,43,0.36 [0.11-1.18],0.091455376157234
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,21142,45,1.04 [0.56-1.93],0.8959370764568517
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,24494,49,0.78 [0.51-1.19],0.2438657061393716
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITPA,Inosine triphosphate pyrophosphatase,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",20670,44,0.76 [0.47-1.22],0.2533310164142938
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",20603,44,0.95 [0.51-1.76],0.8592791181914079
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",23928,49,0.83 [0.48-1.43],0.4927054080425874
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IZUMO1,Izumo sperm-egg fusion protein 1,20504,44,0.67 [0.32-1.43],0.3049654019343262
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,24738,48,2.53 [0.99-6.45],0.0529042503004704
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",JAM3,Junctional adhesion molecule C,20778,43,0.69 [0.37-1.30],0.2522265096006562
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,24058,48,0.65 [0.44-0.98],0.0395222847211222
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,20504,44,0.60 [0.33-1.12],0.1094983619560946
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",JPT2,Jupiter microtubule associated homolog 2,21165,44,0.87 [0.63-1.21],0.4155286490735198
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,24058,48,0.90 [0.53-1.53],0.7050755713372262
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,24384,48,0.97 [0.56-1.69],0.9120223103252102
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KAZN,Kazrin,21165,44,0.91 [0.69-1.20],0.5045348130350877
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KCNC4,Potassium voltage-gated channel subfamily C member 4,20603,44,0.83 [0.46-1.50],0.5296379895852006
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KCNH2,Potassium voltage-gated channel subfamily H member 2,20673,44,0.98 [0.66-1.44],0.9146660695458164
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KCNIP4,Kv channel-interacting protein 4,23928,49,0.99 [0.60-1.62],0.9637773808134518
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,20785,44,1.24 [0.69-2.22],0.4771849613731508
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KDM3A,Lysine-specific demethylase 3A,20649,43,0.87 [0.61-1.24],0.4470001925472457
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,24552,49,2.07 [0.76-5.64],0.1557651430584797
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,23928,49,1.74 [0.88-3.43],0.1109649975928866
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KHDC3L,KH domain-containing protein 3,20504,44,0.88 [0.54-1.44],0.6162945778573206
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KHK,Ketohexokinase,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIAA0319,Dyslexia-associated protein KIAA0319,21200,44,1.38 [0.60-3.22],0.4500904476235225
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIAA1549,UPF0606 protein KIAA1549,20859,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIAA1549L,UPF0606 protein KIAA1549L,20859,45,0.26 [0.09-0.79],0.0174930845782304
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIAA2013,Uncharacterized protein KIAA2013,21142,45,1.11 [0.72-1.72],0.6343199178762522
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIF1C,Kinesin-like protein KIF1C,20593,42,0.47 [0.16-1.39],0.1719926802410066
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIF20B,Kinesin-like protein KIF20B,20603,44,0.94 [0.63-1.39],0.7519868342462237
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIF22,Kinesin-like protein KIF22,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIFBP,KIF-binding protein,24384,48,0.95 [0.70-1.28],0.7201680190025825
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,21142,45,0.88 [0.63-1.24],0.4747083876739874
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,23919,48,0.88 [0.62-1.25],0.4869919603152832
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,21165,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,23919,48,1.10 [0.89-1.36],0.365992680477552
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,20504,44,0.80 [0.51-1.26],0.3311764509489036
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIRREL1,Kin of IRRE-like protein 1,20603,44,1.01 [0.63-1.62],0.9759844241965578
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,23928,49,1.04 [0.55-1.96],0.9155745069160294
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIT,Mast/stem cell growth factor receptor Kit,24532,49,0.90 [0.38-2.12],0.8112069195910954
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KITLG,Kit ligand,24515,49,1.31 [0.65-2.66],0.4492574048839248
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLB,Beta-klotho,23928,49,0.99 [0.70-1.40],0.9446806938033264
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLF4,Krueppel-like factor 4,20603,44,1.53 [0.88-2.64],0.1308589239821234
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLHL41,Kelch-like protein 41,21225,45,1.00 [0.58-1.70],0.994524636660954
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK1,Kallikrein-1,24248,48,1.06 [0.87-1.29],0.5682616632570426
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK10,Kallikrein-10,24479,49,1.36 [0.74-2.51],0.3195844870340869
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK11,Kallikrein-11,24303,49,1.54 [0.70-3.36],0.2788380088524075
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK12,Kallikrein-12,23919,48,1.04 [0.86-1.26],0.6518928516988489
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK13,Kallikrein-13,23930,46,0.72 [0.39-1.32],0.2927617858717026
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK14,Kallikrein-14,24723,49,1.00 [0.58-1.72],0.991595135653932
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK15,Kallikrein-15,21109,45,1.31 [0.76-2.25],0.3344095824474088
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK3,Prostate-specific antigen,21249,44,0.94 [0.75-1.16],0.5532660914791512
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,24723,49,0.95 [0.63-1.43],0.7988242980198869
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK6,Kallikrein-6,24517,49,1.14 [0.48-2.67],0.7673000880338738
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK7,Kallikrein-7,20233,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK8,Kallikrein-8,23653,49,0.60 [0.29-1.23],0.1607462730300596
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLKB1,Plasma kallikrein,20877,41,1.21 [0.37-3.94],0.7472497624290337
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,24803,49,1.59 [0.80-3.14],0.1818156662748831
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,20603,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,24803,49,1.08 [0.62-1.88],0.7925798509902288
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLRF1,Killer cell lectin-like receptor subfamily F member 1,20649,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,21200,44,1.06 [0.55-2.01],0.870191652815363
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KRT14,"Keratin, type I cytoskeletal 14",23173,47,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KRT17,"Keratin, type I cytoskeletal 17",20593,42,0.62 [0.27-1.42],0.2572851021972177
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",24384,48,1.09 [0.81-1.47],0.569337410068356
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",24465,49,1.18 [0.82-1.72],0.3734456334784429
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KRT5,"Keratin, type II cytoskeletal 5",23928,49,1.30 [0.82-2.05],0.2597056083604423
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KRT6C,"Keratin, type II cytoskeletal 6C",20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KRT8,"Keratin, type II cytoskeletal 8",20603,44,1.18 [0.81-1.73],0.3812945598460469
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KYAT1,Kynurenine--oxoglutarate transaminase 1,24465,49,0.91 [0.58-1.43],0.6789805486119935
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KYNU,Kynureninase,24803,49,1.13 [0.66-1.94],0.6629996522798061
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,24552,49,0.93 [0.39-2.24],0.8720138618714113
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,21256,43,1.02 [0.73-1.41],0.9281608851087844
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LACRT,Extracellular glycoprotein lacritin,21105,45,1.02 [0.57-1.83],0.9414756403804564
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LACTB2,Endoribonuclease LACTB2,24515,49,0.99 [0.68-1.45],0.9617464232637536
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,24384,48,1.68 [1.01-2.79],0.045058142333708
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,24478,49,2.05 [1.08-3.89],0.029109461660112
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,24344,45,1.26 [0.96-1.65],0.1006797401089042
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAMA1,Laminin subunit alpha-1,20593,42,0.66 [0.32-1.37],0.2655730669308838
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAMA4,Laminin subunit alpha-4,24599,50,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAMB1,Laminin subunit beta-1,20670,44,3.05 [1.16-7.97],0.0232703980057853
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAMP1,Lysosome-associated membrane glycoprotein 1,20676,44,1.60 [0.98-2.59],0.0577070061581224
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAMP2,Lysosome-associated membrane glycoprotein 2,23764,46,1.60 [0.41-6.20],0.5003005061526602
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,24755,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAMTOR5,Ragulator complex protein LAMTOR5,21142,45,1.28 [0.72-2.29],0.3978255800597131
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAP3,Cytosol aminopeptidase,24058,48,0.94 [0.55-1.59],0.8055283998373016
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LARP1,La-related protein 1,21142,45,0.62 [0.36-1.06],0.0821567461139899
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAT,Linker for activation of T-cells family member 1,24803,49,1.09 [0.78-1.53],0.5964348630478271
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAT2,Linker for activation of T-cells family member 2,24384,48,0.96 [0.78-1.18],0.7078394696003825
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LATS1,Serine/threonine-protein kinase LATS1,20649,43,0.88 [0.62-1.25],0.4793596237781241
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,24297,45,1.37 [0.61-3.09],0.4437181099232796
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,24561,49,1.29 [0.84-1.97],0.2485644229421107
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LBR,Delta(14)-sterol reductase LBR,24738,48,0.94 [0.64-1.37],0.7427669395566396
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LCAT,Phosphatidylcholine-sterol acyltransferase,21262,44,0.89 [0.24-3.30],0.8646819646225097
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LCN15,Lipocalin-15,21225,45,0.90 [0.54-1.48],0.6732620994791183
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LCN2,Neutrophil gelatinase-associated lipocalin,23723,49,1.45 [0.77-2.76],0.2512326230281494
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LCP1,Plastin-2,21249,44,0.72 [0.38-1.38],0.3279514950047029
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LDLR,Low-density lipoprotein receptor,24562,50,0.95 [0.58-1.53],0.8240178483905993
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LDLRAP1,Low density lipoprotein receptor adapter protein 1,21225,45,0.91 [0.68-1.22],0.5491909750910554
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LECT2,Leukocyte cell-derived chemotaxin-2,21256,43,1.03 [0.66-1.60],0.908530396322035
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LEFTY2,Left-right determination factor 2,24691,49,1.18 [0.75-1.86],0.4804773835767938
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LEG1,Protein LEG1 homolog,20036,41,1.06 [0.67-1.66],0.8092290229239525
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LELP1,Late cornified envelope-like proline-rich protein 1,20603,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LEO1,RNA polymerase-associated protein LEO1,21225,45,1.30 [0.63-2.69],0.4840241333785637
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LEP,Leptin,24515,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LEPR,Leptin receptor,24515,49,1.58 [0.76-3.29],0.2229624210026397
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LETM1,Mitochondrial proton/calcium exchanger protein,21225,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LGALS1,Galectin-1,24515,49,1.31 [0.63-2.73],0.474168234481655
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LGALS3,Galectin-3,24557,48,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,21281,43,1.27 [0.54-3.03],0.5833195915895821
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,24478,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LGALS7_LGALS7B,Galectin-7,24468,48,0.61 [0.31-1.19],0.1458199982912566
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LGALS8,Galectin-8,24738,48,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,24476,50,1.39 [0.63-3.08],0.4155990167100294
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LGMN,Legumain,24599,50,1.08 [0.54-2.16],0.8203862149231291
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LHB,Lutropin subunit beta,23919,48,1.01 [0.76-1.34],0.9437544149065048
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,24511,50,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LIF,Leukemia inhibitory factor,23928,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,24494,49,1.05 [0.36-3.01],0.93134051302155
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,24493,47,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,21249,44,0.83 [0.73-0.96],0.0103098100476337
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,24487,49,1.32 [0.60-2.93],0.4937609837081055
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,21256,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,24798,50,1.45 [0.59-3.58],0.4174807073289279
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,24660,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,24058,48,2.03 [1.15-3.60],0.0145007960739502
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,24798,50,1.75 [1.14-2.69],0.010290329042806
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LIPF,Gastric triacylglycerol lipase,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,21120,44,0.83 [0.51-1.37],0.4707651217814305
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,21200,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LMOD1,Leiomodin-1,21225,45,1.16 [0.54-2.50],0.6976413878935678
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LMOD2,Leiomodin-2,20603,44,0.91 [0.56-1.45],0.6826440359435293
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LONP1,"Lon protease homolog, mitochondrial",20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LPA,Apolipoprotein(a),20766,41,1.05 [0.89-1.24],0.5688406914507158
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LPCAT2,Lysophosphatidylcholine acyltransferase 2,24384,48,1.25 [0.80-1.95],0.3185319475092427
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LPL,Lipoprotein lipase,24515,49,1.29 [0.79-2.10],0.3111909906544534
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LPO,Lactoperoxidase,23727,43,1.09 [0.69-1.73],0.7165423120990891
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LPP,Lipoma-preferred partner,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,20593,42,0.76 [0.48-1.20],0.2334546661697993
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,20673,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,21281,43,2.97 [1.25-7.08],0.0139092444084611
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,24660,49,0.79 [0.38-1.65],0.5344846626622815
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,20578,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,24384,48,1.09 [0.42-2.82],0.8568477696913545
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRP11,Low-density lipoprotein receptor-related protein 11,24515,49,1.59 [0.78-3.24],0.2035551769711583
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRP2,Low-density lipoprotein receptor-related protein 2,20673,44,1.06 [0.49-2.26],0.8898884487344936
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRP2BP,LRP2-binding protein,20673,44,1.00 [0.70-1.43],0.9862983978722606
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,24738,48,0.94 [0.59-1.51],0.8039604076918714
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,24384,48,1.60 [0.95-2.70],0.0789186523563247
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,21165,44,1.54 [0.79-3.01],0.2082272087611059
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRRC38,Leucine-rich repeat-containing protein 38,20673,44,1.38 [0.84-2.26],0.2045608492024125
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRRC59,Leucine-rich repeat-containing protein 59,21256,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,21142,45,0.84 [0.46-1.54],0.5691378377192184
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRRN1,Leucine-rich repeat neuronal protein 1,24058,48,2.36 [1.21-4.58],0.0115108606807417
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,20673,44,1.17 [0.63-2.18],0.6201330080074279
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,21225,45,0.87 [0.29-2.59],0.8043207687241618
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LSM1,U6 snRNA-associated Sm-like protein LSm1,23919,48,0.72 [0.42-1.25],0.2453713137973062
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LSM8,U6 snRNA-associated Sm-like protein LSm8,20859,45,1.00 [0.73-1.39],0.9804879619771764
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,24494,49,0.74 [0.39-1.40],0.3532428392263952
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,24494,49,1.01 [0.54-1.89],0.9730445327268962
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LTA4H,Leukotriene A-4 hydrolase,24723,49,0.99 [0.64-1.54],0.9753196021807856
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LTB,Lymphotoxin-beta,21142,45,1.08 [0.49-2.34],0.8528118533327405
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,24798,50,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,23919,48,1.18 [0.78-1.80],0.4324771964109619
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,24339,49,2.16 [0.89-5.25],0.0881940871910325
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LTO1,Protein LTO1 homolog,24058,48,1.13 [0.64-2.00],0.6711642856388125
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LUZP2,Leucine zipper protein 2,21142,45,1.34 [0.79-2.28],0.2847290539385176
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LXN,Latexin,24226,44,0.83 [0.55-1.26],0.3879704768436128
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LY6D,Lymphocyte antigen 6D,24339,50,0.90 [0.44-1.84],0.7643117346335782
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,24494,49,0.95 [0.50-1.83],0.8847566132443392
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,24266,47,1.90 [0.77-4.67],0.1631202333373401
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,24344,45,0.98 [0.46-2.07],0.9590867769709804
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,23919,48,1.15 [0.77-1.70],0.4948608357915021
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LYN,Tyrosine-protein kinase Lyn,24384,48,1.03 [0.76-1.39],0.8410690890390178
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LYPD1,Ly6/PLAUR domain-containing protein 1,23928,49,0.85 [0.53-1.36],0.5043419515832249
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,24367,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,23919,48,0.73 [0.42-1.28],0.2706265894127054
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LYPLA2,Acyl-protein thioesterase 2,20603,44,1.01 [0.77-1.32],0.9438515071400216
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,20673,44,0.83 [0.60-1.15],0.2593223321775076
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,21281,43,0.85 [0.19-3.74],0.8325760632080856
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,20504,44,0.96 [0.45-2.04],0.9218818383594644
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LZTFL1,Leucine zipper transcription factor-like protein 1,20778,43,0.84 [0.55-1.28],0.4161296574959684
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",M6PR,Cation-dependent mannose-6-phosphate receptor,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,24266,45,1.12 [0.69-1.83],0.6451923889739634
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAEA,E3 ubiquitin-protein transferase MAEA,23919,48,0.94 [0.49-1.80],0.845223499276104
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAG,Myelin-associated glycoprotein,20673,44,0.90 [0.48-1.68],0.7436325806124177
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAGEA3,Melanoma-associated antigen 3,20859,45,0.82 [0.62-1.09],0.1639432838834407
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAGED1,Melanoma-associated antigen D1,23919,48,0.95 [0.55-1.62],0.8436128479861207
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,21256,43,1.49 [0.62-3.57],0.3665481343293234
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAMDC4,Apical endosomal glycoprotein,21142,45,0.99 [0.59-1.67],0.967068224938892
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAN2B2,Epididymis-specific alpha-mannosidase,21256,43,0.89 [0.55-1.44],0.627965176925994
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",20504,44,1.25 [0.73-2.14],0.4198653880495915
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MANF,Mesencephalic astrocyte-derived neurotrophic factor,24599,50,1.00 [0.81-1.22],0.9702809086895736
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MANSC1,MANSC domain-containing protein 1,24552,49,0.90 [0.35-2.28],0.8184821812514612
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MANSC4,MANSC domain-containing protein 4,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,20603,44,1.46 [0.63-3.41],0.3816172301354187
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,20593,42,0.74 [0.40-1.40],0.3590119943853491
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,21200,44,0.65 [0.32-1.31],0.2258957516590978
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,21165,44,0.87 [0.56-1.37],0.5508502532244761
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,24494,49,0.96 [0.75-1.24],0.7687279439083254
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,23919,48,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,24297,45,0.93 [0.73-1.17],0.5282422063622065
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,20504,44,1.52 [0.96-2.39],0.0733341975018189
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAPK9,Mitogen-activated protein kinase 9,24494,49,0.61 [0.35-1.07],0.0864551104130913
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAPKAPK2,MAP kinase-activated protein kinase 2,20859,45,0.93 [0.63-1.37],0.7041544420096327
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAPRE3,Microtubule-associated protein RP/EB family member 3,20504,44,0.90 [0.72-1.13],0.3515151746705816
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAPT,Microtubule-associated protein tau,23928,49,0.96 [0.60-1.54],0.8635185933413726
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,24515,49,1.01 [0.38-2.68],0.9898448608388752
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MARS1,"Methionine--tRNA ligase, cytoplasmic",20732,43,0.98 [0.70-1.38],0.9115846023251424
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MASP1,Mannan-binding lectin serine protease 1,24297,45,3.12 [1.00-9.75],0.0507110967001658
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,24523,50,1.43 [0.62-3.29],0.3994919465567965
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MATN3,Matrilin-3,24303,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAVS,Mitochondrial antiviral-signaling protein,23919,48,0.88 [0.66-1.17],0.3771893133194535
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAX,Protein max,23928,49,1.01 [0.79-1.28],0.9514929676126136
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MB,Myoglobin,24798,50,1.15 [0.76-1.72],0.5109565907199407
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MBL2,Mannose-binding protein C,20980,41,1.36 [1.01-1.82],0.0394788108142687
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,24561,49,1.39 [0.66-2.92],0.3913918406267518
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",21225,45,1.00 [0.52-1.95],0.991332787960708
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MCEMP1,Mast cell-expressed membrane protein 1,20649,43,0.56 [0.39-0.82],0.0028782244165291
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MCFD2,Multiple coagulation factor deficiency protein 2,24407,49,0.96 [0.55-1.70],0.9007503344654488
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MCTS1,Malignant T-cell-amplified sequence 1,21165,44,0.24 [0.06-0.99],0.0485986640631572
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,24344,45,1.01 [0.70-1.47],0.9480654268226716
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MDH1,"Malate dehydrogenase, cytoplasmic",21139,44,0.80 [0.39-1.66],0.5500084684166364
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MDK,Midkine,24472,49,0.85 [0.51-1.43],0.5433173360598439
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MDM1,Nuclear protein MDM1,20673,44,0.87 [0.34-2.22],0.7759865717010475
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MED18,Mediator of RNA polymerase II transcription subunit 18,23919,48,1.00 [0.72-1.40],0.9824473523807477
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MED21,Mediator of RNA polymerase II transcription subunit 21,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MEGF10,Multiple epidermal growth factor-like domains protein 10,24478,49,1.26 [0.67-2.35],0.4697686393566112
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MEGF11,Multiple epidermal growth factor-like domains protein 11,20593,42,0.69 [0.24-1.98],0.4926137992294284
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MEGF9,Multiple epidermal growth factor-like domains protein 9,24708,50,0.67 [0.20-2.27],0.5181545156918493
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MELTF,Melanotransferrin,21256,43,0.93 [0.34-2.55],0.885837467131485
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,20778,43,1.02 [0.28-3.66],0.980056083387316
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MEP1A,Meprin A subunit alpha,21165,44,0.81 [0.53-1.23],0.3248454511149842
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MEP1B,Meprin A subunit beta,24515,49,0.96 [0.77-1.19],0.6961724242413593
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MEPE,Matrix extracellular phosphoglycoprotein,24478,49,0.93 [0.35-2.46],0.8822853694007174
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,24803,49,1.06 [0.39-2.86],0.906450659708181
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MESD,LRP chaperone MESD,24493,47,0.93 [0.76-1.15],0.5168390286358153
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MET,Hepatocyte growth factor receptor,24555,50,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",METAP1,Methionine aminopeptidase 1,23928,49,1.04 [0.46-2.36],0.9295764433526872
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",24494,49,0.90 [0.66-1.22],0.4863937430958629
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",METAP2,Methionine aminopeptidase 2,24691,49,0.92 [0.60-1.42],0.7156186186532627
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MFAP3,Microfibril-associated glycoprotein 3,24075,50,0.89 [0.51-1.53],0.6652875107225809
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MFAP3L,Microfibrillar-associated protein 3-like,20673,44,1.08 [0.73-1.61],0.686810942013788
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MFAP4,Microfibril-associated glycoprotein 4,20778,43,1.57 [0.63-3.90],0.3342717598359571
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MFAP5,Microfibrillar-associated protein 5,24798,50,2.03 [1.09-3.77],0.0247417342047513
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MFGE8,Lactadherin,24493,47,0.83 [0.46-1.51],0.5473441570622839
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MGLL,Monoglyceride lipase,24564,50,0.96 [0.73-1.27],0.7866952947964431
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MGMT,Methylated-DNA--protein-cysteine methyltransferase,24494,49,0.99 [0.81-1.21],0.9057475372330852
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MIA,Melanoma-derived growth regulatory protein,24552,49,1.60 [0.83-3.09],0.1583866881402141
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MICALL2,MICAL-like protein 2,20673,44,0.96 [0.63-1.46],0.8463437894604194
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,24494,49,1.20 [0.95-1.53],0.1231339078909634
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MIF,Macrophage migration inhibitory factor,24450,47,0.96 [0.66-1.39],0.8118738464187831
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,24058,48,1.69 [1.07-2.68],0.0244808789200381
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,21142,45,0.99 [0.76-1.29],0.9425669831537676
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MINK1,Misshapen-like kinase 1,21200,44,0.92 [0.68-1.26],0.6097956015359974
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MITD1,MIT domain-containing protein 1,24344,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MKI67,Proliferation marker protein Ki-67,20649,43,0.85 [0.39-1.87],0.6934729823320587
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MLLT1,Protein ENL,20504,44,0.85 [0.54-1.35],0.4934632151861966
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MLN,Promotilin,24494,49,0.83 [0.62-1.09],0.182555541166292
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,24384,48,0.87 [0.63-1.21],0.414046855588689
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMP1,Interstitial collagenase,23634,46,0.99 [0.74-1.32],0.9548992994658392
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMP10,Stromelysin-2,24456,50,0.93 [0.60-1.45],0.7522514857354545
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,24546,48,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMP13,Collagenase 3,23928,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMP15,Matrix metalloproteinase-15,21256,43,1.37 [0.96-1.94],0.0824135798321437
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMP3,Stromelysin-1,24493,47,1.00 [0.66-1.52],0.9954891634482737
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,24035,49,1.23 [0.72-2.11],0.4537449177217438
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMP8,Neutrophil collagenase,24700,48,0.90 [0.63-1.28],0.5604021190730891
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMP9,Matrix metalloproteinase-9,24460,47,0.85 [0.56-1.30],0.4623324388644169
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",20593,42,0.61 [0.32-1.18],0.1445904856546776
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MN1,Transcriptional activator MN1,20673,44,1.39 [0.97-1.98],0.0719793082386402
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MNAT1,CDK-activating kinase assembly factor MAT1,20859,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MNDA,Myeloid cell nuclear differentiation antigen,24480,49,1.21 [0.99-1.49],0.0690530251339712
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MOCS2,Molybdopterin synthase catalytic subunit,20778,43,0.66 [0.42-1.05],0.0776334453071618
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MOG,Myelin-oligodendrocyte glycoprotein,24723,49,1.90 [0.87-4.17],0.1094931799220635
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,21200,44,0.95 [0.33-2.70],0.9219053694194466
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MORF4L1,Mortality factor 4-like protein 1,20859,45,1.28 [0.88-1.87],0.1991661882348874
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MORF4L2,Mortality factor 4-like protein 2,20504,44,0.41 [0.15-1.12],0.0826900225437011
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MORN4,MORN repeat-containing protein 4,20504,44,0.93 [0.63-1.37],0.7019751516392262
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MPHOSPH8,M-phase phosphoprotein 8,24075,50,1.13 [0.82-1.55],0.4699548440384555
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MPI,Mannose-6-phosphate isomerase,24384,48,0.87 [0.64-1.17],0.3604112740231955
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,24564,50,0.98 [0.71-1.35],0.8793111892965128
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MPO,Myeloperoxidase,24493,47,1.52 [0.94-2.47],0.087952955761237
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MPRIP,Myosin phosphatase Rho-interacting protein,21107,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,21262,44,1.39 [0.49-3.94],0.5310376529559231
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MRI1,Methylthioribose-1-phosphate isomerase,20673,44,0.90 [0.59-1.36],0.6082057396053961
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MRPL24,"39S ribosomal protein L24, mitochondrial",20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MRPL28,"39S ribosomal protein L28, mitochondrial",21225,45,1.07 [0.52-2.18],0.8577588441126118
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MRPL46,"39S ribosomal protein L46, mitochondrial",23928,49,0.75 [0.28-2.01],0.5663880857842158
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MRPL52,"39S ribosomal protein L52, mitochondrial",20468,44,0.18 [0.06-0.59],0.0045671168271632
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",21225,45,0.90 [0.58-1.39],0.6335140677598385
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MRPS16,"28S ribosomal protein S16, mitochondrial",20649,43,,
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MSLN,Mesothelin,24352,47,1.12 [0.69-1.82],0.6517689144828209
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MSLNL,Mesothelin-like protein,20673,44,0.72 [0.31-1.67],0.4447997683073753
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MSMB,Beta-microseminoprotein,24426,48,1.10 [0.77-1.57],0.6034292188784222
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,24738,48,1.60 [0.90-2.82],0.1067232257485267
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MSRA,Mitochondrial peptide methionine sulfoxide reductase,24552,49,0.94 [0.66-1.32],0.706961550365574
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MST1,Hepatocyte growth factor-like protein,20955,43,1.13 [0.67-1.90],0.6542194427510079
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MSTN,Growth/differentiation factor 8,24075,50,1.00 [0.65-1.56],0.9906870630038448
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MTDH,Protein LYRIC,20649,43,0.83 [0.60-1.14],0.2501568186576418
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",21200,44,0.73 [0.21-2.48],0.6124207110760476
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,20859,45,0.95 [0.74-1.23],0.7166376641912742
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MTIF3,"Translation initiation factor IF-3, mitochondrial",21165,44,1.00 [0.72-1.40],0.9890869551589851
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MTPN,Myotrophin,24075,50,0.69 [0.29-1.63],0.3964097974522261
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MTR,Methionine synthase,20593,42,0.73 [0.41-1.29],0.2751743404653494
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MTSS1,Protein MTSS 1,21165,44,0.93 [0.72-1.21],0.5969297969789213
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MTSS2,Protein MTSS 2,21142,45,0.84 [0.63-1.13],0.2514801949074036
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MTUS1,Microtubule-associated tumor suppressor 1,20859,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MUC13,Mucin-13,23928,49,1.12 [0.67-1.86],0.6775336669682352
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MUC16,Mucin-16,24384,48,1.06 [0.92-1.22],0.4509128356079963
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MUC2,Mucin-2,21249,44,0.88 [0.63-1.21],0.4205499751147645
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MUCL3,Mucin-like protein 3,20504,44,0.75 [0.33-1.67],0.4780319586630668
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MVK,Mevalonate kinase,24058,48,0.88 [0.63-1.23],0.4473851638841124
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MXRA8,Matrix remodeling-associated protein 8,20778,43,1.58 [0.62-4.04],0.335919110055313
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYBPC1,"Myosin-binding protein C, slow-type",21256,43,1.00 [0.67-1.50],0.9986685975740934
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYBPC2,"Myosin-binding protein C, fast-type",20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,21225,45,0.57 [0.34-0.96],0.0343211491321802
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYDGF,Myeloid-derived growth factor,21256,43,1.02 [0.77-1.36],0.892564030495838
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYH4,Myosin-4,20593,42,1.46 [0.97-2.20],0.0665783820112611
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYH7B,Myosin-7B,20504,44,0.89 [0.44-1.79],0.7336250842378327
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYH9,Myosin-9,21249,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",20593,42,0.48 [0.19-1.24],0.1301958888715721
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYL3,Myosin light chain 3,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYL4,Myosin light chain 4,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYL6B,Myosin light chain 6B,20673,44,0.79 [0.54-1.16],0.2291185304769808
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",20673,44,0.64 [0.30-1.37],0.2486759377603061
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYO6,Unconventional myosin-VI,21225,45,1.43 [0.87-2.34],0.1592732933359185
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYO9B,Unconventional myosin-IXb,24058,48,0.94 [0.64-1.40],0.7705195329690201
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYOC,Myocilin,24493,47,1.15 [0.65-2.01],0.6370491496517565
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYOM1,Myomesin-1,20603,44,1.03 [0.56-1.87],0.9360784266505906
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYOM2,Myomesin-2,20593,42,0.73 [0.38-1.41],0.3479496197513275
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYOM3,Myomesin-3,20778,43,0.94 [0.70-1.28],0.7133642953101911
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,24558,50,0.94 [0.56-1.58],0.8162576273383664
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MZT1,Mitotic-spindle organizing protein 1,23919,48,0.76 [0.45-1.30],0.322987247207634
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NAA10,N-alpha-acetyltransferase 10,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NAA80,N-alpha-acetyltransferase 80,20673,44,0.92 [0.72-1.17],0.498161809139758
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NAAA,N-acylethanolamine-hydrolyzing acid amidase,24234,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,21142,45,0.95 [0.56-1.61],0.8536646024610834
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NADK,NAD kinase,24515,49,1.30 [0.89-1.89],0.1741590407773545
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NAGA,Alpha-N-acetylgalactosaminidase,20615,43,0.87 [0.52-1.46],0.5944930036662497
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,20632,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,20778,43,0.93 [0.23-3.68],0.9157314329681572
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NAMPT,Nicotinamide phosphoribosyltransferase,23919,48,0.93 [0.56-1.55],0.7909339068465503
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NAP1L4,Nucleosome assembly protein 1-like 4,21129,44,0.67 [0.38-1.16],0.1547843294214729
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NAPRT,Nicotinate phosphoribosyltransferase,21200,44,1.00 [0.43-2.34],0.9929602413335452
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NARS1,"Asparagine--tRNA ligase, cytoplasmic",21225,45,0.91 [0.51-1.65],0.7675016862152679
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,24552,49,2.29 [0.89-5.91],0.0859485694792312
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,24058,48,0.86 [0.50-1.48],0.5833237449838702
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NCAM1,Neural cell adhesion molecule 1,24561,49,1.25 [0.57-2.72],0.5735399598903381
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NCAM2,Neural cell adhesion molecule 2,24493,47,0.89 [0.34-2.32],0.8108170627003706
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NCAN,Neurocan core protein,24738,48,2.28 [1.16-4.51],0.0172675652104213
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NCF2,Neutrophil cytosol factor 2,24453,49,0.89 [0.65-1.22],0.4862595212905357
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NCK2,Cytoplasmic protein NCK2,24599,50,0.91 [0.72-1.14],0.3931307212022702
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NCLN,Nicalin,24058,48,1.04 [0.67-1.59],0.8715147419900255
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NCR1,Natural cytotoxicity triggering receptor 1,24460,48,1.48 [0.72-3.05],0.2830008712972981
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,21165,44,0.99 [0.42-2.33],0.9863537350644468
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NCS1,Neuronal calcium sensor 1,24723,49,1.10 [0.46-2.63],0.8263629052458104
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NDRG1,Protein NDRG1,23928,49,0.76 [0.47-1.22],0.2576539905046652
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,21142,45,0.89 [0.53-1.49],0.6472403260932282
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,20604,43,0.72 [0.31-1.65],0.4330136627028264
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,21165,44,0.89 [0.64-1.24],0.4943255070134962
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",23919,48,0.97 [0.69-1.35],0.8572883921813916
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NEB,Nebulin,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NECAP2,Adaptin ear-binding coat-associated protein 2,20593,42,0.58 [0.34-1.00],0.0481805508161055
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NECTIN1,Nectin-1,20649,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,24487,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,24552,49,1.21 [0.51-2.88],0.6595698638531557
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,20649,43,0.77 [0.43-1.35],0.3608797205856691
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NEDD9,Enhancer of filamentation 1,20649,43,1.07 [0.48-2.41],0.8693935305318953
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,23851,49,1.48 [0.85-2.55],0.1634143475759517
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NEK7,Serine/threonine-protein kinase Nek7,20859,45,0.65 [0.39-1.07],0.0898672841228792
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NELL1,Protein kinase C-binding protein NELL1,24552,49,0.99 [0.53-1.84],0.9698955875045538
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NELL2,Protein kinase C-binding protein NELL2,24599,50,0.98 [0.41-2.35],0.9631780859355544
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NENF,Neudesin,21142,45,0.93 [0.71-1.21],0.5824837119022377
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NEO1,Neogenin,21225,45,1.80 [0.67-4.86],0.245283064272482
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NEXN,Nexilin,21262,44,0.89 [0.58-1.36],0.589138823059961
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,24803,49,2.11 [0.87-5.08],0.0970541283325299
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFAT5,Nuclear factor of activated T-cells 5,20649,43,0.91 [0.64-1.29],0.6016421970345103
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",24494,49,0.86 [0.66-1.12],0.265519128118626
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",24058,48,0.92 [0.60-1.43],0.7211592621474808
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFE2,Transcription factor NF-E2 45 kDa subunit,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFIC,Nuclear factor 1 C-type,21225,45,1.09 [0.59-1.99],0.7884776468576051
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFKB1,Nuclear factor NF-kappa-B p105 subunit,20593,42,0.87 [0.58-1.30],0.4913393008837188
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFKB2,Nuclear factor NF-kappa-B p100 subunit,20859,45,0.86 [0.48-1.54],0.6077984220080976
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,23919,48,0.79 [0.46-1.35],0.38675514620946
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",21165,44,0.98 [0.74-1.30],0.910583384789372
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFX1,Transcriptional repressor NF-X1,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NGF,Beta-nerve growth factor,24344,45,0.92 [0.11-7.46],0.934299001842736
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NGFR,Tumor necrosis factor receptor superfamily member 16,21256,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NGRN,Neugrin,21200,44,0.64 [0.15-2.65],0.5334416800777063
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,20295,43,1.26 [0.49-3.25],0.6303625340522933
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NID1,Nidogen-1,24489,48,,
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NID2,Nidogen-2,24493,47,0.85 [0.60-1.21],0.3688271101631651
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NINJ1,Ninjurin-1,23919,48,1.08 [0.73-1.61],0.6971353071746376
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NIT1,Deaminated glutathione amidase,20670,44,0.71 [0.40-1.26],0.2405764628473365
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NIT2,Omega-amidase NIT2,21179,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NLGN1,Neuroligin-1,20673,44,1.07 [0.73-1.57],0.7426441498648917
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NLGN2,Neuroligin-2,20603,44,0.63 [0.29-1.37],0.2457913097399219
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NME1,Nucleoside diphosphate kinase A,20649,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NME3,Nucleoside diphosphate kinase 3,24523,50,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NMI,N-myc-interactor,21055,45,0.76 [0.50-1.15],0.1926165822651276
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,24344,45,1.21 [0.90-1.62],0.2116521964197614
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NMRK2,Nicotinamide riboside kinase 2,20504,44,0.70 [0.29-1.69],0.4312252976419048
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,21225,45,0.82 [0.51-1.32],0.4056731131174378
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,24493,47,1.56 [0.55-4.40],0.4031324503457324
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NOP56,Nucleolar protein 56,20593,42,1.24 [1.03-1.49],0.0246828696754581
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",23928,49,1.18 [0.77-1.83],0.4477528391208266
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NOS2,"Nitric oxide synthase, inducible",20593,42,0.69 [0.31-1.53],0.3568585687913425
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",23928,49,0.83 [0.49-1.42],0.50602767863093
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,24798,50,1.75 [0.37-8.31],0.4803743895528184
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NOTCH2,Neurogenic locus notch homolog protein 2,21249,44,3.55 [1.05-12.00],0.0416866421220068
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,24798,50,1.21 [0.59-2.49],0.598725554911451
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,20898,44,2.67 [1.60-4.46],0.0001828974460973
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,24515,49,1.28 [0.55-2.95],0.5636223097321067
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPHS1,Nephrin,20649,43,0.58 [0.23-1.45],0.2426447295990643
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPHS2,Podocin,20649,43,1.19 [0.94-1.50],0.1554222333163564
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPL,N-acetylneuraminate lyase,21256,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPPB,Natriuretic peptides B,24075,50,0.81 [0.70-0.95],0.0084879681386519
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,24494,49,0.95 [0.58-1.57],0.8442617218558612
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPR1,Atrial natriuretic peptide receptor 1,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPTN,Neuroplastin,23919,48,1.11 [0.85-1.44],0.4444902045498605
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPTX1,Neuronal pentraxin-1,24493,47,0.64 [0.33-1.24],0.1844496848386779
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,21249,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPTXR,Neuronal pentraxin receptor,24515,49,1.44 [0.72-2.87],0.2966861872486594
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPY,Pro-neuropeptide Y,24723,49,0.86 [0.59-1.24],0.4127474950392574
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,24515,49,1.39 [0.56-3.43],0.4784059119123074
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NRGN,Neurogranin,21262,44,0.94 [0.69-1.29],0.7229670445851204
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NRN1,Neuritin,21225,45,1.53 [0.97-2.42],0.0671296745196873
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,24614,49,1.64 [0.67-4.03],0.277742622789476
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,24493,47,1.44 [0.62-3.36],0.3934924388311372
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NRTN,Neurturin,24058,48,0.91 [0.54-1.54],0.722078143950625
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NRXN3,Neurexin-3,20673,44,0.60 [0.22-1.64],0.3177228635365853
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NSFL1C,NSFL1 cofactor p47,24738,48,0.90 [0.61-1.31],0.5715128179298381
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",21256,43,1.01 [0.68-1.48],0.975019571393893
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,21200,44,0.84 [0.32-2.24],0.7294931287811388
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NT5C3A,Cytosolic 5'-nucleotidase 3A,24451,49,0.91 [0.68-1.20],0.4931965196501966
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,24552,49,0.79 [0.49-1.27],0.3268646649184021
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NTF3,Neurotrophin-3,24494,49,1.01 [0.49-2.07],0.9828857975872104
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NTF4,Neurotrophin-4,23919,48,1.22 [0.71-2.09],0.4728983982349363
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NTRK2,BDNF/NT-3 growth factors receptor,24515,49,1.69 [0.63-4.55],0.2965118296220597
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NTRK3,NT-3 growth factor receptor,24738,48,1.32 [0.40-4.39],0.6493729445338735
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,24515,49,0.85 [0.65-1.12],0.2550605950538476
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUB1,NEDD8 ultimate buster 1,24494,49,0.87 [0.64-1.18],0.3678562655357945
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,21142,45,0.99 [0.75-1.30],0.9348490374722156
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUCB2,Nucleobindin-2,24687,48,1.10 [0.57-2.15],0.7752409000615222
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUDC,Nuclear migration protein nudC,24803,49,0.89 [0.60-1.31],0.5470541516829514
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,20593,42,0.64 [0.31-1.33],0.2322707137474553
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUDT16,U8 snoRNA-decapping enzyme,21133,44,0.93 [0.67-1.29],0.6529105768191406
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],24384,48,0.83 [0.53-1.32],0.4341929314489253
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUDT5,ADP-sugar pyrophosphatase,24493,47,0.93 [0.56-1.54],0.7772724007513969
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUMB,Protein numb homolog,20649,43,0.91 [0.64-1.29],0.6055533511684414
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUP50,Nuclear pore complex protein Nup50,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NXPE4,NXPE family member 4,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NXPH1,Neurexophilin-1,23928,49,1.47 [0.87-2.50],0.1509957504756476
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NXPH3,Neurexophilin-3,20649,43,1.61 [0.61-4.30],0.3385173499247595
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OBP2B,Odorant-binding protein 2b,24263,45,0.95 [0.67-1.35],0.782070502908552
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,21225,45,1.71 [0.94-3.12],0.0805782424777194
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ODAM,Odontogenic ameloblast-associated protein,23891,49,0.92 [0.55-1.54],0.7480908102208913
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OFD1,Oral-facial-digital syndrome 1 protein,20859,45,1.05 [0.69-1.57],0.8301462554113632
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OGA,Protein O-GlcNAcase,21165,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,24384,48,1.17 [0.55-2.48],0.6886834792397092
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,24493,47,2.04 [1.12-3.70],0.0192482206900996
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,20859,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OLFM4,Olfactomedin-4,20014,41,0.96 [0.75-1.23],0.760852095031107
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OLR1,Oxidized low-density lipoprotein receptor 1,24267,49,1.14 [0.77-1.70],0.5121425030955121
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,24599,50,1.35 [0.75-2.45],0.3171063597523446
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OMG,Oligodendrocyte-myelin glycoprotein,24384,48,1.03 [0.70-1.53],0.8699055234328658
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OMP,Olfactory marker protein,20603,44,1.03 [0.58-1.84],0.9173886738696972
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OPHN1,Oligophrenin-1,21200,44,0.91 [0.70-1.19],0.5061783054520377
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OPLAH,5-oxoprolinase,20670,44,0.83 [0.54-1.27],0.3980921963747839
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OPTC,Opticin,24384,48,1.34 [0.84-2.13],0.2148287275659495
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,21207,43,1.09 [0.25-4.66],0.9112613358739872
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OSBPL2,Oxysterol-binding protein-related protein 2,21200,44,1.01 [0.49-2.08],0.9833451896913732
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,24523,50,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OSM,Oncostatin-M,24363,49,0.80 [0.56-1.15],0.2231529944334555
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,24614,49,0.89 [0.26-3.05],0.8502947495596327
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OSTN,Osteocrin,20673,44,0.74 [0.32-1.69],0.4715790553931245
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OTOA,Otoancorin,20603,44,1.09 [0.66-1.79],0.7434584229049217
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OTUD6B,Deubiquitinase OTUD6B,21165,44,0.82 [0.50-1.36],0.4469798625117491
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OTUD7B,OTU domain-containing protein 7B,21225,45,0.91 [0.58-1.41],0.6627289487446587
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OXT,Oxytocin-neurophysin 1,24738,48,1.02 [0.85-1.22],0.867821324127435
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",P4HB,Protein disulfide-isomerase,24360,49,0.75 [0.39-1.44],0.3884880389163329
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PACS2,Phosphofurin acidic cluster sorting protein 2,20593,42,0.74 [0.45-1.22],0.2312361344120476
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PADI2,Protein-arginine deiminase type-2,24058,48,1.04 [0.69-1.57],0.8565281934640041
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PADI4,Protein-arginine deiminase type-4,23891,49,1.09 [0.80-1.49],0.5883419322638301
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,24344,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,21225,45,0.80 [0.59-1.09],0.1593524348098046
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",20859,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,24075,50,0.98 [0.74-1.31],0.9046006128390028
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAGR1,PAXIP1-associated glutamate-rich protein 1,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,20461,44,0.88 [0.50-1.54],0.6557836496626002
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAK4,Serine/threonine-protein kinase PAK 4,23928,49,0.83 [0.53-1.28],0.394674180424118
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PALLD,Palladin,20649,43,0.95 [0.44-2.05],0.9046314163622198
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PALM,Paralemmin-1,21050,44,0.89 [0.33-2.42],0.8208511652577036
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,21200,44,0.73 [0.33-1.66],0.456940493534489
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PALM3,Paralemmin-3,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAM,Peptidyl-glycine alpha-amidating monooxygenase,24670,49,1.33 [0.43-4.14],0.6212594321428047
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,24493,47,1.34 [0.52-3.42],0.5441170307992251
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAPPA,Pappalysin-1,24058,48,0.74 [0.44-1.26],0.2717764644379932
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PARD3,Partitioning defective 3 homolog,20859,45,0.58 [0.37-0.89],0.014150394292408
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PARK7,Parkinson disease protein 7,24493,47,0.84 [0.52-1.37],0.4951047937618713
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,24494,49,1.09 [0.73-1.62],0.6678343131461315
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAXX,Protein PAXX,20778,43,0.75 [0.39-1.44],0.3921950510441374
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PBK,Lymphokine-activated killer T-cell-originated protein kinase,20504,44,1.42 [0.57-3.55],0.4489586816149065
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PBLD,Phenazine biosynthesis-like domain-containing protein,23928,49,0.77 [0.46-1.30],0.3265691202031761
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,21165,44,0.46 [0.16-1.34],0.1545547267176537
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCARE,Photoreceptor cilium actin regulator,20603,44,0.95 [0.67-1.36],0.7963466634651737
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,20728,43,0.95 [0.50-1.78],0.869258009808888
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCBP2,Poly(rC)-binding protein 2,21225,45,0.83 [0.56-1.24],0.3630949229556401
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCDH1,Protocadherin-1,24720,49,0.52 [0.14-1.94],0.3298922904464125
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCDH12,Protocadherin-12,21225,45,0.52 [0.17-1.60],0.2528053617726268
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,24515,49,1.45 [0.72-2.91],0.2968763927609887
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCDH7,Protocadherin-7,21165,44,0.89 [0.37-2.14],0.7944935944687909
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,21165,44,1.03 [0.43-2.46],0.9448121322310796
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCDHB15,Protocadherin beta-15,21142,45,1.66 [0.95-2.93],0.0774209322969979
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCNA,Proliferating cell nuclear antigen,20504,44,0.73 [0.40-1.32],0.2977268300472494
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCSK7,Proprotein convertase subtilisin/kexin type 7,21142,45,1.04 [0.56-1.93],0.9029893496818372
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCSK9,Proprotein convertase subtilisin/kexin type 9,24798,50,0.93 [0.49-1.74],0.8102660803392849
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCYT2,Ethanolamine-phosphate cytidylyltransferase,21165,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDAP1,28 kDa heat- and acid-stable phosphoprotein,21256,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,24688,49,2.13 [1.24-3.63],0.0057705121456794
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,24384,48,0.92 [0.40-2.11],0.849428041889859
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDCD5,Programmed cell death protein 5,24738,48,0.92 [0.59-1.41],0.6904390166203138
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDCD6,Programmed cell death protein 6,24515,49,1.25 [0.81-1.93],0.3112875741441997
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDCL2,Phosducin-like protein 2,20504,44,1.31 [0.89-1.94],0.1718764901124325
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",20504,44,0.57 [0.27-1.23],0.1551008861639491
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",20778,43,0.99 [0.74-1.31],0.922774707325408
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDGFA,Platelet-derived growth factor subunit A,24798,50,1.11 [0.78-1.57],0.5598057395941024
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDGFB,Platelet-derived growth factor subunit B,24599,50,0.99 [0.74-1.32],0.9222031005440924
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDGFC,Platelet-derived growth factor C,23919,48,1.68 [0.77-3.68],0.1898041749825538
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,24515,49,1.06 [0.43-2.61],0.9019236098679247
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDGFRB,Platelet-derived growth factor receptor beta,24798,50,0.94 [0.46-1.91],0.8644728625420339
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDIA2,Protein disulfide-isomerase A2,20504,44,0.82 [0.37-1.80],0.6165613206680125
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDIA3,Protein disulfide-isomerase A3,20778,43,1.37 [0.53-3.52],0.5188990132337342
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDIA4,Protein disulfide-isomerase A4,21249,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDIA5,Protein disulfide-isomerase A5,20504,44,1.23 [0.82-1.85],0.3152883376527363
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDLIM5,PDZ and LIM domain protein 5,21225,45,1.02 [0.80-1.29],0.8947233212462656
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDLIM7,PDZ and LIM domain protein 7,24599,50,0.97 [0.80-1.18],0.7402258909122323
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",23919,48,0.99 [0.61-1.60],0.9705536815681948
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDRG1,p53 and DNA damage-regulated protein 1,20673,44,0.84 [0.46-1.54],0.578613535302251
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,20504,44,1.41 [1.05-1.88],0.0207545761541131
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDZD2,PDZ domain-containing protein 2,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,20649,43,0.97 [0.51-1.86],0.9259028640558912
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PEAR1,Platelet endothelial aggregation receptor 1,24798,50,0.98 [0.32-2.97],0.9742023786963652
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PEBP1,Phosphatidylethanolamine-binding protein 1,24493,47,0.87 [0.56-1.36],0.5457828478390632
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PECAM1,Platelet endothelial cell adhesion molecule,24493,47,0.57 [0.23-1.37],0.2088536914825906
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PECR,Peroxisomal trans-2-enoyl-CoA reductase,20670,44,0.57 [0.18-1.76],0.3255629816001878
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PENK,Proenkephalin-A,20778,43,1.20 [0.45-3.20],0.7160664563386632
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PEPD,Xaa-Pro dipeptidase,21262,44,1.77 [0.58-5.37],0.314263796655626
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PER3,Period circadian protein homolog 3,20649,43,0.72 [0.55-0.94],0.0160276591432722
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PF4,Platelet factor 4,21118,41,0.97 [0.71-1.32],0.8422302525537743
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PFDN2,Prefoldin subunit 2,23928,49,1.03 [0.65-1.62],0.9003238610233255
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PFDN4,Prefoldin subunit 4,20504,44,0.67 [0.36-1.26],0.2104288235007809
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PFDN6,Prefoldin subunit 6,20673,44,0.99 [0.64-1.54],0.98048336008735
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",24350,48,0.81 [0.58-1.12],0.2032938202395551
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PGA4,Pepsin A-4,21262,44,1.00 [0.63-1.59],0.9951924305552796
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",21256,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,24803,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PGLYRP1,Peptidoglycan recognition protein 1,24660,49,1.50 [0.87-2.59],0.1437736103824813
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,21004,42,0.53 [0.21-1.32],0.1743708801452148
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PGLYRP4,Peptidoglycan recognition protein 4,20593,42,0.80 [0.46-1.41],0.4434810257931346
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PGM2,Phosphoglucomutase-2,20673,44,0.60 [0.30-1.21],0.1523890463146246
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PGR,Progesterone receptor,20649,43,0.78 [0.54-1.14],0.2037854452797559
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PHACTR2,Phosphatase and actin regulator 2,21225,45,0.90 [0.70-1.15],0.3889234283406774
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PHLDB1,Pleckstrin homology-like domain family B member 1,21165,44,0.95 [0.55-1.63],0.8385513409665674
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PHLDB2,Pleckstrin homology-like domain family B member 2,20504,44,1.04 [0.77-1.41],0.7908832730779443
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,24344,45,0.60 [0.26-1.36],0.2191234329655977
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,20778,43,0.75 [0.38-1.50],0.4183746003925831
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PI16,Peptidase inhibitor 16,21262,44,2.11 [0.64-6.95],0.219726075314285
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PI3,Elafin,24155,47,0.73 [0.44-1.22],0.22449685736677
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",21225,45,0.94 [0.65-1.36],0.7532901955447977
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,24192,47,0.64 [0.30-1.36],0.2458906462209772
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,24494,49,1.02 [0.68-1.54],0.915012908068871
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,24493,47,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,20649,43,0.82 [0.47-1.43],0.4801500586394935
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,24493,47,1.33 [0.70-2.50],0.3827730873473546
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PILRB,Paired immunoglobulin-like type 2 receptor beta,24515,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,20778,43,0.80 [0.53-1.21],0.2863343775798208
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PITHD1,PITH domain-containing protein 1,20461,44,0.92 [0.62-1.36],0.6682856750663582
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PKD1,Polycystin-1,21256,43,2.35 [0.78-7.04],0.1285174839155958
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PKD2,Polycystin-2,20593,42,0.71 [0.41-1.23],0.2196823837065683
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,24513,50,1.09 [0.76-1.58],0.6301018273877479
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PKN3,Serine/threonine-protein kinase N3,20859,45,0.77 [0.51-1.15],0.2032874184182174
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLA2G10,Group 10 secretory phospholipase A2,24344,45,0.99 [0.64-1.54],0.9788412527123412
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,24552,49,0.86 [0.33-2.27],0.7640044081819312
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLA2G1B,Phospholipase A2,24755,50,1.09 [0.59-1.98],0.7896398292917037
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLA2G2A,"Phospholipase A2, membrane associated",24441,50,1.13 [0.76-1.68],0.5574333355446608
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLA2G4A,Cytosolic phospholipase A2,24599,50,0.93 [0.70-1.24],0.6266500828798196
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLA2G7,Platelet-activating factor acetylhydrolase,24493,47,2.01 [0.86-4.69],0.1080379969865878
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLAT,Tissue-type plasminogen activator,24708,50,1.13 [0.70-1.84],0.615101698271364
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,24493,47,1.40 [0.61-3.22],0.4219903069840623
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,24313,48,1.11 [0.42-2.92],0.8379038907000409
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLB1,"Phospholipase B1, membrane-associated",21200,44,0.89 [0.57-1.40],0.6253739278835626
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",20649,43,0.71 [0.33-1.50],0.3668783967066897
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",21200,44,0.94 [0.70-1.26],0.6635396822275104
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLEKHO1,Pleckstrin homology domain-containing family O member 1,21200,44,0.85 [0.56-1.30],0.4554624805216789
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLG,Plasminogen,20723,40,0.76 [0.20-2.86],0.6826743727449939
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLIN1,Perilipin-1,23928,49,0.87 [0.41-1.87],0.728181343350595
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLIN3,Perilipin-3,24515,49,1.07 [0.60-1.90],0.8147789680065954
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLPBP,Pyridoxal phosphate homeostasis protein,24515,49,1.00 [0.69-1.45],0.998112713564414
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLSCR3,Phospholipid scramblase 3,21169,44,0.83 [0.51-1.36],0.4662701411361016
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLTP,Phospholipid transfer protein,24703,49,1.18 [0.58-2.40],0.6461062962822152
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLXDC1,Plexin domain-containing protein 1,23919,48,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLXDC2,Plexin domain-containing protein 2,21200,44,1.26 [0.46-3.48],0.6551266785386396
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLXNA4,Plexin-A4,24494,49,0.84 [0.62-1.14],0.2693599680174728
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,24680,49,0.80 [0.27-2.40],0.6884677263504408
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLXNB3,Plexin-B3,24435,49,1.02 [0.60-1.73],0.9500211382267192
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,24421,49,0.94 [0.83-1.07],0.340237833249328
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PMCH,Pro-MCH,20593,42,1.24 [0.97-1.58],0.0801239290272688
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PMM2,Phosphomannomutase 2,20593,42,0.59 [0.35-0.99],0.0451007057950207
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,20673,44,1.24 [0.75-2.04],0.4084765989342597
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PMVK,Phosphomevalonate kinase,23890,49,0.99 [0.79-1.25],0.9453864557860684
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PNLIP,Pancreatic triacylglycerol lipase,21262,44,0.91 [0.56-1.48],0.7096883169238943
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PNLIPRP1,Inactive pancreatic lipase-related protein 1,21200,44,0.96 [0.66-1.39],0.8169431318972525
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PNLIPRP2,Pancreatic lipase-related protein 2,24478,49,1.03 [0.94-1.12],0.5635153760539298
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PNMA1,Paraneoplastic antigen Ma1,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,20603,44,0.83 [0.42-1.66],0.6019404190456588
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",24058,48,1.06 [0.88-1.29],0.521729450596043
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PODXL,Podocalyxin,24384,48,2.46 [0.46-13.18],0.2938454523718257
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PODXL2,Podocalyxin-like protein 2,24552,49,1.60 [0.65-3.97],0.3090396015777128
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,20649,43,1.08 [0.58-2.01],0.7985583895371409
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",POLR2A,DNA-directed RNA polymerase II subunit RPB1,20649,43,1.05 [0.41-2.72],0.9149719396677128
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",24384,48,0.83 [0.37-1.87],0.6542969018370033
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",POMC,Pro-opiomelanocortin,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PON1,Serum paraoxonase/arylesterase 1,21262,44,0.83 [0.27-2.55],0.750011694781431
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PON2,Serum paraoxonase/arylesterase 2,24075,50,0.81 [0.39-1.69],0.5731010833822785
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PON3,Serum paraoxonase/lactonase 3,24599,50,0.63 [0.30-1.33],0.2287023492397489
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",POSTN,Periostin,21249,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPBP,Platelet basic protein,21110,41,1.01 [0.73-1.40],0.9565422007245292
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPCDC,Phosphopantothenoylcysteine decarboxylase,24738,48,0.91 [0.53-1.57],0.7410322841157778
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPIB,Peptidyl-prolyl cis-trans isomerase B,24485,49,0.99 [0.77-1.29],0.968031748147236
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPIE,Peptidyl-prolyl cis-trans isomerase E,20859,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",21249,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPL,Periplakin,20649,43,0.45 [0.17-1.20],0.1109376316980145
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPM1A,Protein phosphatase 1A,23919,48,0.95 [0.42-2.18],0.9065640749412984
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPM1B,Protein phosphatase 1B,20649,43,0.92 [0.58-1.47],0.7353430379289468
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPM1F,Protein phosphatase 1F,21256,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPME1,Protein phosphatase methylesterase 1,24384,48,0.93 [0.62-1.42],0.746824197777263
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,21142,45,0.84 [0.59-1.20],0.3346331039005504
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,24552,49,0.94 [0.72-1.23],0.6440675841331904
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,20859,45,0.99 [0.67-1.48],0.9631643370994613
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,21225,45,0.75 [0.51-1.11],0.1487203462651166
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,21225,45,1.32 [0.68-2.58],0.4158323621246338
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPP1R2,Protein phosphatase inhibitor 2,24515,49,0.94 [0.68-1.28],0.6782851050489646
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPP1R9B,Neurabin-2,24803,49,0.97 [0.74-1.26],0.8072949127604178
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,21165,44,0.99 [0.78-1.27],0.962420230911636
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPP3R1,Calcineurin subunit B type 1,24344,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPT1,Palmitoyl-protein thioesterase 1,20673,44,0.93 [0.62-1.39],0.716088247560046
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPY,Pancreatic prohormone,24426,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,23919,48,1.06 [0.69-1.62],0.7895165426373059
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRAME,Melanoma antigen preferentially expressed in tumors,20504,44,0.61 [0.19-1.98],0.4139644531953288
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRAP1,Proline-rich acidic protein 1,21249,44,0.57 [0.30-1.09],0.0906238958477426
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRC1,Protein regulator of cytokinesis 1,21142,45,1.32 [0.92-1.88],0.1291155881951138
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,24634,50,1.37 [0.63-2.98],0.4277869853509637
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRDX1,Peroxiredoxin-1,23840,44,0.75 [0.54-1.04],0.0824549156491824
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRDX2,Peroxiredoxin-2,20919,43,1.00 [0.63-1.57],0.9840000471718188
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",24058,48,0.88 [0.61-1.27],0.4898546899993433
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRDX5,"Peroxiredoxin-5, mitochondrial",24803,49,0.91 [0.64-1.29],0.5880881395886466
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRDX6,Peroxiredoxin-6,24723,49,0.62 [0.40-0.97],0.0377347236462738
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PREB,Prolactin regulatory element-binding protein,24058,48,0.55 [0.21-1.45],0.2237529068307875
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRELP,Prolargin,24478,49,1.27 [0.39-4.19],0.6892556417547842
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRG2,Bone marrow proteoglycan,21249,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRG3,Proteoglycan 3,21249,44,0.78 [0.43-1.41],0.4084134677131412
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,24058,48,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,20673,44,0.50 [0.18-1.43],0.1964469220000247
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,24515,49,1.01 [0.75-1.36],0.945241638455386
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,21160,44,0.93 [0.65-1.31],0.6682824593096208
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRKCQ,Protein kinase C theta type,24058,48,0.68 [0.34-1.35],0.2683001681385462
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRKD2,Serine/threonine-protein kinase D2,20593,42,0.79 [0.38-1.66],0.5328803167695482
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRKG1,cGMP-dependent protein kinase 1,20778,43,1.06 [0.84-1.33],0.6421371662688137
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,23919,48,0.83 [0.56-1.23],0.3655436546858509
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRL,Prolactin,24738,48,0.94 [0.67-1.32],0.718535057839641
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,21200,44,0.86 [0.48-1.56],0.6200301688484963
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,24532,49,1.30 [0.48-3.53],0.6012547777153148
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PROCR,Endothelial protein C receptor,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,24494,49,0.86 [0.63-1.18],0.3418918966015231
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PROS1,Vitamin K-dependent protein S,21281,43,0.72 [0.22-2.37],0.591132978141901
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRR4,Proline-rich protein 4,20638,41,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRR5,Proline-rich protein 5,20649,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,20670,44,2.00 [0.95-4.23],0.0693511608124003
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRSS2,Trypsin-2,24561,49,0.88 [0.53-1.47],0.6295934443652846
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRSS22,Brain-specific serine protease 4,20649,43,1.28 [0.60-2.74],0.5291251145173729
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRSS27,Serine protease 27,24425,49,0.99 [0.53-1.88],0.9826724836792954
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRSS53,Serine protease 53,21200,44,0.45 [0.20-1.00],0.0510712214506757
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRSS8,Prostasin,24389,50,0.92 [0.50-1.71],0.7956192049789893
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,23928,49,0.96 [0.77-1.20],0.7046373628289742
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRTG,Protogenin,24723,49,1.61 [0.62-4.17],0.3248943221038951
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRTN3,Myeloblastin,23876,49,1.88 [1.35-2.62],0.0001940378191436
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRUNE2,Protein prune homolog 2,20859,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,21058,44,1.70 [0.72-4.01],0.2223756695303543
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSAPL1,Proactivator polypeptide-like 1,21165,44,0.88 [0.49-1.57],0.6695650140339942
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSCA,Prostate stem cell antigen,21165,44,1.03 [0.92-1.16],0.6142964509522482
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSG1,Pregnancy-specific beta-1-glycoprotein 1,24344,45,1.06 [0.83-1.35],0.6423285212645702
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,24494,49,0.81 [0.52-1.27],0.3622279384948093
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSMA1,Proteasome subunit alpha type-1,23919,48,1.14 [0.69-1.89],0.5999100735622427
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSMC3,26S proteasome regulatory subunit 6A,20504,44,0.86 [0.33-2.25],0.7555801192690706
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSMD1,26S proteasome non-ATPase regulatory subunit 1,21225,45,1.08 [0.62-1.88],0.7752916726953433
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSMD5,26S proteasome non-ATPase regulatory subunit 5,20673,44,0.82 [0.45-1.52],0.5377769420232315
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSMD9,26S proteasome non-ATPase regulatory subunit 9,24384,48,1.10 [0.71-1.70],0.6797656153935989
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSME1,Proteasome activator complex subunit 1,24317,45,0.76 [0.38-1.55],0.4542837777971134
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,24231,44,0.73 [0.36-1.50],0.3944902616833077
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,24494,49,1.00 [0.62-1.62],0.9910064122906752
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSMG4,Proteasome assembly chaperone 4,20649,43,1.06 [0.65-1.73],0.8161091327637515
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSPN,Persephin,24494,49,1.06 [0.87-1.29],0.5692335730682612
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSRC1,Proline/serine-rich coiled-coil protein 1,23919,48,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,20005,40,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",23928,49,0.88 [0.38-2.04],0.7716476714361762
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,24292,48,2.35 [1.17-4.71],0.0163052209583812
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTGES2,Prostaglandin E synthase 2,20494,43,0.85 [0.50-1.47],0.5669058120396353
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTGR1,Prostaglandin reductase 1,21256,43,0.95 [0.66-1.38],0.7978990706945541
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTH,Parathyroid hormone,20673,44,0.82 [0.56-1.19],0.2894956394409096
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,24494,49,0.99 [0.51-1.95],0.9840071159628936
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,23928,49,1.54 [0.81-2.92],0.1846525880718758
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTN,Pleiotrophin,24075,50,1.36 [0.85-2.18],0.1947503763583807
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTP4A3,Protein tyrosine phosphatase type IVA 3,20649,43,1.04 [0.60-1.80],0.9008509865633236
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,24344,45,0.94 [0.67-1.32],0.7253717984617072
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,24564,50,1.00 [0.76-1.32],0.991975209734362
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,20606,43,1.05 [0.52-2.11],0.90150265684034
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRB,Receptor-type tyrosine-protein phosphatase beta,21256,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,21249,44,1.94 [0.58-6.46],0.2796647631936145
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRF,Receptor-type tyrosine-protein phosphatase F,24798,50,1.22 [0.52-2.89],0.6445413442950325
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,21165,44,1.03 [0.58-1.84],0.9148078358816948
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,21165,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,24448,49,0.64 [0.22-1.82],0.4000680207446088
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,24254,45,1.68 [0.73-3.90],0.2248054575964382
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRR,Receptor-type tyrosine-protein phosphatase R,21200,44,1.70 [0.83-3.48],0.1441031272021025
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRS,Receptor-type tyrosine-protein phosphatase S,24798,50,1.43 [0.52-3.97],0.4866085437586339
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,21256,43,1.20 [0.49-2.90],0.691894742768032
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,20778,43,0.91 [0.56-1.49],0.7112914471015849
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,23820,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTTG1,Securin,20859,45,1.23 [0.67-2.25],0.5074742769267961
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,24494,49,0.87 [0.54-1.41],0.5797189344200756
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PVALB,Parvalbumin alpha,24629,49,1.03 [0.83-1.29],0.762486378641267
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PVR,Poliovirus receptor,24738,48,0.73 [0.54-1.00],0.0475845446066441
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PXDNL,Peroxidasin-like protein,21142,45,0.58 [0.28-1.18],0.1327027034588312
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PXN,Paxillin,23928,49,0.97 [0.61-1.56],0.9139181295874328
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PYDC1,Pyrin domain-containing protein 1,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PYY,Peptide YY,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PZP,Pregnancy zone protein,21281,43,0.92 [0.61-1.37],0.6735837937528277
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",QDPR,Dihydropteridine reductase,24396,48,0.98 [0.55-1.76],0.9544519392696866
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,24499,50,0.91 [0.34-2.43],0.851433662000394
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,20836,39,1.06 [0.55-2.01],0.8663426651627897
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB10,Ras-related protein Rab-10,21256,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB11FIP3,Rab11 family-interacting protein 3,21256,43,1.04 [0.80-1.37],0.7544898337601718
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB27B,Ras-related protein Rab-27B,21256,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB2B,Ras-related protein Rab-2B,21142,45,0.91 [0.57-1.44],0.679184193647423
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB33A,Ras-related protein Rab-33A,20593,42,1.21 [0.79-1.85],0.3815379149282905
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB37,Ras-related protein Rab-37,24058,48,0.93 [0.68-1.28],0.6523410622766985
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB39B,Ras-related protein Rab-39B,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,20603,44,1.11 [0.73-1.70],0.6202833538386108
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB44,Ras-related protein Rab-44,21142,45,1.28 [0.82-2.02],0.2803626373925884
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB6A,Ras-related protein Rab-6A,24494,49,0.87 [0.51-1.50],0.6148581600791045
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB6B,Ras-related protein Rab-6B,23928,49,0.54 [0.29-1.01],0.0542476707941469
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RABEP1,Rab GTPase-binding effector protein 1,20778,43,0.88 [0.60-1.29],0.5176721181287516
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RABEPK,Rab9 effector protein with kelch motifs,23919,48,0.70 [0.42-1.15],0.1589784995041268
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,24058,48,0.82 [0.52-1.27],0.3687607593403479
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAC3,Ras-related C3 botulinum toxin substrate 3,20673,44,0.96 [0.62-1.49],0.8446413237966063
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAD23B,UV excision repair protein RAD23 homolog B,23919,48,1.15 [0.69-1.94],0.587510098662269
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAD51,DNA repair protein RAD51 homolog 1,20859,45,0.94 [0.54-1.64],0.8347141484032735
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RALB,Ras-related protein Ral-B,20649,43,0.80 [0.30-2.18],0.6687675666802053
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,21142,45,1.44 [0.98-2.11],0.0609222636624869
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RANBP1,Ran-specific GTPase-activating protein,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RANBP2,E3 SUMO-protein ligase RanBP2,20603,44,0.73 [0.30-1.79],0.4918293326060039
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RANGAP1,Ran GTPase-activating protein 1,23919,48,1.01 [0.62-1.64],0.9807834153673708
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAP1A,Ras-related protein Rap-1A,20649,43,0.94 [0.60-1.48],0.7883658416481159
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAPGEF2,Rap guanine nucleotide exchange factor 2,20859,45,0.55 [0.30-1.03],0.0630207220042008
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RARRES1,Retinoic acid receptor responder protein 1,23919,48,0.58 [0.22-1.58],0.28852014569659
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RARRES2,Retinoic acid receptor responder protein 2,24614,49,1.02 [0.60-1.74],0.9324098027162468
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RASA1,Ras GTPase-activating protein 1,23928,49,0.75 [0.34-1.66],0.4818317580248481
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,20504,44,1.16 [0.61-2.20],0.6585848402029879
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,23919,48,0.75 [0.44-1.28],0.2911651923637389
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,21225,45,0.81 [0.36-1.80],0.599398697511238
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,23946,45,1.09 [0.66-1.82],0.7324380231534907
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBM17,Splicing factor 45,21225,45,0.93 [0.64-1.36],0.7228034013890776
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBM25,RNA-binding protein 25,20504,44,0.53 [0.27-1.04],0.0656550582893604
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBP1,Retinol-binding protein 1,20673,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBP2,Retinol-binding protein 2,24384,48,1.20 [0.86-1.66],0.2795611435666942
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,24384,48,1.05 [0.67-1.66],0.8175417920833846
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBP7,Retinoid-binding protein 7,21165,44,1.07 [0.68-1.67],0.7731058845687275
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBPMS,RNA-binding protein with multiple splicing,20649,43,1.16 [0.81-1.66],0.421828651015112
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBPMS2,RNA-binding protein with multiple splicing 2,20670,44,0.87 [0.65-1.15],0.3264001197144558
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,21142,45,1.32 [0.88-1.98],0.1783084632364706
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RCOR1,REST corepressor 1,24075,50,1.25 [0.84-1.86],0.2661994622004981
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REEP4,Receptor expression-enhancing protein 4,21225,45,0.68 [0.41-1.13],0.1384071007425132
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,24343,48,1.26 [0.76-2.07],0.3673760913660256
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,24798,50,1.07 [0.69-1.65],0.7761174228724481
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,24798,50,1.10 [0.73-1.65],0.6601799554314888
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REG3G,Regenerating islet-derived protein 3-gamma,21142,45,0.41 [0.19-0.90],0.0254803874419807
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,24523,50,1.25 [0.73-2.11],0.4144966774889165
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RELB,Transcription factor RelB,20649,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,24493,47,2.66 [1.19-5.96],0.0172811307335697
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REN,Renin,24515,49,0.96 [0.66-1.39],0.828178828674603
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REPS1,RalBP1-associated Eps domain-containing protein 1,20649,43,0.61 [0.26-1.44],0.257171769817887
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REST,RE1-silencing transcription factor,20504,44,0.81 [0.34-1.93],0.6309779112477188
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,24384,48,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RETN,Resistin,24424,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REXO2,"Oligoribonuclease, mitochondrial",20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RFC4,Replication factor C subunit 4,21142,45,1.05 [0.29-3.82],0.9376410983590427
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RGCC,Regulator of cell cycle RGCC,21225,45,0.90 [0.62-1.31],0.5864034051132812
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,20859,45,0.60 [0.33-1.10],0.0995027263777258
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RGMA,Repulsive guidance molecule A,24738,48,1.70 [0.75-3.83],0.2009304489925202
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RGMB,RGM domain family member B,24738,48,2.11 [0.82-5.43],0.1221302426482677
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RGS10,Regulator of G-protein signaling 10,21225,45,0.92 [0.56-1.48],0.7196644043704075
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RGS8,Regulator of G-protein signaling 8,24058,48,1.08 [0.75-1.56],0.6614932882905615
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RHOC,Rho-related GTP-binding protein RhoC,24193,45,0.92 [0.74-1.14],0.4538445411929377
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RICTOR,Rapamycin-insensitive companion of mTOR,20649,43,0.77 [0.37-1.61],0.4820225827320332
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,20778,43,0.96 [0.53-1.73],0.8910730132426185
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RILP,Rab-interacting lysosomal protein,24660,49,0.94 [0.62-1.44],0.7918031462898276
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RILPL2,RILP-like protein 2,21256,43,0.95 [0.71-1.27],0.7278026360350108
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,20593,42,0.36 [0.17-0.79],0.0101837361666027
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RLN1,Prorelaxin H1,21225,45,0.77 [0.44-1.34],0.3576838255239931
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RLN2,Prorelaxin H2,20746,43,0.94 [0.72-1.22],0.6392970982814612
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNASE1,Ribonuclease pancreatic,21262,44,2.27 [0.82-6.30],0.1139509381238143
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNASE10,Inactive ribonuclease-like protein 10,20670,44,1.37 [0.83-2.27],0.220064936240599
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNASE3,Eosinophil cationic protein,24390,49,1.21 [1.00-1.46],0.0560977352070031
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNASE4,Ribonuclease 4,20574,42,1.42 [0.49-4.10],0.5187013201116566
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,21108,44,1.51 [0.71-3.23],0.2836341048158874
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNASEH2A,Ribonuclease H2 subunit A,21225,45,1.37 [0.91-2.06],0.1289462670495325
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,24678,50,1.85 [0.76-4.47],0.1742813399845164
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,20670,44,1.73 [0.67-4.43],0.2553830388151371
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNF168,E3 ubiquitin-protein ligase RNF168,20649,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNF31,E3 ubiquitin-protein ligase RNF31,20649,43,1.05 [0.50-2.22],0.8940438056125094
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNF4,E3 ubiquitin-protein ligase RNF4,20859,45,0.93 [0.60-1.46],0.7644970548391338
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNF41,E3 ubiquitin-protein ligase NRDP1,23919,48,0.95 [0.65-1.39],0.7818641383440167
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNF43,E3 ubiquitin-protein ligase RNF43,20859,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNF5,E3 ubiquitin-protein ligase RNF5,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,24523,50,1.37 [0.48-3.92],0.558939780144894
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,24738,48,1.24 [0.42-3.64],0.7012028314782479
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ROBO4,Roundabout homolog 4,20670,44,1.84 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,24515,49,2.14 [0.95-4.84],0.0678041895425579
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RP2,Protein XRP2,24384,48,0.89 [0.48-1.65],0.7132155587656431
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RPA2,Replication protein A 32 kDa subunit,20649,43,1.24 [0.52-2.94],0.6220866403097866
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RPE,Ribulose-phosphate 3-epimerase,20859,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RPGR,X-linked retinitis pigmentosa GTPase regulator,20673,44,0.94 [0.45-1.95],0.8586234682191579
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RPS10,40S ribosomal protein S10,20593,42,0.65 [0.28-1.52],0.3169439972452125
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RRAS,Ras-related protein R-Ras,20673,44,0.91 [0.72-1.14],0.4107188000407537
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,23919,48,0.65 [0.34-1.25],0.19579968703095
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,23919,48,0.94 [0.65-1.37],0.7443130376158398
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RRP15,RRP15-like protein,20603,44,0.84 [0.62-1.16],0.2920874044104953
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RSPO1,R-spondin-1,24344,45,1.33 [0.64-2.75],0.449104621489755
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RSPO3,R-spondin-3,24723,49,2.82 [1.24-6.43],0.0135118099975912
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RTBDN,Retbindin,24384,48,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RTKN2,Rhotekin-2,20593,42,0.73 [0.36-1.46],0.3679890906760158
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",21225,45,0.99 [0.72-1.35],0.9537279887673948
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,24723,49,0.81 [0.38-1.74],0.5868809290876944
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RUVBL1,RuvB-like 1,23919,48,0.89 [0.68-1.18],0.4214498741225476
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RWDD1,RWD domain-containing protein 1,24738,48,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RYR1,Ryanodine receptor 1,20593,42,0.63 [0.22-1.79],0.3899784399050934
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",S100A11,Protein S100-A11,24315,49,1.32 [0.87-2.02],0.194243213459103
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",S100A12,Protein S100-A12,24150,46,1.01 [0.71-1.43],0.9625725914072416
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,20649,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",S100A14,Protein S100-A14,21225,45,1.17 [0.69-1.96],0.5584319984904821
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",S100A16,Protein S100-A16,23891,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",S100A3,Protein S100-A3,21142,45,1.29 [0.81-2.06],0.2807727146561543
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",S100A4,Protein S100-A4,24552,49,0.81 [0.52-1.25],0.3447211475198836
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",S100G,Protein S100-G,21225,45,1.35 [0.76-2.41],0.310936053314105
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",S100P,Protein S100-P,24075,50,1.54 [1.11-2.15],0.0105139801304877
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SAA4,Serum amyloid A-4 protein,21281,43,0.87 [0.30-2.54],0.8023211201176187
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,21225,45,0.38 [0.12-1.24],0.1090949306988199
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SAG,S-arrestin,20603,44,1.08 [0.65-1.80],0.7749795738420633
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SAMD9L,Sterile alpha motif domain-containing protein 9-like,24494,49,0.88 [0.62-1.25],0.4768573015829576
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SAP18,Histone deacetylase complex subunit SAP18,20859,45,0.62 [0.39-0.99],0.0460908731251492
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SARG,Specifically androgen-regulated gene protein,21188,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SAT1,Diamine acetyltransferase 1,20593,42,1.11 [0.65-1.92],0.6950855605372429
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SAT2,Thialysine N-epsilon-acetyltransferase,20859,45,0.69 [0.41-1.14],0.1469469369929304
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SATB1,DNA-binding protein SATB1,21225,45,1.05 [0.43-2.52],0.9212264074066476
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SBSN,Suprabasin,21211,44,0.74 [0.31-1.75],0.4891323845500246
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCAMP3,Secretory carrier-associated membrane protein 3,24384,48,0.97 [0.72-1.32],0.8636686505569575
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCARA5,Scavenger receptor class A member 5,24738,48,1.88 [0.79-4.49],0.1537096849326447
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCARB1,Scavenger receptor class B member 1,23928,49,1.21 [0.86-1.71],0.276925218652583
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,23876,44,1.74 [0.70-4.32],0.2311091507088331
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCARF1,Scavenger receptor class F member 1,24798,50,0.95 [0.53-1.71],0.8566121348407281
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,24738,48,2.04 [0.82-5.02],0.1230575472411302
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCG2,Secretogranin-2,24624,48,1.56 [0.68-3.55],0.2918055320700274
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCG3,Secretogranin-3,24523,50,1.48 [0.70-3.15],0.3086728030680857
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCGB1A1,Uteroglobin,24532,50,1.97 [1.17-3.30],0.0101526398269295
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCGB2A2,Mammaglobin-A,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCGB3A1,Secretoglobin family 3A member 1,20778,43,1.97 [0.61-6.35],0.2564321429274618
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCGB3A2,Secretoglobin family 3A member 2,24564,50,0.90 [0.64-1.26],0.5318987355051489
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCGN,Secretagogin,24058,48,1.33 [0.76-2.35],0.3193430533005088
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCIN,Adseverin,20603,44,1.03 [0.70-1.50],0.8938196026866276
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,24660,49,0.83 [0.50-1.40],0.4958169240485212
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCN2A,Sodium channel protein type 2 subunit alpha,20603,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCN2B,Sodium channel subunit beta-2,20673,44,1.24 [0.48-3.18],0.6520643434237277
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCN3A,Sodium channel protein type 3 subunit alpha,20673,44,1.16 [0.59-2.28],0.6705595963389823
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCN3B,Sodium channel subunit beta-3,20603,44,0.81 [0.40-1.65],0.5652335079020316
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCN4B,Sodium channel subunit beta-4,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCP2,Non-specific lipid-transfer protein,23919,48,1.00 [0.73-1.38],0.9953216310274076
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCPEP1,Retinoid-inducible serine carboxypeptidase,20599,44,0.73 [0.40-1.32],0.2967587922220434
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCRG1,Scrapie-responsive protein 1,21256,43,1.45 [0.53-4.01],0.4705091498420322
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCRIB,Protein scribble homolog,20670,44,0.98 [0.70-1.35],0.8808928060955526
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCRN1,Secernin-1,24494,49,0.60 [0.37-0.97],0.0382536886319971
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCT,Secretin,20673,44,0.90 [0.46-1.75],0.7519196880882802
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,24515,49,1.30 [0.70-2.39],0.4074994719396217
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,24515,49,0.95 [0.55-1.65],0.8561288106144559
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SDCCAG8,Serologically defined colon cancer antigen 8,21142,45,0.99 [0.78-1.28],0.9667932602170436
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SDHB,Succinate dehydrogenase,21165,44,0.52 [0.30-0.90],0.0185330256147744
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,20778,43,1.44 [0.69-3.00],0.336213327251137
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEC31A,Protein transport protein Sec31A,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SELE,E-selectin,24798,50,0.73 [0.45-1.18],0.2012943200586058
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SELENOP,Selenoprotein P,21281,43,1.87 [0.59-5.94],0.286049196181434
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,21281,43,1.47 [0.42-5.14],0.5460787453349896
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SELP,P-selectin,24561,49,1.23 [0.80-1.88],0.3483607357281179
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,24494,49,0.52 [0.21-1.30],0.1644112110471285
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,24515,49,1.32 [0.50-3.51],0.577569469272045
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,20778,43,1.42 [0.76-2.65],0.2700404769381233
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,24384,48,1.14 [0.50-2.59],0.752457893186236
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,24738,48,0.56 [0.25-1.28],0.1690542872332362
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEMA6C,Semaphorin-6C,20649,43,1.54 [0.66-3.61],0.3209445298390897
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,24708,50,2.89 [1.33-6.25],0.007132459123436
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEPTIN3,Neuronal-specific septin-3,21225,45,1.28 [0.93-1.76],0.1268821882615075
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEPTIN7,Septin-7,20859,45,1.01 [0.59-1.75],0.9577081723684464
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,21152,44,0.59 [0.22-1.54],0.2766094508365937
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,24384,48,0.39 [0.14-1.08],0.069531007256722
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINA1,Alpha-1-antitrypsin,20895,42,2.32 [0.07-78.04],0.637957987013327
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,24798,50,0.95 [0.55-1.64],0.8540622447927327
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINA12,Serpin A12,23843,48,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,21215,42,0.86 [0.11-6.61],0.8825662859610143
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINA4,Kallistatin,20894,42,0.46 [0.13-1.57],0.2141661328867671
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,20970,43,1.02 [0.42-2.47],0.9695640497577198
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,21281,43,0.46 [0.09-2.31],0.3428364714310821
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINA7,Thyroxine-binding globulin,21281,43,2.04 [0.45-9.21],0.3527480226272711
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,24262,48,0.99 [0.69-1.44],0.9727536916266084
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINB1,Leukocyte elastase inhibitor,24417,47,0.98 [0.74-1.31],0.9151613616298276
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINB5,Serpin B5,24075,50,1.02 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINB6,Serpin B6,24661,48,0.91 [0.60-1.39],0.6664801820370303
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,24803,49,1.18 [0.81-1.71],0.3963143168146872
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINB9,Serpin B9,24344,45,0.95 [0.43-2.08],0.8988300171041853
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,21239,43,0.31 [0.04-2.14],0.234508365703463
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPIND1,Heparin cofactor 2,21239,43,0.55 [0.20-1.53],0.2534986667829012
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINE1,Plasminogen activator inhibitor 1,24798,50,1.13 [0.78-1.63],0.5310064789891513
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINE2,Glia-derived nexin,21256,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINF1,Pigment epithelium-derived factor,20973,42,1.19 [0.40-3.51],0.7589749421391774
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINF2,Alpha-2-antiplasmin,20888,42,0.11 [0.02-0.86],0.035320727600736
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPING1,Plasma protease C1 inhibitor,21239,43,0.86 [0.18-4.08],0.8533598705097722
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINH1,Serpin H1,20859,45,0.98 [0.80-1.21],0.866358438482574
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINI1,Neuroserpin,20732,43,0.83 [0.32-2.16],0.7013092456604899
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINI2,Serpin I2,21165,44,0.92 [0.55-1.56],0.7660737722912412
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,23928,49,0.77 [0.51-1.17],0.2224229189191913
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,24267,45,1.21 [0.52-2.84],0.6550614011082179
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEZ6,Seizure protein 6 homolog,20673,44,1.29 [0.53-3.17],0.5775728904642234
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEZ6L,Seizure 6-like protein,24552,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,24384,48,1.64 [0.63-4.26],0.3080613468361515
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SF3B4,Splicing factor 3B subunit 4,24384,48,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SFRP1,Secreted frizzled-related protein 1,24260,45,1.60 [0.93-2.75],0.0872532195148722
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SFRP4,Secreted frizzled-related protein 4,20778,43,1.57 [0.79-3.12],0.2014821274491433
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SFTPA1,Pulmonary surfactant-associated protein A1,23919,48,1.20 [0.83-1.73],0.3388406918324838
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,23919,48,1.17 [0.70-1.94],0.5482749470656723
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SFTPD,Pulmonary surfactant-associated protein D,24515,49,0.89 [0.60-1.30],0.536564124485823
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SGSH,N-sulphoglucosamine sulphohydrolase,20919,43,0.82 [0.47-1.42],0.4809791955392433
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SH2B3,SH2B adapter protein 3,23919,48,0.96 [0.74-1.24],0.7444390901584159
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,24494,49,0.86 [0.53-1.38],0.5294904151812154
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,20603,44,1.01 [0.63-1.61],0.9621534507815724
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SH3BP1,SH3 domain-binding protein 1,21165,44,1.21 [0.74-1.97],0.4444243348261857
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SH3GL3,Endophilin-A3,20731,45,0.75 [0.56-1.00],0.048823154554867
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SH3GLB2,Endophilin-B2,21200,44,0.85 [0.55-1.31],0.4563617667479568
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SHBG,Sex hormone-binding globulin,21262,44,1.18 [0.71-1.95],0.520207739736136
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SHC1,SHC-transforming protein 1,20504,44,1.07 [0.87-1.31],0.5373537849622445
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SHD,SH2 domain-containing adapter protein D,20558,42,1.28 [1.01-1.63],0.0424917964363525
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SHH,Sonic hedgehog protein,20649,43,1.17 [0.63-2.19],0.6120847811618138
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,21249,44,2.03 [0.79-5.26],0.1437317370835965
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SHMT1,"Serine hydroxymethyltransferase, cytosolic",24564,50,1.03 [0.77-1.37],0.8594923582374965
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SHPK,Sedoheptulokinase,20859,45,1.08 [0.56-2.06],0.8204800623348848
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIAE,Sialate O-acetylesterase,24509,49,0.94 [0.55-1.61],0.8164404763888116
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,24599,50,1.00 [0.54-1.83],0.9937532041809723
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,24494,49,1.03 [0.47-2.30],0.933114110933832
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIGLEC15,Sialic acid-binding Ig-like lectin 15,23928,49,1.07 [0.79-1.44],0.6761785567074677
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,24493,47,1.23 [0.93-1.62],0.1540692520885563
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,24723,49,1.13 [0.52-2.47],0.7545482839867468
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,24515,49,2.48 [1.03-5.95],0.0422676436993117
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,20670,44,1.21 [1.16-1.26],1.4532290345653089e-21
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIGLEC9,Sialic acid-binding Ig-like lectin 9,24692,49,0.77 [0.33-1.79],0.5420738393129674
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIL1,Nucleotide exchange factor SIL1,20670,44,1.53 [0.85-2.76],0.1584522729068267
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,24543,48,0.93 [0.60-1.45],0.7551974680257937
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,24427,49,1.49 [0.85-2.63],0.1629274687778789
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,20649,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIRT2,NAD-dependent protein deacetylase sirtuin-2,24384,48,0.92 [0.69-1.23],0.5765219822604861
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",23928,49,0.95 [0.59-1.52],0.8244607428822891
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,24058,48,0.81 [0.50-1.32],0.4016298127536881
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,24297,45,0.89 [0.62-1.29],0.5352702364655091
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SKAP2,Src kinase-associated phosphoprotein 2,24599,50,0.93 [0.73-1.18],0.5449879529121988
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SKIV2L,Helicase SKI2W,20593,42,0.72 [0.31-1.68],0.4518031266163843
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLA2,Src-like-adapter 2,21225,45,0.88 [0.67-1.16],0.3631283298876226
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,24058,48,1.27 [0.81-1.98],0.2927064591144999
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,23919,48,1.79 [1.02-3.14],0.0423745146254232
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,24494,49,1.08 [0.69-1.66],0.7436444430821456
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,23919,48,1.12 [0.68-1.85],0.6528188635386551
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC12A2,Solute carrier family 12 member 2,20593,42,0.34 [0.10-1.13],0.077961741993284
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC13A1,Solute carrier family 13 member 1,21142,45,1.00 [0.63-1.58],0.9971079289296224
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC16A1,Monocarboxylate transporter 1,23928,49,0.83 [0.51-1.35],0.442991634655655
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC1A4,Neutral amino acid transporter A,20673,44,0.94 [0.53-1.65],0.8227123999722336
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC27A4,Long-chain fatty acid transport protein 4,23928,49,0.78 [0.50-1.20],0.2582008799129124
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC28A1,Sodium/nucleoside cotransporter 1,20504,44,0.63 [0.34-1.19],0.1537968197351421
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC34A3,Sodium-dependent phosphate transport protein 2C,20504,44,1.09 [0.62-1.91],0.774594974141896
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC39A14,Zinc transporter ZIP14,23928,49,1.02 [0.47-2.21],0.9611158365307984
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC39A5,Zinc transporter ZIP5,24494,49,0.62 [0.38-1.01],0.0545776214711863
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC44A4,Choline transporter-like protein 4,20673,44,0.79 [0.47-1.33],0.3745605303905315
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC4A1,Band 3 anion transport protein,21249,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC51B,Organic solute transporter subunit beta,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,20778,43,0.90 [0.64-1.28],0.5643978393109345
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,21165,44,0.68 [0.33-1.39],0.289578708762405
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",20504,44,1.12 [0.71-1.79],0.626386145724488
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLIT2,Slit homolog 2 protein,23928,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLITRK1,SLIT and NTRK-like protein 1,20649,43,1.94 [0.85-4.44],0.1182371814132739
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,24723,49,1.28 [0.67-2.45],0.4485001007604137
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,24075,50,1.67 [0.87-3.23],0.125513662343618
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLK,STE20-like serine/threonine-protein kinase,20859,45,1.17 [0.88-1.56],0.2709425707186534
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLMAP,Sarcolemmal membrane-associated protein,21165,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLURP1,Secreted Ly-6/uPAR-related protein 1,21099,44,1.00 [0.46-2.17],0.998294000796626
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMAD1,Mothers against decapentaplegic homolog 1,23919,48,0.95 [0.69-1.30],0.75041978300728
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMAD2,Mothers against decapentaplegic homolog 2,21142,45,0.82 [0.54-1.26],0.365615537311841
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMAD3,Mothers against decapentaplegic homolog 3,21142,45,0.73 [0.41-1.30],0.2838813968157304
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMAD5,Mothers against decapentaplegic homolog 5,24384,48,0.95 [0.28-3.26],0.936937787988834
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMARCA2,Probable global transcription activator SNF2L2,23928,49,0.77 [0.52-1.13],0.1813406328848079
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMC3,Structural maintenance of chromosomes protein 3,20504,44,0.59 [0.30-1.16],0.1281493130850172
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,21165,44,1.01 [0.65-1.58],0.9609727036979528
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,24723,49,1.43 [0.67-3.04],0.3516873725955817
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMOC2,SPARC-related modular calcium-binding protein 2,24599,50,1.00 [0.53-1.90],0.9880072290289196
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,24619,48,0.71 [0.42-1.22],0.2205135591830468
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMPD3,Sphingomyelin phosphodiesterase 3,20649,43,1.10 [0.74-1.64],0.6465160588117338
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,24548,50,0.87 [0.60-1.27],0.466609728887722
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,21142,45,1.20 [0.90-1.61],0.2178864777716909
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMS,Spermine synthase,20603,44,0.63 [0.36-1.11],0.1097740532352314
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMTN,Smoothelin,21153,44,0.94 [0.70-1.28],0.7005390530910145
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNAP23,Synaptosomal-associated protein 23,24515,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNAP25,Synaptosomal-associated protein 25,20603,44,0.70 [0.37-1.31],0.2643287053381689
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNAP29,Synaptosomal-associated protein 29,24552,49,0.91 [0.69-1.20],0.5219516753148484
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNAPIN,SNARE-associated protein Snapin,21225,45,0.94 [0.58-1.53],0.8019930446604397
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNCA,Alpha-synuclein,20778,43,0.95 [0.74-1.23],0.710748436619566
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNCG,Gamma-synuclein,24344,45,0.80 [0.59-1.09],0.1642975304015428
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',21200,44,1.34 [0.91-1.99],0.1406089925107192
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNX15,Sorting nexin-15,20778,43,0.91 [0.53-1.56],0.7414324196700384
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNX18,Sorting nexin-18,21165,44,0.81 [0.41-1.62],0.5543331273369183
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNX2,Sorting nexin-2,21142,45,0.93 [0.64-1.33],0.6767056017005627
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNX5,Sorting nexin-5,20670,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNX9,Sorting nexin-9,24515,49,1.00 [0.69-1.44],0.9972939113653868
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SOD1,Superoxide dismutase [Cu-Zn],23964,47,1.11 [0.66-1.85],0.7019423364111721
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SOD2,"Superoxide dismutase [Mn], mitochondrial",24493,47,0.91 [0.45-1.82],0.7885222337214515
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SOD3,Extracellular superoxide dismutase,21262,44,0.72 [0.36-1.44],0.3559577851507233
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SORBS1,Sorbin and SH3 domain-containing protein 1,21225,45,1.03 [0.50-2.13],0.9388080141894942
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,23919,48,2.16 [1.04-4.48],0.0393149024902148
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SORD,Sorbitol dehydrogenase,24614,49,0.88 [0.61-1.25],0.460856981361726
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SORT1,Sortilin,24487,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SOST,Sclerostin,24487,49,1.49 [0.79-2.83],0.2171194396573827
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,20673,44,1.17 [0.70-1.95],0.5530430279143652
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SOX2,Transcription factor SOX-2,21189,45,1.31 [0.43-3.98],0.6338655144088838
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SOX9,Transcription factor SOX-9,20673,44,1.56 [0.54-4.53],0.4167467905872342
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,21225,45,1.33 [0.59-3.01],0.4875149121916448
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPAG1,Sperm-associated antigen 1,21225,45,1.13 [0.73-1.75],0.5766071592435759
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPARC,SPARC,24552,49,1.04 [0.73-1.49],0.8177037868572927
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPARCL1,SPARC-like protein 1,24480,49,1.85 [0.96-3.54],0.0653346806475446
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPART,Spartin,20778,43,1.01 [0.70-1.47],0.9507183840280916
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,21256,43,2.09 [0.94-4.65],0.0721725104358062
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,24493,47,1.14 [0.59-2.19],0.7039478492337432
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,20778,43,0.88 [0.41-1.90],0.7539524526352317
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPINK4,Serine protease inhibitor Kazal-type 4,24494,49,0.91 [0.60-1.38],0.653555178196703
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPINK5,Serine protease inhibitor Kazal-type 5,24493,47,0.75 [0.34-1.63],0.4644639294852583
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPINK6,Serine protease inhibitor Kazal-type 6,24723,49,0.84 [0.53-1.32],0.4436413011308963
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPINK8,Serine protease inhibitor Kazal-type 8,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,24405,46,1.59 [0.59-4.24],0.3559256650904243
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPINT2,Kunitz-type protease inhibitor 2,24599,50,1.01 [0.55-1.84],0.987018050800882
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,21165,44,0.96 [0.86-1.06],0.4008260431369326
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPOCK1,Testican-1,24344,45,1.38 [0.50-3.87],0.5353764567670123
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,24523,50,1.25 [0.58-2.68],0.5749524335944798
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPON2,Spondin-2,24401,49,1.43 [0.68-3.01],0.344068025385627
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,24750,49,1.50 [0.86-2.61],0.1558916858154754
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",20649,43,0.88 [0.45-1.70],0.6961545803432497
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,20504,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPRR1B,Cornifin-B,20859,45,0.94 [0.66-1.33],0.7208175636318881
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPRR3,Small proline-rich protein 3,21200,44,1.53 [1.07-2.20],0.0203783243904507
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPRY2,Protein sprouty homolog 2,24058,48,0.80 [0.72-0.89],3.704127626129807e-05
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",20603,44,0.69 [0.26-1.83],0.4550962260314387
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPTLC1,Serine palmitoyltransferase 1,21200,44,1.50 [0.88-2.56],0.132422104675504
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SRC,Proto-oncogene tyrosine-protein kinase Src,24512,49,1.02 [0.83-1.25],0.8800102881852259
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,24384,48,0.98 [0.65-1.48],0.9156682758960062
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SRPK2,SRSF protein kinase 2,24494,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,21256,43,1.62 [0.70-3.77],0.2605537659909712
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SSB,Lupus La protein,23928,49,0.56 [0.31-1.00],0.0519623563561713
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",20649,43,0.82 [0.34-1.99],0.6555650286881567
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,24487,49,1.08 [0.88-1.33],0.4407476313313709
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,24561,49,1.46 [0.81-2.61],0.2057190280723203
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SSH3,Protein phosphatase Slingshot homolog 3,20504,44,1.05 [0.40-2.76],0.9193411600437916
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SSNA1,Sjoegren syndrome nuclear autoantigen 1,21165,44,0.77 [0.43-1.39],0.3874931383809412
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ST13,Hsc70-interacting protein,20778,43,0.84 [0.50-1.43],0.5299783304771019
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",24384,48,0.77 [0.41-1.46],0.4308851876945915
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",24798,50,1.09 [0.46-2.60],0.8488811740732431
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",20649,43,1.44 [1.01-2.04],0.0433054759357966
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STAB2,Stabilin-2,21249,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STAM,Signal transducing adapter molecule 1,21142,45,1.10 [0.54-2.27],0.7899369823043838
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STAMBP,STAM-binding protein,24297,45,0.89 [0.59-1.35],0.5835114276152205
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STAT2,Signal transducer and activator of transcription 2,20649,43,0.82 [0.55-1.20],0.3032368310092965
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STAT5B,Signal transducer and activator of transcription 5B,24384,48,0.99 [0.82-1.19],0.92046966928643
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,20504,44,0.64 [0.37-1.12],0.1205362855850641
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,24738,48,1.53 [0.88-2.67],0.1358828759615888
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,24455,47,1.18 [0.43-3.27],0.7474200555816287
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STEAP4,Metalloreductase STEAP4,20603,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STIP1,Stress-induced-phosphoprotein 1,24450,47,0.87 [0.58-1.30],0.4961664651827023
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STK11,Serine/threonine-protein kinase STK11,24075,50,0.89 [0.62-1.26],0.5026749594062837
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STK24,Serine/threonine-protein kinase 24,23928,49,0.96 [0.64-1.45],0.8469903879922552
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STK4,Serine/threonine-protein kinase 4,24515,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STOML2,"Stomatin-like protein 2, mitochondrial",20504,44,0.83 [0.59-1.17],0.2864564764879894
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STX16,Syntaxin-16,23919,48,0.93 [0.59-1.46],0.7468503282651242
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STX1B,Syntaxin-1B,20673,44,1.25 [0.74-2.11],0.4063705387767644
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STX3,Syntaxin-3,21200,44,0.95 [0.45-2.02],0.8984398021221006
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STX4,Syntaxin-4,24384,48,0.97 [0.64-1.48],0.8889237616630511
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STX5,Syntaxin-5,20649,43,0.96 [0.47-1.97],0.9042722945595748
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STX6,Syntaxin-6,23919,48,0.97 [0.67-1.41],0.8832810707835306
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,20649,43,1.06 [0.60-1.87],0.8285015782427803
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STX8,Syntaxin-8,24494,49,0.74 [0.43-1.26],0.2671062140022066
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STXBP1,Syntaxin-binding protein 1,21225,45,0.97 [0.67-1.39],0.8580283603175902
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STXBP3,Syntaxin-binding protein 3,23919,48,0.99 [0.55-1.77],0.9698625903337866
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,21165,44,0.85 [0.41-1.76],0.6558898578917558
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SUGT1,Protein SGT1 homolog,23919,48,1.00 [0.73-1.38],0.980708961484462
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SULT1A1,Sulfotransferase 1A1,24738,48,1.00 [0.82-1.22],0.9788407285880644
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,24494,49,1.07 [0.69-1.66],0.7489618091997323
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SUMF1,Formylglycine-generating enzyme,20649,43,1.05 [0.71-1.54],0.8241271976870683
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,24738,48,1.10 [0.68-1.79],0.6971448228251573
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SUOX,"Sulfite oxidase, mitochondrial",21225,45,0.95 [0.60-1.48],0.8076951122839741
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SUSD1,Sushi domain-containing protein 1,24075,50,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SUSD2,Sushi domain-containing protein 2,24493,47,0.94 [0.66-1.36],0.7506901184580415
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SUSD4,Sushi domain-containing protein 4,21142,45,1.12 [0.59-2.11],0.7376419854113367
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,20668,43,2.78 [1.20-6.43],0.0170370306720729
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SV2A,Synaptic vesicle glycoprotein 2A,20673,44,0.86 [0.52-1.41],0.5420466923371743
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,21165,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SYAP1,Synapse-associated protein 1,20778,43,0.71 [0.41-1.23],0.2218339340334889
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,20603,44,1.14 [0.71-1.81],0.5858856829742672
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SYT1,Synaptotagmin-1,21200,44,0.98 [0.45-2.12],0.9597123688929248
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SYTL4,Synaptotagmin-like protein 4,21256,43,0.97 [0.65-1.45],0.886565478016268
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,20859,45,0.92 [0.70-1.20],0.5417337323816669
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TACC3,Transforming acidic coiled-coil-containing protein 3,24384,48,0.96 [0.77-1.19],0.6989349739002368
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TACSTD2,Tumor-associated calcium signal transducer 2,21741,47,0.80 [0.33-1.98],0.6336189243911498
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TADA3,Transcriptional adapter 3,21142,45,0.64 [0.30-1.34],0.2336309525636788
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TAFA5,Chemokine-like protein TAFA-5,24384,48,1.18 [0.55-2.54],0.6792282131655238
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TAGLN3,Transgelin-3,20504,44,0.71 [0.44-1.15],0.1640627460812038
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TALDO1,Transaldolase,21179,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TANK,TRAF family member-associated NF-kappa-B activator,24058,48,0.83 [0.57-1.21],0.3443517797145261
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TAP1,Antigen peptide transporter 1,20859,45,0.79 [0.43-1.44],0.4384066635214565
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TARBP2,RISC-loading complex subunit TARBP2,23928,49,0.89 [0.64-1.23],0.4807427301386113
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",20673,44,0.69 [0.42-1.15],0.1514322013660311
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",21142,45,0.86 [0.39-1.88],0.7078978069832174
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,21200,44,0.71 [0.43-1.17],0.1797432399474554
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TBC1D17,TBC1 domain family member 17,23928,49,0.86 [0.47-1.56],0.6193027508233322
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TBC1D23,TBC1 domain family member 23,24384,48,0.99 [0.75-1.31],0.9572941938690154
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TBC1D5,TBC1 domain family member 5,24494,49,1.00 [0.73-1.37],0.9997149670846528
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TBCA,Tubulin-specific chaperone A,20778,43,0.95 [0.67-1.33],0.7532240307359214
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TBCB,Tubulin-folding cofactor B,24344,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TBCC,Tubulin-specific chaperone C,24344,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TBL1X,F-box-like/WD repeat-containing protein TBL1X,23919,48,1.01 [0.80-1.28],0.9162680255041749
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TBR1,T-box brain protein 1,20673,44,0.47 [0.19-1.18],0.1099653405872294
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,24299,45,1.11 [0.84-1.46],0.4799269227117778
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TCL1B,T-cell leukemia/lymphoma protein 1B,24075,50,0.77 [0.51-1.16],0.2122523974394455
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TCN1,Transcobalamin-1,20839,43,1.02 [0.43-2.45],0.957489215391674
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TCN2,Transcobalamin-2,24750,49,0.79 [0.34-1.87],0.5952534805478948
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,21256,43,2.07 [1.20-3.58],0.0085967403237017
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TCP11,T-complex protein 11 homolog,20859,45,0.98 [0.59-1.62],0.9291743085264356
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TCTN3,Tectonic-3,21256,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TDGF1,Teratocarcinoma-derived growth factor 1,23928,49,0.99 [0.84-1.17],0.9107869383801211
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TDO2,"Tryptophan 2,3-dioxygenase",20673,44,0.73 [0.31-1.71],0.4655547892598133
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,21142,45,1.08 [0.76-1.54],0.6583488679965962
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TDRKH,Tudor and KH domain-containing protein,23928,49,0.76 [0.55-1.06],0.1044810938888505
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TEF,Thyrotroph embryonic factor,20593,42,0.47 [0.21-1.02],0.0569217447344033
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,24552,49,1.13 [0.35-3.61],0.8360415989271276
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TERF1,Telomeric repeat-binding factor 1,20649,43,0.87 [0.32-2.39],0.7896775603279269
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TET2,Methylcytosine dioxygenase TET2,20830,45,0.86 [0.61-1.22],0.405687430826559
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TEX101,Testis-expressed protein 101,20673,44,0.79 [0.52-1.22],0.2938175745491647
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TEX33,Testis-expressed protein 33,20859,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TF,Serotransferrin,21281,43,0.35 [0.10-1.32],0.1213995670386006
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TFAP2A,Transcription factor AP-2-alpha,20603,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TFF1,Trefoil factor 1,24382,47,1.06 [0.74-1.50],0.7518863512995038
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,24564,50,1.25 [0.82-1.92],0.303215081128775
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,24463,49,0.92 [0.52-1.64],0.7830869627906014
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TFPI,Tissue factor pathway inhibitor,24400,48,1.25 [0.59-2.67],0.5655156167075344
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,24469,49,1.21 [0.69-2.12],0.4974118439875883
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,24580,49,1.40 [0.75-2.62],0.2870764266921336
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TG,Thyroglobulin,21142,45,1.10 [0.86-1.41],0.436269128263078
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TGFA,Protransforming growth factor alpha,24494,49,0.56 [0.30-1.05],0.0716070898863947
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TGFB1,Transforming growth factor beta-1 proprotein,24755,49,1.28 [0.68-2.43],0.4438401368271951
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TGFB2,Transforming growth factor beta-2 proprotein,21142,45,1.25 [0.77-2.05],0.3659604489732007
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TGFBI,Transforming growth factor-beta-induced protein ig-h3,24323,48,1.03 [0.40-2.61],0.9567654679993204
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TGFBR1,TGF-beta receptor type-1,20649,43,0.49 [0.12-2.07],0.3294697461357995
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,24552,49,1.92 [0.88-4.16],0.0990643928474159
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TGFBR3,Transforming growth factor beta receptor type 3,24798,50,1.52 [0.67-3.49],0.3185706007547333
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,24472,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,21262,44,2.81 [0.97-8.15],0.0567278464449217
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THAP12,52 kDa repressor of the inhibitor of the protein kinase,20461,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,24515,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,24493,47,1.13 [0.56-2.29],0.7298890897464378
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THBS4,Thrombospondin-4,24489,48,1.40 [0.80-2.47],0.2376753348183891
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,24416,49,1.19 [0.55-2.59],0.6536244511356661
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THPO,Thrombopoietin,24075,50,1.36 [0.71-2.61],0.3576984846885349
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THRAP3,Thyroid hormone receptor-associated protein 3,20593,42,0.85 [0.62-1.18],0.3321763569596804
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THSD1,Thrombospondin type-1 domain-containing protein 1,20499,43,1.21 [0.54-2.70],0.6388290673482236
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THTPA,Thiamine-triphosphatase,21101,45,0.89 [0.65-1.24],0.5002885907055545
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,24738,48,3.00 [1.33-6.81],0.0084009996104241
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIA1,Nucleolysin TIA-1 isoform p40,23810,50,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,24798,50,0.85 [0.49-1.48],0.5707636135805406
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",23881,49,1.04 [0.63-1.74],0.8672347818218995
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,20859,45,1.44 [0.70-2.94],0.3208574442296856
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,24561,49,1.95 [1.13-3.37],0.0161188181153883
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,21256,43,0.87 [0.41-1.82],0.7088555904236936
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,21200,44,0.94 [0.67-1.30],0.6944007349907975
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,24200,48,2.01 [0.94-4.30],0.0705482290580098
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIMP2,Metalloproteinase inhibitor 2,21256,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIMP3,Metalloproteinase inhibitor 3,24599,50,0.98 [0.81-1.19],0.875764060170326
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIMP4,Metalloproteinase inhibitor 4,24493,47,1.53 [0.85-2.76],0.1594397014161284
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,24441,49,2.19 [0.73-6.60],0.1617595659952992
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TJAP1,Tight junction-associated protein 1,24552,49,0.96 [0.71-1.29],0.7727958847323672
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TJP3,Tight junction protein ZO-3,20603,44,0.96 [0.48-1.90],0.9026165863946836
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",20859,45,0.82 [0.41-1.65],0.5834923024937829
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,20649,43,1.10 [0.36-3.38],0.8699807721836805
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TLR2,Toll-like receptor 2,20859,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TLR3,Toll-like receptor 3,24803,49,1.10 [0.73-1.66],0.6471741922567253
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TLR4,Toll-like receptor 4,20649,43,1.49 [0.56-3.98],0.4259940172902199
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,20673,44,1.14 [0.69-1.87],0.6097307034970316
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMED1,Transmembrane emp24 domain-containing protein 1,20859,45,0.83 [0.47-1.48],0.5341316237468752
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMED10,Transmembrane emp24 domain-containing protein 10,20593,42,0.66 [0.28-1.59],0.3573710465517672
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMED4,Transmembrane emp24 domain-containing protein 4,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMED8,Protein TMED8,21165,44,0.94 [0.71-1.24],0.6408105645222878
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMEM106A,Transmembrane protein 106A,21142,45,1.12 [0.76-1.63],0.5768038877296204
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMEM132A,Transmembrane protein 132A,20670,44,1.35 [0.88-2.06],0.1648835447833029
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMEM25,Transmembrane protein 25,21225,45,1.49 [0.94-2.34],0.0872406843862825
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMOD4,Tropomodulin-4,20504,44,0.69 [0.32-1.46],0.327764980776553
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMPRSS11B,Transmembrane protease serine 11B,20603,44,0.62 [0.37-1.05],0.0739007776723545
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMPRSS11D,Transmembrane protease serine 11D,21152,44,1.81 [0.96-3.44],0.0685636607618815
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMPRSS15,Enteropeptidase,24384,48,0.93 [0.70-1.24],0.6295897062151499
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMPRSS5,Transmembrane protease serine 5,24220,45,1.83 [0.90-3.75],0.0964865462963058
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,24493,47,0.96 [0.69-1.33],0.798864347645655
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,24561,49,0.96 [0.56-1.64],0.8760772979586571
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,24034,50,1.45 [0.90-2.32],0.1247933603922897
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,21165,44,1.14 [0.65-1.99],0.6540830022846368
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,24058,48,0.84 [0.41-1.71],0.6252382863758217
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,20778,43,0.81 [0.50-1.30],0.3873318908159913
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,24344,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,24344,45,1.19 [0.77-1.84],0.4372205265971257
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,24531,49,0.88 [0.53-1.46],0.628155611862709
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,24803,49,1.50 [0.76-2.96],0.237743342712747
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,24478,49,1.36 [0.59-3.15],0.4749359513161522
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,24552,49,1.10 [0.54-2.26],0.7894690249032424
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,24523,50,1.04 [0.45-2.40],0.93529060277299
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,24058,48,0.88 [0.46-1.68],0.6975354441437741
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,24523,50,1.39 [0.60-3.22],0.4385762892521616
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,20778,43,0.63 [0.30-1.33],0.2263198155200889
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,24723,49,2.28 [1.09-4.79],0.0290355440205751
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,24493,47,1.53 [0.61-3.84],0.3686807996007196
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,24493,47,1.49 [0.91-2.43],0.1105133760592114
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,24738,48,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,24755,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,24344,45,0.92 [0.55-1.52],0.7417299073079345
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,24738,48,1.22 [0.71-2.11],0.474188023244944
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,24344,45,1.88 [1.05-3.38],0.0340661745320817
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,24803,49,1.58 [0.59-4.20],0.361491130828686
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,24494,49,1.02 [0.68-1.53],0.9315852026103024
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFSF12,Tumor necrosis factor ligand superfamily member 12,24803,49,1.30 [0.54-3.08],0.5585855627392791
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,24599,50,2.71 [1.09-6.74],0.0325345721985903
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,24748,50,1.53 [0.62-3.76],0.3522874222115884
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFSF14,Tumor necrosis factor ligand superfamily member 14,24344,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,21249,44,1.67 [0.79-3.53],0.1776159721946729
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNIP1,TNFAIP3-interacting protein 1,21200,44,0.92 [0.67-1.28],0.6341047429666962
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNN,Tenascin-N,21249,44,1.30 [0.68-2.51],0.4273314504028661
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNNI3,"Troponin I, cardiac muscle",24075,50,0.93 [0.70-1.24],0.6319194145590096
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNPO1,Transportin-1,20859,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,24344,45,0.78 [0.42-1.44],0.4230211265414144
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNXB,Tenascin-X,24493,47,1.23 [0.45-3.42],0.6858924251671579
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,21256,43,0.95 [0.65-1.40],0.813441457187252
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TOP1,DNA topoisomerase 1,21165,44,0.86 [0.67-1.11],0.2537332595267528
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TOP1MT,"DNA topoisomerase I, mitochondrial",20504,44,0.94 [0.50-1.77],0.8598936311707726
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,20649,43,0.88 [0.60-1.29],0.5050359724298745
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TOR1AIP1,Torsin-1A-interacting protein 1,20670,44,1.11 [0.67-1.83],0.6900124872204147
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,23919,48,1.11 [0.90-1.38],0.3181082285614349
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,20649,43,1.14 [0.83-1.57],0.4032334697132791
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TP53I3,Quinone oxidoreductase PIG3,20323,42,0.91 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TP53INP1,Tumor protein p53-inducible nuclear protein 1,24075,50,0.68 [0.25-1.83],0.4465550421295212
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TP73,Tumor protein p73,20673,44,0.90 [0.39-2.09],0.8112609139334507
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPBGL,Trophoblast glycoprotein-like,20673,44,0.68 [0.30-1.53],0.3494361112471185
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPD52L2,Tumor protein D54,20778,43,0.96 [0.73-1.25],0.7532591910919006
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,21256,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPM3,Tropomyosin alpha-3 chain,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPMT,Thiopurine S-methyltransferase,23919,48,0.99 [0.70-1.41],0.966003785061878
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPP1,Tripeptidyl-peptidase 1,24327,49,0.52 [0.28-0.98],0.0436009119674738
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPPP2,Tubulin polymerization-promoting protein family member 2,20859,45,0.77 [0.51-1.17],0.2260196598095892
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPPP3,Tubulin polymerization-promoting protein family member 3,23928,49,1.07 [0.58-1.97],0.8200542453995393
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPRKB,EKC/KEOPS complex subunit TPRKB,20504,44,0.85 [0.51-1.44],0.5518656169181766
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPSAB1,Tryptase alpha/beta-1,24762,48,1.60 [0.99-2.58],0.0530639013897313
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPSD1,Tryptase delta,21225,45,1.06 [0.51-2.21],0.8669518045919716
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPSG1,Tryptase gamma,20649,43,1.03 [0.37-2.88],0.950758867503015
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPT1,Translationally-controlled tumor protein,24058,48,1.03 [0.71-1.50],0.8701387105425011
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRAF2,TNF receptor-associated factor 2,24494,49,0.86 [0.59-1.23],0.3992962505222386
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",20649,43,1.08 [0.52-2.24],0.8372858810733563
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,20859,45,0.93 [0.65-1.34],0.7013019107251102
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TREH,Trehalase,21249,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,24478,49,1.39 [0.86-2.24],0.1835175458768903
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TREML1,Trem-like transcript 1 protein,21262,44,1.06 [0.62-1.82],0.8261703797069824
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,24493,47,1.31 [0.61-2.85],0.4911545938819774
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRIAP1,TP53-regulated inhibitor of apoptosis 1,24723,49,0.98 [0.66-1.45],0.901881858260447
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRIM21,E3 ubiquitin-protein ligase TRIM21,24494,49,0.86 [0.62-1.18],0.3383610850923357
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRIM24,Transcription intermediary factor 1-alpha,20813,45,1.03 [0.68-1.58],0.8813293019414152
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,21165,44,1.04 [0.80-1.36],0.7630037314216034
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRIM26,Tripartite motif-containing protein 26,20504,44,1.01 [0.62-1.66],0.9629426836636712
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRIM40,E3 ubiquitin ligase TRIM40,20673,44,0.85 [0.56-1.28],0.4384160808625651
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRIM5,Tripartite motif-containing protein 5,24494,49,0.87 [0.64-1.16],0.3340509952910444
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRIM58,E3 ubiquitin-protein ligase TRIM58,21142,45,1.10 [0.79-1.53],0.577430585475878
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRPV3,Transient receptor potential cation channel subfamily V member 3,20593,42,0.72 [0.36-1.45],0.3547158038828962
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSC1,Hamartin,20649,43,0.69 [0.41-1.17],0.1687150118936072
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSC22D1,TSC22 domain family protein 1,21225,45,0.66 [0.41-1.04],0.0747480176922304
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSHB,Thyrotropin subunit beta,24515,49,1.06 [0.76-1.47],0.7457157063819899
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSLP,Thymic stromal lymphopoietin,24075,50,1.00 [0.67-1.49],0.9970761387605894
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSNAX,Translin-associated protein X,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSPAN1,Tetraspanin-1,24075,50,1.34 [0.82-2.19],0.241665103276659
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSPAN15,Tetraspanin-15,20593,42,0.72 [0.35-1.47],0.3670077973727054
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSPAN7,Tetraspanin-7,20603,44,0.80 [0.55-1.16],0.2324193538536645
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSPAN8,Tetraspanin-8,21165,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSPYL1,Testis-specific Y-encoded-like protein 1,20649,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TST,Thiosulfate sulfurtransferase,23897,49,0.86 [0.61-1.22],0.4039429228401845
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TTF2,Transcription termination factor 2,20673,44,0.71 [0.38-1.33],0.2862688176817922
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TTN,Titin,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TTR,Transthyretin,21048,42,0.80 [0.27-2.40],0.6901001457417559
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TUBB3,Tubulin beta-3 chain,20603,44,0.50 [0.18-1.43],0.1974041020325848
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TWF2,Twinfilin-2,21249,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TXK,Tyrosine-protein kinase TXK,20859,45,1.09 [0.78-1.54],0.6099473348853843
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TXLNA,Alpha-taxilin,24344,45,0.87 [0.64-1.16],0.338206598985922
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TXN,Thioredoxin,20907,44,0.93 [0.47-1.84],0.8324482424877659
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TXNDC15,Thioredoxin domain-containing protein 15,24552,49,0.72 [0.28-1.84],0.4898619511842792
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TXNDC5,Thioredoxin domain-containing protein 5,24738,48,0.90 [0.62-1.31],0.5885753735466499
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TXNDC9,Thioredoxin domain-containing protein 9,21200,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TXNL1,Thioredoxin-like protein 1,20566,44,0.84 [0.60-1.18],0.3183360175111668
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",24493,47,0.79 [0.45-1.39],0.417600383368779
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TYMP,Thymidine phosphorylase,24365,49,1.03 [0.71-1.49],0.8905079246191586
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TYRO3,Tyrosine-protein kinase receptor TYRO3,24515,49,1.49 [0.62-3.61],0.3761373054091986
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",20649,43,1.16 [0.71-1.91],0.5578564773480816
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,24384,48,0.98 [0.48-2.03],0.9658491405920782
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UBE2B,Ubiquitin-conjugating enzyme E2 B,21142,45,0.68 [0.24-1.88],0.4539355918890626
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,21256,43,1.01 [0.63-1.61],0.966406180733316
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,20649,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UBQLN3,Ubiquilin-3,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UBXN1,UBX domain-containing protein 1,20778,43,0.87 [0.57-1.34],0.5314293345625121
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,21165,44,0.96 [0.78-1.17],0.681603218481861
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UGDH,UDP-glucose 6-dehydrogenase,20593,42,0.86 [0.61-1.22],0.4016818919462984
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UHRF2,E3 ubiquitin-protein ligase UHRF2,20593,42,0.64 [0.23-1.77],0.3930464091808995
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,24344,45,1.51 [0.73-3.11],0.2621252666595042
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UMOD,Uromodulin,24712,50,1.00 [0.63-1.57],0.9975930824744302
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UNC5D,Netrin receptor UNC5D,20649,43,1.96 [0.88-4.34],0.097775772815611
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UNC79,Protein unc-79 homolog,20504,44,0.79 [0.45-1.37],0.3990291723394766
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UNG,Uracil-DNA glycosylase,21142,45,0.92 [0.40-2.13],0.853675633100796
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UPB1,Beta-ureidopropionase,21256,43,0.98 [0.72-1.35],0.9196511242168326
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UPK3A,Uroplakin-3a,20603,44,1.26 [0.75-2.14],0.3804030623869091
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UPK3BL1,Uroplakin-3b-like protein 1,20823,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UROD,Uroporphyrinogen decarboxylase,20778,43,0.73 [0.48-1.11],0.1414011999365639
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UROS,Uroporphyrinogen-III synthase,20673,44,0.91 [0.59-1.42],0.6862690084587846
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",USO1,General vesicular transport factor p115,24384,48,0.93 [0.70-1.23],0.6101591772253389
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",USP25,Ubiquitin carboxyl-terminal hydrolase 25,21142,45,0.88 [0.59-1.31],0.5179421398079148
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,21200,44,0.66 [0.26-1.71],0.3960743401886779
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",USP47,Ubiquitin carboxyl-terminal hydrolase 47,20593,42,0.74 [0.49-1.12],0.1567581871900773
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",USP8,Ubiquitin carboxyl-terminal hydrolase 8,24075,50,0.87 [0.66-1.14],0.3032748108277766
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UXS1,UDP-glucuronic acid decarboxylase 1,23919,48,0.78 [0.47-1.30],0.3368685160734408
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VAMP5,Vesicle-associated membrane protein 5,24075,50,0.78 [0.46-1.35],0.381854099837884
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VAMP8,Vesicle-associated membrane protein 8,20649,43,1.00 [0.72-1.40],0.9935847207894676
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VASH1,Tubulinyl-Tyr carboxypeptidase 1,24494,49,0.84 [0.61-1.15],0.2818005779216416
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VASN,Vasorin,24092,48,0.99 [0.39-2.51],0.9755708378765736
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VASP,Vasodilator-stimulated phosphoprotein,21262,44,0.95 [0.64-1.42],0.8099300151782777
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,24384,48,0.93 [0.25-3.36],0.9059325942604444
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VAV3,Guanine nucleotide exchange factor VAV3,20603,44,0.92 [0.69-1.24],0.6006452690191983
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,24532,49,1.91 [0.77-4.74],0.160076669842719
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VCAN,Versican core protein,24738,48,1.75 [0.75-4.06],0.1935635032969995
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VCPKMT,Protein-lysine methyltransferase METTL21D,20504,44,0.83 [0.57-1.21],0.3330276449252818
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VEGFA,Vascular endothelial growth factor A,24724,49,1.09 [0.71-1.68],0.6977218942455757
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VEGFB,Vascular endothelial growth factor B,20649,43,1.22 [0.44-3.37],0.6989440755084328
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VEGFC,Vascular endothelial growth factor C,24552,49,1.16 [0.74-1.83],0.5240032321710717
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VEGFD,Vascular endothelial growth factor D,24763,49,1.10 [0.54-2.23],0.7983955515196037
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VGF,Neurosecretory protein VGF,21225,45,2.00 [0.80-5.02],0.1403158371475947
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VIM,Vimentin,24075,50,1.07 [0.85-1.34],0.5567881169894033
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VIPR1,Vasoactive intestinal polypeptide receptor 1,20670,44,0.48 [0.13-1.80],0.2765664207027725
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VIT,Vitrin,21256,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VMO1,Vitelline membrane outer layer protein 1 homolog,24384,48,0.77 [0.55-1.07],0.1225406866598712
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VNN1,Pantetheinase,21262,44,1.09 [0.73-1.64],0.6590761270505849
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VNN2,Vascular non-inflammatory molecule 2,24384,48,1.24 [0.70-2.20],0.4575885199522415
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VPS28,Vacuolar protein sorting-associated protein 28 homolog,20859,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VPS37A,Vacuolar protein sorting-associated protein 37A,24384,48,0.75 [0.53-1.04],0.0873442583487185
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VPS4B,Vacuolar protein sorting-associated protein 4B,21142,45,0.90 [0.67-1.22],0.5170744672471326
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VPS53,Vacuolar protein sorting-associated protein 53 homolog,24384,48,0.90 [0.64-1.26],0.5320604484579403
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VSIG10,V-set and immunoglobulin domain-containing protein 10,21142,45,0.63 [0.25-1.60],0.3291340936840892
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,20593,42,0.55 [0.21-1.46],0.2290022754353029
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,21142,45,1.14 [0.68-1.92],0.6123238343862349
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,24455,47,1.49 [0.76-2.90],0.2439087632112466
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,24480,49,1.01 [0.67-1.52],0.9588112422228222
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VSNL1,Visinin-like protein 1,21200,44,0.92 [0.45-1.88],0.8156536325965125
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VSTM1,V-set and transmembrane domain-containing protein 1,23928,49,0.59 [0.35-1.01],0.0563477560502209
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VSTM2B,V-set and transmembrane domain-containing protein 2B,20859,45,1.03 [0.58-1.81],0.9250627305366816
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,24075,50,0.98 [0.63-1.53],0.9310598653566726
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,24738,48,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,23919,48,1.01 [0.45-2.27],0.9740811007566272
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,20778,43,0.72 [0.42-1.24],0.2397143293406183
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VWA1,von Willebrand factor A domain-containing protein 1,24691,49,1.18 [0.65-2.12],0.58920570250115
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VWA5A,von Willebrand factor A domain-containing protein 5A,20504,44,0.65 [0.38-1.13],0.1308136911927209
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,24256,45,0.81 [0.41-1.60],0.5406707429506639
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VWC2L,von Willebrand factor C domain-containing protein 2-like,21225,45,0.51 [0.21-1.25],0.1421475439865011
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,24798,50,1.10 [0.78-1.54],0.5819781219933277
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",24493,47,0.91 [0.46-1.81],0.782644949310964
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WAS,Wiskott-Aldrich syndrome protein,24058,48,0.83 [0.56-1.23],0.3474084157085672
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WASF1,Wiskott-Aldrich syndrome protein family member 1,24075,50,1.03 [0.79-1.34],0.831955193139551
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WASF3,Wiskott-Aldrich syndrome protein family member 3,23928,49,0.88 [0.66-1.17],0.3812818348663184
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WASHC3,WASH complex subunit 3,21200,44,0.92 [0.63-1.35],0.6743511898345596
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WASL,Neural Wiskott-Aldrich syndrome protein,20649,43,1.01 [0.63-1.62],0.9740629973628396
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WDR46,WD repeat-containing protein 46,21142,45,1.14 [0.57-2.27],0.7046887753167024
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WFDC1,WAP four-disulfide core domain protein 1,20727,45,1.02 [0.61-1.73],0.9299815761956072
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WFDC12,WAP four-disulfide core domain protein 12,24681,49,0.89 [0.62-1.30],0.5568238642736258
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,23213,45,1.61 [0.80-3.24],0.1800239156178407
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",24267,45,0.98 [0.52-1.83],0.9447931479468618
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",24523,50,1.02 [0.49-2.15],0.9537646248258148
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WIF1,Wnt inhibitory factor 1,24723,49,1.06 [0.51-2.23],0.8684253613465274
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WNT9A,Protein Wnt-9a,24058,48,2.10 [1.01-4.35],0.0465772427004972
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,24344,45,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,24723,49,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",XG,Glycoprotein Xg,24670,50,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",XIAP,E3 ubiquitin-protein ligase XIAP,20649,43,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",XPNPEP2,Xaa-Pro aminopeptidase 2,24552,49,1.01 [0.78-1.30],0.9679753281137786
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",XRCC4,DNA repair protein XRCC4,23928,49,0.44 [0.21-0.92],0.0278958120688355
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,21200,44,0.92 [0.30-2.86],0.888491466834506
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",21165,44,0.99 [0.82-1.21],0.9297750120903892
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",YES1,Tyrosine-protein kinase Yes,24384,48,0.94 [0.81-1.09],0.4127606759187714
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,21142,45,0.81 [0.33-1.99],0.6457333741876801
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",YOD1,Ubiquitin thioesterase OTU1,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",YTHDF3,YTH domain-containing family protein 3,24058,48,0.90 [0.75-1.08],0.2752724779378606
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",YWHAQ,14-3-3 protein theta,20778,43,0.88 [0.58-1.32],0.5273723850034772
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",YY1,Transcriptional repressor protein YY1,20649,43,0.93 [0.32-2.67],0.8951149604863388
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,20649,43,0.97 [0.49-1.94],0.932012375199529
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZBTB16,Zinc finger and BTB domain-containing protein 16,23919,48,0.88 [0.61-1.28],0.512939774908489
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,24075,50,1.61 [1.05-2.46],0.028542208882013
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZCCHC8,Zinc finger CCHC domain-containing protein 8,20593,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZFYVE19,Abscission/NoCut checkpoint regulator,21165,44,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,21200,44,1.44 [0.83-2.52],0.1949002260406636
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZNF174,Zinc finger protein 174,20649,43,1.21 [0.62-2.36],0.5683396095867795
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZNF75D,Zinc finger protein 75D,20859,45,1.20 [0.81-1.77],0.3644026947306813
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZNF830,Zinc finger protein 830,21142,45,1.21 [0.90-1.61],0.2041224513400911
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,21165,44,0.85 [0.55-1.33],0.4880245095627106
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,21142,45,0.90 [0.52-1.56],0.7118826930565227
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZP3,Zona pellucida sperm-binding protein 3,20670,44,0.91 [0.82-1.01],0.0889495451962863
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZP4,Zona pellucida sperm-binding protein 4,20504,44,0.92 [0.35-2.36],0.8553904675159476
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZPR1,Zinc finger protein ZPR1,20603,44,0.92 [0.66-1.29],0.6291655766651152
